Mesh in Abdominal Wall Hernia: New insights by Posthuma-Kaufmann, R. (Ruth)


Mesh in 
abdominal  
wall hernia:
new insights
R. Posthuma-Kaufmann
ISBN: 978-94-6361-240-1
Cover design: Sebastiaan Hendriks
Layout and printing: Optima Grafische Communicatie, Rotterdam, The Netherlands
Photo page 339: Max Koot Studio, The Hague, The Netherlands
The printing of this thesis has been financially supported by:
ABN AMRO Bank N.V., The Hague
Albert Schweitzer Ziekenhuis, Dordrecht
Dutch Hernia Society
Erasmus University Medical Center, Rotterdam
Erasmus University, Rotterdam
© R. Posthuma-Kaufmann, Rotterdam, the Netherlands
All right reserved. No part of this thesis may be reproduced, stored in a retrieval system, 
or transmitted in any form or by any means, without written permission of the author or 
the corresponding journals for previously published chapters.
MESH IN ABDOMINAL WALL HERNIA: NEW INSIGHTS
MESH BIJ BUIKWANDHERNIA: NIEUWE INZICHTEN
PROEFSCHRIFT
ter verkrijging van de graad van doctor aan de
Erasmus Universiteit Rotterdam
op gezag van de rector magnificus
Prof. dr. R.C.M.E. Engels
en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op
vrijdag 29 maart 2019 om 11:30 uur
door
Ruth Posthuma-Kaufmann
geboren te Kamp-Lintfort, Duitsland
PROMOTIECOMMISSIE
Promotor
Prof. dr. J.F. Lange
Overige leden
Prof. dr. N.D. Bouvy
Prof. dr. C. Verhoef
Prof. dr. R.M.H. Wijnen
Copromotor
Prof. dr. J. Jeekel
Voor Leon, Dia en Victor 

7CONTENTS
Chapter 1 Introduction and outline of thesis 11
PART 1. MESH IN EXPERIMENTAL MODELS
Chapter 2 Critical overview of all available animal models for abdominal 
wall hernia research
29
Chapter 3 Non-cross-linked collagen mesh performs best in a physiologic, 
non-contaminated rat model
65
Chapter 4 Characteristics of different mesh types for abdominal wall repair 
in an experimental model of peritonitis
95
Chapter 5 META-consensus score: an international consensus score on 
mesh-tissue adhesions (not included)
PART 2. USE OF MESH
Chapter 6 Mesh versus suture repair of umbilical hernia in adults: a 
randomized, double-blind, controlled, multicenter trial
141
Chapter 7 Lower risk of recurrence after mesh repair versus non-mesh 
sutured repair in open umbilical hernia repair: a systematic 
review and meta-analysis of randomized controlled trials
165
Chapter 8 The feasibility of local anesthesia for the surgical treatment of 
umbilical hernia: a systematic review of the literature
181
PART 3. COMPLICATIONS OF MESH
Chapter 9 Comparison of self-gripping mesh and sutured mesh in open 
inguinal hernia repair: a meta-analysis of long-term results
203
Chapter 10 An international consensus algorithm for management of 
chronic postoperative inguinal pain
227
Chapter 11 Repair of complex abdominal wall hernias with a cross-linked 
porcine acellular matrix: cross-sectional results of the Dutch 
cohort study (not included)
Chapter 12 Non-cross-linked biological mesh in complex abdominal wall 
hernia: a cohort study (not included)
8Contents
PART 4. SUMMARY, GENERAL DISCUSSION AND FUTURE PERSPECTIVES
Chapter 13 Summary 283
Chapter 14 General discussion 291
Chapter 15 Future perspectives 307
Appendices Nederlandse samenvatting (Summary, in Dutch) 313
List of abbrevations 319
List of contributing authors 323
List of publications 327
Dankwoord (Acknowledgements, in Dutch) 329
PhD portfolio 335
Curriculum vitae auctoris 339


1
Introduction and outline of thesis

13
Introduction and outline of thesis
1
“MESH IN ABDOMINAL WALL HERNIA: NEW INSIGHTS”
Abdominal wall hernia is one of the earliest diseases described in ancient literature. The 
first description of abdominal wall hernia dates back to the Ebers papyrus (1552 BC): a 
swelling that comes out during coughing [1]. Later, the Phoenicians (900 BC) and the an-
cient Greeks (400 BC) described abdominal wall hernia and its surgical treatment. Until 
the end of the 18th century (inguinal) hernia surgery consisted of ligation and section of 
the sac including removal of the testicle [2]. From the 18th century, hernia surgery was 
improved by a better description of the anatomy of the inguinal canal.
In 1700, the French surgeon Alexis Littre described an omphalomesenteric duct that 
was trapped in a hernia [3]. In 1756, the Scottish anatomist and surgeon John Hunter 
reported with help of his older brother and anatomist William Hunter the details of the 
embryological origin of the indirect inguinal hernia [4]. In 1785, the German surgeon 
August Gottlieb Richter described an incarcerated yet non-obstructing hernia [5]. And 
in 1846, the British surgeon Thomas Pridgin Teale reported the first prevascular femoral 
hernia [6].
Other eponyms in inguinal hernia relate to anatomical landmarks described by the 
Dutch surgeon Anton Nuck (canal; 1650-1692), the French surgeon Jean Louis Petit 
(hernia; in 1783), the Dutch physician and anatomist Petrus Camper (fascia; in 1801), 
the English surgeon and anatomist Sir Astley Paston Cooper (ligament; in 1804), the 
Italian anatomist and surgeon Antonio Scarpa (fascia; in 1814), the German physician, 
surgeon, and anatomist Franz Kaspar Hesselbach (triangle; in 1814), the French surgeon 
Jules Germain Cloquet (hernia; in 1817), the French surgeon Stanislas Laugier (hernia; in 
1833), and the French surgeon Joseph Casimir Grynfeltt (hernia; in 1866) [5, 6]. Sir Astley 
Cooper was the first to define important structures such as the pectineal ligament and 
cremasteric muscles [7]. Since the 18th century developments in abdominal wall surgery 
happened quickly regarding not only the type of operations but also the indications for 
hernia repair.
Anatomy
The abdominal cavity is located between the diaphragm and the pelvic floor. Within the 
abdominal cavity lay various organs, like the liver, small bowels, colon, preperitoneal 
fat, and omentum. The boundaries of the abdominal cavity are formed by the abdomi-
nal wall. The anterior part of the abdominal wall is proximally defined by the xyphoid 
process and the costal margins and distally by the iliac crests and the pubic bone. The 
abdominal wall consists of skin, subcutaneous fat, various muscle layers, nerves, blood 
vessels and connective tissue. From the outside in are these muscles layers: the rectus 
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abdominis muscle, the external oblique muscle, the internal oblique muscle and the 
transversus abdominis muscle. Between the two rectus abdominis muscles lays the linea 
alba (also called “white line” or “midline”). The linea alba is a three-layered collagen struc-
ture, reflecting the insertions of the three lateral muscles of the abdominal wall. The 
linea alba is barely vascularized causing possible difficulties healing after an operation. 
As the French anatomist Henri Fruchaud (1894-1960) already reported, all regions within 
the abdominal wall where aponeurosis and fascia are lacking the support of muscles 
are prone to hernia development [8]. These areas are the hiatus of the diaphragm, the 
umbilicus, inguinal, femoral and lumbar regions and badly healed incisions.
Abdominal wall hernia
The integrity or function of the abdominal wall can be compromised due to various 
reasons. This can happen at birth (congenital problem), during life (acquired problem), 
or after surgery (iatrogenic problem). This impairment of the abdominal wall can lead 
to an abdominal wall hernia. Abdominal wall hernia is a collective term for a variety of 
hernias in the abdominal wall. The word “hernia” is known in both Greek and Latin. In 
Greek it means “bud” or “sprout”; in Latin “tear” or “rupture”. An abdominal wall hernia 
or herniation is a defect in the abdominal wall with an intermittent or continuous pro-
trusion of the abdominal wall with or without intra-abdominal content. A hernia can 
be asymptomatic, but can also lead to complaints like pain, discomfort, cosmetic com-
plaints, core instability (in case of very large hernia), and incarceration of the hernia. The 
latter is an indication for an emergency operation. In this thesis, three types of hernias 
will be discussed.
Umbilical hernia
Umbilical hernia is defined as a midline abdominal wall defect from 3 cm above to 3 
cm below the umbilicus [9]. This type of hernia can be congenital or acquired. It is a 
common diagnosis in both children and adults [10, 11]. Of all abdominal wall hernias, 
approximately 10 percent are defined as umbilical hernia [12], and the prevalence of 
umbilical hernia in the adult population is 2 percent [13]. Each year, approximately 
4500 umbilical hernias are repaired in the Netherlands. Surgical repair is recommended 
for most symptomatic or clinically apparent umbilical hernias. Umbilical hernia repair 
can be achieved by suture repair or use of mesh (surgical prosthesis to reinforce the 
abdominal wall). Suture repair caused high recurrence rates of up to 54.5 percent [14]. 
The use of mesh was proven to be beneficial in incisional and inguinal hernia repair, and 
mesh repair has therefore become the gold standard repair for these types of hernia [15-
18]. Mesh repair in umbilical hernia was associated with low recurrence rates of up to 
1 percent of large umbilical hernias in two randomized controlled trials of mesh versus 
suture repair and in a long-term follow-up, retrospective study [19-21].
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Inguinal hernia
The inguinal hernia or groin hernia is located in one or both groins. This type of hernia 
can be congenital or acquired. Inguinal hernia repair is the most frequently performed 
operation in general surgery worldwide. The incidence is 6 to 12 percent in adult males. 
The incidence is increasing with age reaching 22.8 percent in people aged 60 to 74 years 
[22]. Men are affected more often than females. There are many different techniques to 
operate inguinal hernias. Ways to classify inguinal hernia operations are based on mate-
rial (sutured versus mesh repair), approach (open versus endoscopic versus robotic), 
and anatomical plane (anterior versus posterior approach). Open anterior hernia repair 
according to the Lichtenstein technique and endoscopic inguinal hernia techniques are 
recommended as the best evidence-based options for the repair of a symptomatic pri-
mary unilateral inguinal hernia (given that the surgeon is sufficiently experienced in the 
specific procedure) [23]. The recurrence rates for both techniques have been reduced 
to less than the rate of chronic postoperative inguinal pain (CPIP). Therefore, CPIP and 
its consequences for the quality of life are the challenges of modern inguinal hernia 
surgery [24].
Incisional hernia
Incisional hernia is a defect of the fascia of the abdominal wall, that occurs after abdomi-
nal surgery. It is defined as “any abdominal wall gap with or without a bulge in the area 
of a postoperative scar perceptible or palpable by clinical examination or imaging” [25]. 
The incidence of incisional hernia ranges from 11 to 20 percent [26, 27] and up to 35 
percent in “high-risk patient groups” [28-35]. High-risk patient groups are patients with 
obesity and/or an abdominal aneurysm. Nowadays, incisional hernias are most often 
reinforced with mesh material [15]. The use of mesh significantly decreases the 10-year 
recurrence rates [17]. Ways to classify incisional hernia operations are based on mate-
rial (sutured versus mesh repair), approach (open versus laparoscopic versus robotic), 
and anatomical position of the mesh (onlay, inlay, sublay/retromuscular, retrorectus, or 
intraperitoneal position).
Diagnosis
The diagnosis of hernia is mostly a clinical diagnosis: the patient’s history combined 
with a physical examination often lead to the diagnosis. In case of doubt various imag-
ing modalities are available. When imaging is necessary, the first choice is ultrasound in 
case of a suspected inguinal or umbilical hernia. This technique is also useful for small 
incisional hernias. For larger incisional hernias a CT scan could be helpful to assess the 
size of the hernia, but also the “loss of domain” prior to a possible surgical repair [36].
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Mesh prosthesis
The first attempts to use a mesh in inguinal hernia repair were done by Phelps [37], 
Goepel [38], Witzel [39] and Perry [40] using a silver mesh (1894-1904) [41]. Other sur-
geons used gold, silicon and other materials. They experienced various complications 
resulting in the quick abandonment of these types of mesh [42]. In 1954, polypropylene 
was introduced as a mesh material by Nobel Prize winner Giulio Natta together with Karl 
Ziegler [43]. Polypropylene quickly gained terrain in hernia surgery and became a key 
part of various hernia repairs according to Lichtenstein [44], Trabucco [45], and in other 
repairs [46-49]. Nowadays, there are many different meshes available, of which the syn-
thetic non-resorbable meshes are used most often in general practice; polypropylene 
mesh being the most widely used material [50, 51]. Meshes can be grossly differentiated 
by their material or materials of origin or their shape (flat, plug, 3D structures). Below, 
meshes will be discussed according to their material of origin.
Synthetic mesh
Synthetic meshes are made from polymers derived from oil. In 1944, the first meshes 
of perlon and nylon were implanted. The results however were somehow disappoint-
ing; perlon triggered an extreme inflammatory response and nylon tended to lose 
its strength quickly and to disintegrate. In the following years new synthetic meshes 
made of polypropylene, polyethylene, polyester and expanded-polytetrafluoroethylene 
(e-PTFE) were introduced. These polymers have the advantage that they maintain their 
strength during implantation and that they are relatively cheap. The main disadvantages 
are a pronounced foreign body response and their susceptibility for infections. Examples 
of these meshes are Parietene™ (polypropylene) and Omyra® Mesh (condensed polytet-
rafluoroethylene). These meshes will be investigated in this thesis.
Biological mesh
Biological meshes are made from collagen containing tissues of human or animal origin 
[52]. These collagen containing tissues originate from intestines, heart valves, or skin. 
The tissues are processed in various steps to remove cells, cell components and hair (if 
present) as well as other antigens present in the tissue [53, 54]. After degradation and 
decellularization of these tissues, a 3D structure of collagen and some protein remnants 
remains. In this group of meshes, two subtypes can be distinguished: non-cross-linked 
and cross-linked biological meshes. Although all collagen-containing meshes have 
some cross-linking within the collagen structures, these meshes are called non-cross-
linked meshes. Additional chemical cross-linking of the mesh can be done to increase 
its strength and to slow down its degradation [53, 55, 56]. After implantation of the 
mesh starts the degradation of the mesh. There is incorporation of host fibroblasts and 
collagen replacement occurs. This so-called xenograft remodeling begins within a few 
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hours after implantation and continues for several months to years. The advantage is 
that these meshes would be less susceptible to infection. In the presence of infection, 
the mesh should not get infected. The main disadvantage is their price. Examples of 
these meshes are Permacol™ (cross-linked porcine acellular dermal matrix), Strattice™ 
(non-cross-linked porcine acellular dermal matrix) and XCM Biologic® (non-cross-linked 
porcine acellular dermal matrix). These meshes will be investigated in this thesis.
Resorbable synthetic mesh
Apart from the older synthetic quickly resorbable polyglactin 910 (Vicryl®) mesh, a rela-
tively new category of meshes is represented by the slowly resorbable synthetic meshes. 
These meshes consist of materials that are fully degradable over time. These meshes 
are said to have the advantages of biological meshes, but for a much lower price [57]. 
Examples of these meshes are GORE® BIO-A® Mesh (polyglycolic acid and trimethylene 
carbonate), TIGR® Matrix Surgical Mesh (copolymers of glycolide, lactide, and trimethyl-
ene carbonate), and Phasix™ mesh (poly-4-hydroxybutyrate). None of these meshes will 
be investigated in this thesis.
Anatomical positions of mesh
Meshes can be placed in various anatomical planes of the abdominal wall (Figure 1). The 
position of the mesh within the abdominal wall appears to influence outcomes. A recent 
systematic review found that retromuscular and underlay mesh repair are associated 
with a lower recurrence rate compared with onlay and interposition mesh repair [58].
Subcutaneous/Onlay/Overlay
Retro-rectus/Sublay Pre-peritoneal/Underlay Intra-abdominal/Intra-peritoneal (IPOM)
Interposition/Inlay
Figure 1. Different positions of the mesh in relation to the abdominal wall layers to repair an abdominal 
wall hernia by mesh reinforcement
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Complications of mesh
The use of mesh in abdominal wall hernia can lead to complications. These complica-
tions can be defined as acute and chronic complications. Acute complications are com-
plications shortly after the initial operation: bleeding, seroma, hematoma, and surgical 
site infection. The chronic complications can be chronic pain after hernia surgery and 
the occurrence of a complex abdominal wall hernia.
Chronic postoperative inguinal pain
Chronic postoperative inguinal pain (CPIP) can occur after inguinal hernia surgery. Due 
to different definitions of CPIP the reported incidences of CPIP ranges from 1 to 63 
percent [24, 59-64]. Pain directly postoperative is not regarded being CPIP, since that 
is involving a duration of pain of at least 3 months. CPIP and the consequences for the 
quality of life are the challenges of modern hernia surgery [24]. This is also urged by the 
high incidence of CPIP – which is ≈ 10 percent – and because of its socioeconomic ef-
fects [23, 24, 65]. The pathophysiology of CPIP is regarded multifactorial due to patient-
related and surgery-related risk factors [65-68].
Complex abdominal wall hernia
Complex abdominal wall hernia has different definitions. Following the Ventral Hernia 
Working Group classification, all patients can be classified into four different categories 
[69]. These grades range from grade 1 (low risk) until grade 4 (infected/contaminated). 
The use of synthetic meshes in potentially contaminated (grade 3) or contaminated 
(grade 4) incisional hernias is not unequivocally supported and may lead to a higher 
morbidity (i.e. wound healing problems, adhesions and fistula formation) and mortality 
[51, 70]. As an alternative, a biological mesh might be considered [69].
AIM OF THE THESIS
There are various strategies to investigate meshes. A selection of in vitro, in vivo and 
clinical testing can be used to assess the characteristics of different meshes. This thesis 
intends to assess a wide spectrum and therefore meshes will be assessed in both in vivo 
and in a clinical setting.
The first aim of this thesis was to assess the use of mesh in abdominal wall hernia. The 
second aim of this thesis was to gain new insights on the use of mesh in both experi-
mental and clinical setting and possible complications of mesh.
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OUTLINE OF THE THESIS
The first part of this thesis consists of studies about the use of mesh in experimental 
models.
In Chapter 2 will be assessed which experimental animal models are available for ab-
dominal wall hernia research. This chapter will give an overview of all available models 
to select models for further research.
In Chapter 3 the characteristics of both non-cross-linked and cross-linked biological 
meshes will be evaluated in a rat model.
In Chapter 4 various biological meshes will be tested in a peritonitis rat model as most 
meshes respond differently in presence of an infection [71]. Both non-cross-linked and 
cross-linked meshes will be assessed to define their characteristics in the presence of 
intra-peritoneal infection.
In Chapter 5 a consensus score on adhesions is presented as adhesions are a common 
complication of mesh in the intra-abdominal cavity. There are many different adhesions 
scoring systems, that differ in the ways they score adhesions (qualitative versus quanti-
tative scoring of adhesions). This META-consensus score on mesh-tissue adhesions can 
be helpful to compare future research more easily.
The second part of this thesis consists of studies about the clinical use of mesh. These 
studies will be performed in patients that will undergo a surgical repair of their umbilical 
hernia.
In Chapter 6 data will be presented on the repair of small umbilical hernias. The small 
umbilical hernias of 1–4 cm can be treated with either sutures or mesh. In this randomized 
controlled trial both treatments for umbilical hernia repair in adults will be compared.
In Chapter 7 a meta-analysis will be performed using available literature and the data of 
the previous chapter. In this meta-analysis will be assessed whether treatment of umbili-
cal hernia with mesh or sutures leads to less recurrences.
In Chapter 8 a systematic review of the literature will be presented regarding the types 
of anesthesia in umbilical hernia operations. In this review the feasibility of local anes-
thesia for the surgical treatment of umbilical hernia is assessed.
Chapter 1
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The third part of this thesis consists of studies about possible complications of mesh in 
patients.
In Chapter 9 will be assessed whether the use a new self-gripping mesh instead of a 
sutured mesh will lead to a decrease in chronic postoperative inguinal pain.
In Chapter 10 an algorithm will be presented with a treatment strategy for the manage-
ment of patients with chronic postoperative inguinal pain.
In Chapter 11 data about patients who had to undergo repair of a complex abdominal 
wall hernia will be presented. All patients were treated with a cross-linked biological 
mesh.
In Chapter 12 another group of patients with a complex abdominal wall hernia will be 
presented. These patients were treated with a non-cross-linked biological mesh.
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ABSTRACT
Introduction
Since the introduction of the first prosthetic mesh for abdominal hernia repair, there has 
been a search for the “ideal mesh”. The use of preclinical or animal models for assess-
ment of necessary characteristics of new and existing meshes is an indispensable part 
of hernia research. Unfortunately, in our experience there is a lack of consensus among 
different research groups on which model to use. Therefore, we hypothesized that there 
is a lack of comparability within published animal research on hernia surgery due to 
wide range in experimental setup among different research groups.
Methods
A systematic search of the literature was performed to provide a complete overview of 
all animal models published between 2000 and 2014. Relevant parameters on model 
characteristics and outcome measurement were scored on a standardized scoring sheet.
Results
Due to the wide range in different animals used, ranging from large animal models like 
pigs to rodents, we decided to limit the study to 168 articles concerning rat models. 
Within these rat models, we found wide range of baseline animal characteristics, 
operation techniques, and outcome measurements. Making reliable comparison of 
results among these studies is impossible.
Conclusion
There is a lack of comparability among experimental hernia research, limiting the impact 
of this experimental research. We therefore propose the establishment of guidelines for 
experimental hernia research by the European Hernia Society (EHS).
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INTRODUCTION
Ever since the introduction of the first prosthetic mesh for reinforcement of abdominal 
hernia repair, there has been a search for the ‘‘ideal mesh’’ [1, 2]. After using meshes of 
silver and stainless steel for decades, the first ‘‘modern’’ synthetic polypropylene mesh 
was introduced in the 1950s [1-3]. Today, polypropylene mesh remains the most com-
monly used mesh worldwide in ventral and inguinal hernia repair [1, 2]. The ideal mesh, 
however, still has not been developed [1, 2, 4].
The ideal mesh must be tailored to each patient’s current needs in the current clinical 
situation [4, 5]. In order to provide a mesh for most patients, a continuing growth in 
variety of mesh concepts exists. For instance, meshes of various materials (from pros-
thetic or biological origin), shapes (flat mesh, plugs, and 3D meshes), heavyweight and 
low-weight, and with various coatings are available. Along with this is a growing body 
of data on assessing the feasibility of new meshes with the ultimate goal to improve 
patient outcomes [6].
Even though clinical research is the best method to really assess the outcome of new 
mesh concepts, preclinical animal models remain necessary for the assessment of 
biocompatibility and strength in the long run [7-9]. Especially since several important 
mesh characteristics, such as inflammation, shrinkage, ingrowth, remodeling, and 
adhesion formation to the mesh, can only be researched using experimental models, 
patients cannot be reoperated for evaluation of these key aspects [4]. However, in order 
to compare studies and to reproduce them, it is important that different research groups 
use comparable research methods. However, in our search for hernia models in the past, 
we came across a wide range of different models leading to the hypothesis that there is 
very little comparability within published animal research on hernia surgery [10, 11]. To 
support this hypothesis, we hereby present a systematic review of the literature on all 
available animal models for hernia research between 2000 and 2014.
METHODS
Literature search
A systematic search of the literature was performed using the ‘‘Excerpta Medica data-
base’’ (Embase) and NCBI National Library of Medicine (PubMed). Search strategy was 
aimed at finding all literature concerning surgical meshes used for abdominal wall 
hernia in an animal model. Literature search was conducted as follows with aid of an 
experienced university librarian.
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Embase
(“surgical equipment”/de OR mesh*:ab,ti OR prothes*:ab,ti OR prosthet*:ab,ti) AND 
(herni*:ab,ti OR hernioplasty/de OR herniorrhaphy/de OR herniotomy/de OR hernia/de 
OR ‘‘abdominal wall hernia’’/exp OR ‘‘incisional hernia’’/de) AND [‘‘experimental animal’’/
de OR ‘‘animal model’’/de OR (vertebrate/exp NOT human/de) OR animal/de OR nonhu-
man/de OR rodent/exp OR (animal* OR nonhuman* OR rodent* OR rat OR rats OR mice 
OR mouse OR hamster* OR pigs OR porcine* OR swine* OR goat*)].
PubMed
{mesh*[tw] OR prothes*[tw] OR prosthet*[tw]) AND (herni*[tiab] OR hernia[mesh:noexp] 
OR Hernia, Abdominal[mesh] OR herniorrhaphy[mesh]) AND ((animals[mesh] NOT 
humans[mesh]) OR (animal*[tw] OR nonhuman*[tw] OR rodent*[tw] OR rat[tw] OR 
rats[tw] OR mice[tw] OR mouse[tw] OR hamster*[tw] OR pigs[tw] OR porcine*[tw] OR 
swine*[tw] OR goat*[tw])}.
Study selection
Two independent researchers screened all titles and abstracts to select animal studies 
that were eligible for full-text review. Following primary screening, all full-text articles 
of the remaining studies were screened to identify studies using animal models aimed 
at mesh research. We included all English, Dutch, and German literature using an animal 
model to study meshes designed for abdominal wall hernia repair published between 
January 01, 2000, and January 01, 2014. Clinical trials, abstracts, letters to the editor, or 
studies not primarily aimed at studying meshes were excluded from further analysis.
Study outcome
All included articles were read, and all relevant parameters concerning the studied ani-
mal models used were scored in a standardized scoring sheet. All scored parameters are 
mentioned in Table 1. First, parameters for the animal model were assessed, including 
subspecies. Sex, weight, and age of the animals were recorded when mentioned in the 
article. Also the use of a previously published model was scored; this was defined as a clear 
reference to a previously published use of the same animal model. Details of the model 
used were subsequently scored. This included the creation of a hernia defect and size of 
defect (when applicable), location of the mesh, and size of the implanted mesh. Thereafter, 
the use and type of control group were scored, and duration of follow-up was recorded. 
Finally, used outcome parameters were scored (mentioned in Table 1).
Statistics
When applicable, data were tested using the statistical package for the social sciences 
(SPSS) version 22 for normal distribution using the Kolmogorov–Smirnov test for 
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normality. Normally distributed data were presented as mean and standard deviation. 
Not normally distributed data were presented as median with range. All other data were 
presented as a percentage.
RESULTS
A total of 315 articles (supplementary data) were included in this study, of which 168 
studied rats (53.3 percent), 66 studied rabbits (21.0 percent), and 53 studied pigs (16.8 
percent). The remaining studies described use of mice, guinea pigs, primates, dogs, 
goats, sheep, and hamster models. A representation of the amount of publications per 
year showed an increase in yearly publications (Figure 1). Due to the variety in animals 
used, and the even larger variety in different animal models, all further analyses were 
performed on the 168 articles using a rat model. All other animal types were excluded 
from further analysis. Results are mentioned in Table 2.
Table 1. Scoring system for animal models
Parameter Outcome 
Animal model Pig  Rat  Mice  Rabbit  Guinea Pig  Other: specify
Subspecies Free text
Sex Male  Female  Both  Unknown/not specified
Validated model Yes  No (no reference to previous research)
Infection model Yes   No  Unknown
Defect Yes, size (cm × cm):  No  Unknown/not specified
Mesh location Intraperitoneal  Inlay  Bridging  Subcutaneous  Preperitoneal  Unknown/not 
specified
Technique Laparotomy  Laparoscopy  Other: specify  Unknown 
Mesh size Size of mesh (cm × cm)
Control group Yes: specify  No  Unknown/not specified
Follow-up Duration of follow-up in days (1 month is scored as 30 days)
Outcome parameters
Mesh ingrowth Yes No
Adhesion quality Yes No
Adhesion quantity Yes No
Mechanical testing/tensiometry Yes No 
Mesh shrinkage Yes No 
Histology Yes No
Immunohistochemistry Yes No
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Figure 1. Number of publications per year since 2000
Table 2. Outcome of all scored parameters
Parameter Outcome
Animal model (%)a Pig 16.8%
Rat 53.3%
Mice  3.5%
Rabbit 21.0%
Guinea pig  2.2%
Other  3.2%
Subspecies (%) Wistar 46.4%
Sprague-Dawley 46.4%
Lewis  4.1%
Other  1.9%
Unspecified  1.2%
Sex (%) Male 66.7%
Female 16.7%
Both  1.8%
Unknown/unspecified 15.4%
Reference to previously used model (%) Yes 24.2%
No 75.8%
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Table 2. Outcome of all scored parameters (continued)
Parameter Outcome
Number of meshes/animal (%) 1 85.1%
2 13.1%
3  0.6%
Unspecified  1.2%
Defect (%) Yes, size (cm²) mean (range) 72.2%, 4.2 cm² (0.5–18.0 cm²)
No 27.2%
Unknown  0.6%
Mesh location (%) Intraperitoneal 23.8%
Inlay 11.9%
Bridging 20.0%
Subcutaneous 17.9%
Preperitoneal  5.4%
Unknown 11.9%
Infection model Yes  9.5%
No 90.5%
Mesh size Size of mesh (cm²) mean (range) 5.76 cm² (0.8–20 cm²)
Unspecified (% of articles) 17.3%
Control group Yes 64.3%
Polypropylene mesh 22.6%
Sham 22.6%
Primary repair  6.6%
Other 12.5%
No/not described 35.7%
Antibiotics Yes  7.1%
No 92.9%
Analgetics Yes 15.5%
No 84.5%
Number of endpoints median (range) 2 time points (1–6 time points), undefined in 1 article
Follow-up duration median (range) 28 days (6 hours–365 days)
Outcome parameters used (%)
Mesh ingrowth 10.1%
Adhesions Quality 16.1%
Quantity 10.7%
Both 24.4%
Mechanical testing/tensiometry 48.2%
Mesh shrinkage 17.3%
Histology 81.0%
Immunohistochemistry 23.2%
a For this analysis all animal types were scored, all other parameters only record results for rat studies.
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Rat models
A total of 168 articles described the use of a rat model, using a total of 9150 rats in 164 
studies, four remaining studies did not define the amount of animals. Median number 
of animals used per study was 56 (range 10–218) with a median of three groups per 
study (mean 3.7, mode 2, range 1–20). Most articles described the use of either Sprague-
Dawley (78 studies, 46.4 percent) or Wistar (78 studies, 46.4 percent); subspecies was not 
defined in two studies. Sex of animals was defined in 85.1 percent of studies with 112 
(66.7 percent) using male rats, 28 (16.7 percent) female, and 3 (1.8 percent) using both 
sexes; sex was not defined in the remaining studies (14.9 percent). References, that indi-
cated the use of an established and previously published model, were provided in only 
24.2 percent of articles (41 studies). Frequently used models included those published 
by Alponat and colleagues (12 studies) [12], Peter-Puchner and colleagues (four studies) 
[13], and Klinge and colleagues (three studies) [14].
Methods
All rats underwent open surgery for mesh implantation, receiving one (85.1 percent), 
two (13.1 percent), or three (0.6 percent) meshes per animal. Most models included the 
creation of a true hernia defect model (121 articles, 72.0 percent), one study did not 
define the use of a defect, and the remainder (46 articles, 27.4 percent) did not create a 
hernia defect. Defect size varied between 0.5 and 18.0 cm² with a mean of 4.2 cm² (me-
dian 4.0, mode 6.0). Meshes were either placed as bridging within a defect (49 articles, 
29.2 percent), intraperitoneal (40 articles, 23.8 percent), subcutaneous (30 articles, 17.9 
percent), inlay (20 articles, 11.9 percent), or preperitoneal (nine articles, 5.4 percent). 
Mesh position was not specified in 11.9 percent of articles (20 studies). Models aimed at 
mesh infections were only used in 16 publications (9.5 percent).
Meshes were cut to size with a median size of 6 cm² (mean 5.76 cm², range 0.8–20 cm²); 
size of mesh was not defined in 29 articles (17.3 percent). Control groups were defined 
in 64.3 percent (108 articles). Most articles defined the use of a polypropylene control 
(including brand named polypropylene, e.g., Parietene™) or sham operated animals 
(both 38 articles, 22.6 percent). Others included primary/suture repair (11 articles, 6.6 
percent). Part of included articles compared mesh coatings instead of different meshes; 
this leads to uncoated meshes being control group in 17 studies (10.1 percent).
The use of perioperative antibiotics for infection prevention was only mentioned in 
7.1 percent of articles (12 studies). Out of these studies, antibiotics used were from 
the penicillin group, gentamicin, and fluoroquinolone antibiotics (four studies each). If 
animal models other than rats were added in the analysis, up to 20.6 percent of articles 
described the use of antibiotics, with cephalosporin-type antibiotics being used most.
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Perioperative pain relief using analgesic medication has been mentioned in 15.5 percent 
of rat models (26 studies, versus 22.8 percent or 72 studies when reviewing all animal 
models). Within these 26 studies, opioid-type analgesics were used in majority of cases (17 
articles, 10.1 percent), sometimes combined with NSAIDs (two articles, 1.2 percent), fol-
lowed by NSAID (seven articles, 4.2 percent) or local analgesics (five articles, 3.0 percent).
Follow-up
Duration of follow-up was defined in 167 of 168 included articles. The number of end-
points ranged from one to six per article with a median of two time points per article 
(mean 2.21, mode 1). Duration of follow-up ranged from 6  hours to 365 days, with a 
median duration of 28 days. Time points that were used most frequently were, respec-
tively, 1 month (including follow-up defined as 4 weeks and 30 days), 3 months (or 90 
days), and 1 or 2 weeks.
Outcome parameters
Outcome parameters were scored from all 168 articles. Histological examination of 
explanted meshes was performed in nearly all articles (81.0 percent, or 136 articles), 
39 of these articles (23.2 percent) subsequently added immunohistochemical analysis. 
Strength of ingrowth was either defined as subjective macroscopic ingrowth (scored in 
10.1 percent, 17 articles), or mechanical strength measured by tensiometry (scored in 
48.2 percent, 81 articles). Adhesions were scored in 86 articles (51.1 percent), scored as 
adhesion quality (27 articles, 16.1 percent), adhesion quantity (18 articles, 10.7 percent), 
or both (41 articles, 24.4 percent). Mesh shrinkage was scored in only 17.3 percent of 
articles (29 articles). An analysis of the scoring systems used is presented in Table 3.
Table 3. Overview of scoring systems used
Different 
scoring systems 
(number 
of scoring 
systems)
Validated scoring 
system (number of 
scoring systems/% 
articles)a
(Semi-) 
quantitative or 
objective scoring 
(number of scoring 
systems/% articles)
New 
scoring 
system (% 
articles)b
Unknown 
or pure 
descriptive 
scoring (% 
of articles)
Ingrowth 12  3 / 5.9  4 / 76.4  5.9 11.8
Adhesion quality 24 19 / 75 16 / 73.5 14.7  7.3
Adhesion quantity 11  5 / 86.4  9 / 94.9 18.6  6.7
Shrinkage  9  3 / 89.6 29 / 100 20.7  0.0
Histology 47 13 / 47.1  7 / 36.8 22.8 30.1
Immunohistochemistry  9  2 / 59.0  3 / 61.5 15.4 20.5
Number indicates the number of different scoring systems involved. The percentage is the percentage of 
articles involved.
a Validated scoring system is defined as either a system with clear reference or an accepted system used in 
the same manner in multiple articles.
b New scoring systems are defined as scoring systems used only in one article.
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DISCUSSION
Critical review of the literature revealed a large variety in mesh models; many different 
models, animal species, meshes, and parameters were assessed in the last decade lead-
ing to studies that were difficult to compare among each other.
Identical models including all parameters were not found to be implemented by 
different centers, in other words all centers apparently use their own specific models. 
Due to the growing variety in existing and new concepts of meshes, preclinical animal 
research is necessary to assess biocompatibility and effectiveness of new meshes before 
implementing them in clinical practice [7-9]. Furthermore, many of the important mesh 
characteristics are derived from and can only be properly researched using animal 
models [4]. However, for experimental research to have proper impact, research pub-
lished by different research groups needs to be comparable and reproducible [3, 15].
In this study, we attempted to provide a systematic overview of all available animal 
models for mesh research. However, due to the large amount of different animals used 
we decided to focus on only one species. Although large animal models like pigs are sup-
posed to resemble the human situation most, over 50 percent of all experimental hernia 
research focused on rat models [7, 16]. Therefore, we decided to limit this overview and 
only elaborate on rat models. We realize that limitation to one animal group might lead 
to bias in information leading to a possible underestimation or even overestimation of 
the problem. This could possibly be solved by using a combination of a small animal 
model for preliminary testing and immunohistochemistry, which might be followed by 
testing on a larger animal model, which will better resemble the anatomy of the human 
abdominal wall.
One of the first issues that needs to be addressed concerns the use of mostly young male 
rats. Although incisional hernias occur in both male and female patients, with some clini-
cal studies even reporting female sex as an independent risk factor, almost all included 
experimental studies report the use of male rats only [17, 18]. Furthermore, more than 
one in every seven authors did not report the sex of the animal in their papers, even 
though there is an increasing amount of information on the effect of sex on the outcome 
[19, 20].
Therefore, we believe that in accordance to the ARRIVE guidelines and the recently pub-
lished NIH policy there should be an effort to report on and also balance sex of animals 
in experimental hernia repair [20, 21]. Moreover, most studies used rats that were of 
fairly young age, whereas most patients present with hernias later in life.
39
Critical overview of all available animal models for abdominal wall hernia research
2
The results of our survey lead to the assumption that very few researchers make use 
of already published articles. Although this might be an underestimation due to the 
fact that not all researchers reference to previously published articles, there still seems 
to be a large variety in published models. This could lead to irreproducible results or 
results that cannot be compared between different publications [10, 11]. This also makes 
translation to clinical practice extremely difficult [7, 15, 16]. Hence, we think that limit-
ing the range of mesh models to a smaller selection of models and clear referencing to 
standardized models could lead to increase the impact of future publications and in turn 
benefit hernia surgery [22-24].
We believe one important factor for the choice of hernia models should be that it closely 
resembles the human situation and follows the guidelines for hernia repair in humans. 
One discrepancy between human situation and most hernia models is the “hernia age”. 
Most animal models described use an acute hernia model, where the defect is created 
in the same procedure as the mesh is placed. In the human situation, hernias take time 
to mature, possibly altering postoperative results. Perhaps the use of a ‘‘mature hernia’’ 
model as proposed by Dubay and colleagues in 2006 would better resemble the clinical 
situation [25]. Furthermore, following the 2014 International Endohernia Society (IEHS) 
guidelines intraperitoneal onlay meshes (IPOM) with closed defects should be used [26].
Another point of interest is the mesh positioning. Although some mesh positions are 
considered outdated in the clinical setting, there is no decrease in the use of these 
models over the years. To further increase the impact of the animal studies on clinical 
practice, it might be good to translate guidelines for human hernia surgery to preclini-
cal animal models. In particular, the IPOM with mesh augmentation, as is advocated in 
the recent IEHS guidelines, is only used in less than one-fourth of published studies 
[26]. Furthermore, since the preclinical studies are mostly aimed at investigating host 
response to meshes and mesh materials, the use of a standardized control group could 
improve reproducibility and could help put results in perspective.
Despite official guidelines on laboratory animal welfare in both Europe and the USA 
requiring the use of analgesics when pain is to be expected, analgesics are only reported 
in a minority of studies [27, 28]. Since hernia operations can be considered major ab-
dominal surgery, pain is to be expected and use of analgesics and the reporting on their 
use should be promoted according to international regulations.
Despite the heterogeneity in the included studies, there already seems to be some 
degree in consensus for some aspects. For instance, most authors seem to agree that 
the creation of an abdominal wall defect is preferred above primary closure, be it with a 
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large range in size of defects and meshes used. There also seems to be some degree of 
consensus for outcome parameters, whereas majority of studies use histological analysis 
and adhesion scoring as primary outcome. On the other hand, up to one-fifth of these 
articles seem to introduce new scoring systems to evaluate these outcome measure-
ments instead of using readily available validated methods.
Hence, we believe guidelines for publishing and reporting of experimental research for 
hernia research need to be put in place. Different aspects of hernia research need to be 
standardized in order to increase impact of experimental research.
Furthermore, standardization should lead to a reduction in the discrepancy between re-
sults in animal research and clinical research, as is often seen in many fields of medicine 
[23, 29]. Additionally, standardization would make definitive statements on new mesh 
products easier, as they can easily be compared to results from well-known materials.
Furthermore, the standardization of mesh research should be extended to the industry. 
The current regulations for approval of a new mesh concept by the FDA require the 
material only to be “substantially equivalent” to readily available materials, leaving 
interpretation of this equivalency open to interpretation of the manufacturer [30, 31]. 
The manufacturer does have to compare the new device to similar devices. However, 
new guidance documents from the FDA do note that any change to direct or indirect 
tissue-contacting products should be evaluated using biocompatibility analysis. We 
believe there should be standardized requirements set by the hernia societies for any 
new hernia devices introduced on the market.
One of the limitations of this study could be the lack of information on the quality of the 
animal models, preferably using the ARRIVE guidelines for animal research as proposed 
by Kilkenny and colleagues in 2010 [21]. However, we believe this does not aid the aim of 
our study. Furthermore, we believe the quality assessment of hernia research deserves 
a separate review additionally assessing the implementation of the ARRIVE guidelines 
within the hernia research.
Therefore, following the consensus for clinical research as published by Muysoms 
and colleagues, we believe guidelines and recommendations for experimental mesh 
research need to be put in place or at least start a discussion on the consensus within 
animal hernia research models [32]. We therefore propose the establishment of an EHS 
(European Hernia Society) chapter for experimental research.
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2006; 21(6): 409-15.
 92. Dilege E, Coskun H, Gunduz B, Sakiz D, Mihmanli M. Prevention of adhesion to prosthetic mesh in 
incisional ventral hernias: comparison of different barriers in an experimental model. European 
Surgical Research. 2006; 38(3): 358-64.
 93. Dubay DA, Wang X, Adamson B, Kuzon Jr WM, Dennis RG, Franz MG. Mesh incisional herniorrha-
phy increases abdominal wall elastic properties: a mechanism for decreased hernia recurrences 
in comparison with suture repair. Surgery. 2006; 140(1): 14-24.
 94. Dubova EA, Chekmareva IA, Schegolev AI, Filatkina NV, Chizhov DV. Morphological changes in 
the implantation zone of Prolen and Esfil reticular endoprostheses. Bulletin of Experimental Biol-
ogy and Medicine. 2006; 141(5): 648-52.
 95. Erpek H, Tuncyurek P, Soyder A, Boylu S. Hyaluronic acid/carboxymethylcellulose membrane bar-
rier versus taurolidine for the prevention of adhesions to polypropylene mesh. European Surgical 
Research. 2006; 38(4): 414-7.
 96. Esfandiari A, Nowrouzian I. Efficacy of polypropylene mesh coated with bioresorbable membrane 
for abdominal wall defects in mice. Journal of the American Association for Laboratory Animal 
Science. 2006; 45(1): 48-51.
 97. Gobin AS, Butler CE, Mathur AB. Repair and regeneration of the abdominal wall musculofascial 
defect using silk fibroin-chitosan blend. Tissue Engineering. 2006; 12(12): 3383-94.
 98. Harrell AG, Novitsky YW, Peindl RD, Cobb WS, Austin CE, Cristiano JA, et al. Prospective evalua-
tion of adhesion formation and shrinkage of intra-abdominal prosthetics in a rabbit model. The 
American surgeon. 2006; 72(9): 808-13.
 99. Junge K, Rosch R, Anurov M, Titkova S, Ottinger A, Klinge U, et al. Modification of collagen forma-
tion using supplemented mesh materials. Hernia. 2006; 10(6): 492-7.
 100. Kaya M, Baba F, Bolukbas F, Boleken ME, Kanmaz T, Yucesan S. Use of homologous acellular dermal 
matrix for abdominal wall reconstruction in rats. Journal of Investigative Surgery. 2006; 19(1): 11-7.
 101. Ko R, Kazacos EA, Snyder S, Ernst DMJ, Lantz GC. Tensile strength comparison of small intestinal 
submucosa body wall repair. Journal of Surgical Research. 2006; 135(1): 9-17.
Chapter 2
50
 102. Krause HG, Galloway SJ, Khoo SK, Lourie R, Goh JTW. Biocompatible properties of surgical mesh 
using an animal model. Australian and New Zealand Journal of Obstetrics and Gynaecology. 
2006; 46(1): 42-5.
 103. Leroy JL, Mutter D, Forgione A, Inoue H, Vix M, Bailey C, et al. The new 4DDome prosthesis: an 
original light and partially absorbable composite mesh for hernia repair. Hernia. 2006; 10(5): 
401-8.
 104. Majercik S, Tsikitis V, Iannitti DA. Strength of tissue attachment to mesh after ventral hernia repair 
with synthetic composite mesh in a porcine model. Surgical Endoscopy. 2006; 20(11): 1671-4.
 105. Meyer T, Schwarz K, Ulrichs K, Hocht B. A new biocompatible material (Lyoplant) for the therapy 
of congenital abdominal wall defects: first experimental results in rats. Pediatric Surgery Interna-
tional. 2006; 22(4): 369-74.
 106. Petter-Puchner AH, Fortelny RH, Mittermayr R, Walder N, Ohlinger W, Redl H. Adverse effects 
of porcine small intestine submucosa implants in experimental ventral hernia repair. Surgical 
Endoscopy. 2006; 20(6): 942-6.
 107. Saygun O, Agalar C, Aydinuraz K, Agalar F, Daphan C, Saygun M, et al. Gold and gold-palladium 
coated polypropylene grafts in a S. epidermidis wound infection model. Journal of Surgical 
Research. 2006; 131(1): 73-9.
 108. Schonleben F, Reck T, Tannapfel A, Hohenberger W, Schneider I. Collagen foil (TissuFoil E) reduces 
the formation of adhesions when using polypropylene mesh for the repair of experimental ab-
dominal wall defects. International Journal of Colorectal Disease. 2006; 21(8): 840-6.
 109. Schug-Pass C, Tamme C, Tannapfel A, Köckerling F. A lightweight polypropylene mesh (TiMesh) 
for laparoscopic intraperitoneal repair of abdominal wall hernias: comparison of biocompatibility 
with the DualMesh in an experimental study using the porcine model. Surgical Endoscopy. 2006; 
20(3): 402-9.
 110. Sikkink CJJM, de Reilingh TSV, Malyar AW, Jansen JA, Bleichrodt RP, van Goor H. Adhesion forma-
tion and reherniation differ between meshes used for abdominal wall reconstruction. Hernia. 
2006; 10(3): 218-22.
 111. Voskerician G, Gingras PH, Anderson JM. Macroporous condensed poly(tetrafluoroethylene). I. In 
vivo inflammatory response and healing characteristics. Journal of Biomedical Materials Research 
Part A. 2006; 76A(2): 234-42.
 112. Weyhe D, Schmitz I, Belyaev O, Grabs R, Muller KM, Uhl W, et al. Experimental comparison of 
monofile light and heavy polypropylene meshes: Less weight does not mean less biological 
response. World Journal of Surgery. 2006; 30(8): 1586-91.
 113. D’Acampora AJ, Kestering DDM, Soldi MDS, Rossi LF. Experimental study comparing the tensile 
strength of different surgical meshes following aponeurotic-muscle deformity synthesis on 
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423-7.
 200. Muftuoglu MAT, Gungor O, Odabas M, Ekinci O, Teyyareci A, Sekmen U, et al. The comparison 
of heavyweight mesh and lightweight mesh in an incisional animal model. Hernia. 2010; 14(4): 
397-400.
 201. Otto J, Binnebosel M, Pietsch S, Anurov M, Titkova S, Ottinger AP, et al. Large-pore PDS mesh 
compared to small-pore PG mesh. Journal of Investigative Surgery. 2010; 23(4): 190-6.1
 202. Pereira-Lucena CG, Artigiani-Neto R, Lopes-Filho GJ, Frazao CVG, Goldenberg A, Matos D, et al. 
Experimental study comparing meshes made of polypropylene, polypropylene + polyglactin 
and polypropylene + titanium: inflammatory cytokines, histological changes and morphometric 
analysis of collagen. Hernia. 2010; 14(3): 299-304.
 203. Petter-Puchner AH, Fortelny RH, Walder N, Morales-Conde S, Gruber-Blum S, Ohlinger W, et al. 
Small intestine submucosa (SIS) implants in experimental IPOM repair. Journal of Surgical Re-
search. 2010; 161(2): 264-71.
 204. Rice RD, Ayubi FS, Shaub ZJ, Parker DM, Armstrong PJ, Tsai JW. Comparison of Surgisis, AlloDerm, 
and Vicryl Woven Mesh grafts for abdominal wall defect repair in an animal model. Aesthetic 
Plastic Surgery. 2010; 34(3): 290-6.
 205. Sergent F, Desilles N, Lacoume Y, Tuech JJ, Marie JP, Bunel C. Biomechanical analysis of polypro-
pylene prosthetic implants for hernia repair: an experimental study. American Journal of Surgery. 
2010; 200(3): 406-12.
 206. Zinther NBB, Wara P, Friis-Andersen H. Shrinkage of intraperitoneal onlay mesh in sheep: coated 
polyester mesh versus covered polypropylene mesh. Hernia. 2010; 14(6): 611-5.
 207. Zinther NBB, Wara P, Friis-Andersen H. Intraperitoneal onlay mesh: an experimental study of 
adhesion formation in a sheep model. Hernia. 2010; 14(3): 283-9.
 208. Zogbi L, Portella AOV, Trindade MRM, Trindade EN. Retraction and fibroplasia in a polypropylene 
prosthesis: experimental study in rats. Hernia. 2010; 14(3): 291-8.
57
Critical overview of all available animal models for abdominal wall hernia research
2
 209. Altinli E, Sumer A, Koksal N, Onur E, Senger S, Eroglu E, et al. Prevention of adhesion to prosthetic 
mesh: comparison of oxidized generated cellulose, polyethylene glycol and hylan G-F 20. Ulus 
Travma Acil Cerrahi Derg. 2011; 17(5): 377-82.
 210. Amato G, Lo Monte AI, Cassata G, Damiano G, Romano G, Bussani R. A new prosthetic implant for 
inguinal hernia repair: its features in a porcine experimental model. Artificial Organs. 2011; 35(8): 
181-90.
 211. Anurov MV, Titkova SM, Oettinger AP. Comparison of the results of hernia defect plasty with stan-
dard and light surgical meshes with identical knitted structure. Bulletin of Experimental Biology 
and Medicine. 2011; 150(4): 459-64.
 212. Asarias JR, Nguyen PT, Mings JR, Gehrich AP, Pierce LM. Influence of mesh materials on the expres-
sion of mediators involved in wound healing. Journal of Investigative Surgery. 2011; 24(2): 87-98.
 213. Badiou W, Lavigne JP, Bousquet PJ, O&apos; Callaghan D, Mares P, De Tayrac R. In vitro and in vivo 
assessment of silver-coated polypropylene mesh to prevent infection in a rat model. International 
Urogynecology Journal and Pelvic Floor Dysfunction. 2011; 22(3): 265-72.
 214. Belyansky I, Tsirline VB, Martin TR, Klima DA, Heath J, Lincourt AE, et al. The addition of lysostaphin 
dramatically improves survival, protects porcine biomesh from infection, and improves graft 
tensile shear strength. Journal of Surgical Research. 2011; 171(2): 409-15.
 215. Belyansky I, Tsirline VB, Montero PN, Satishkumar R, Martin TR, Lincourt AE, et al. Lysostaphin-
coated mesh prevents staphylococcal infection and significantly improves survival in a contami-
nated surgical field. The American surgeon. 2011; 77(8): 1025-31.
 216. Bellows CF, Wheatley BM, Moroz K, Rosales SC, Morici LA. The effect of bacterial infection on the 
biomechanical properties of biological mesh in a rat model. Plos One. 2011; 6(6).
 217. Brandt CJ, Kammer D, Fiebeler A, Klinge U. Beneficial effects of hydrocortisone or spironolactone 
coating on foreign body response to mesh biomaterial in a mouse model. Journal of Biomedical 
Materials Research Part A. 2011; 99 A(3): 335-43.
 218. Byrd JF, Agee N, Nguyen PH, Heath JJ, Lau KN, McKillop IH, et al. Evaluation of composite mesh for 
ventral hernia repair. Journal of the Society of Laparoendoscopic Surgeons. 2011; 15(3): 298-304.
 219. Byrd JF, Agee N, Swan RZ, Lau KN, Heath JJ, McKillop IH, et al. Evaluation of absorbable and per-
manent mesh fixation devices: adhesion formation and mechanical strength. Hernia. 2011; 15(5): 
553-8.
 220. Campbell KT, Burns NK, Rios CN, Mathur AB, Butler CE. Human versus non-cross-linked porcine 
acellular dermal matrix used for ventral hernia repair: comparison of in vivo fibrovascular remod-
eling and mechanical repair strength. Plastic and Reconstructive Surgery. 2011; 127(6): 2321-32.
 221. Deeken CR, Melman L, Jenkins ED, Greco SC, Frisella MM, Matthews BD. Histologic and biome-
chanical evaluation of crosslinked and non-crosslinked biologic meshes in a porcine model of 
ventral incisional hernia repair. Journal of the American College of Surgeons. 2011; 212(5): 880-8.
 222. Diaz-Godoy A, Garcia-Urena MA, Lopez-Monclus J, Vega Ruiz V, Melero Montes D, Erquinigo 
Agurto N. Searching for the best polypropylene mesh to be used in bowel contamination. Hernia. 
2011; 15(2): 173-9.
 223. Eberli D, Atala A, Yoo JJ. One and four layer acellular bladder matrix for fascial tissue reconstruc-
tion. Journal of Materials Science: Materials in Medicine. 2011; 22(3): 741-51.
 224. Faleris JA, Hernandez RMC, Wetzel D, Dodds R, Greenspan DC. In-vivo and in-vitro histological 
evaluation of two commercially available acellular dermal matrices. Hernia. 2011; 15(2): 147-56.
 225. Fujino K, Kinoshita M, Saitoh A, Yano H, Nishikawa K, Fujie T, et al. Novel technique of overlaying 
a poly-L: -lactic acid nanosheet for adhesion prophylaxis and fixation of intraperitoneal onlay 
polypropylene mesh in a rabbit model. Surgical Endoscopy. 2011; 25(10): 3428-36.
Chapter 2
58
 226. Gruber-Blum S, Petter-Puchner AH, Brand J, Fortelny RH, Walder N, Oehlinger W, et al. Comparison 
of three separate antiadhesive barriers for intraperitoneal onlay mesh hernia repair in an experi-
mental model. British Journal of Surgery. 2011; 98(3): 442-9.
 227. Harth KC, Broome AM, Jacobs MR, Blatnik JA, Zeinali F, Bajaksouzian S, et al. Bacterial clearance 
of biologic grafts used in hernia repair: an experimental study. Surgical Endoscopy. 2011; 25(7): 
2224-9.
 228. Hjort H, Mathisen T, Alves A, Clermont G, Boutrand JP. Three-year results from a preclinical 
implantation study of a long-term resorbable surgical mesh with time-dependent mechanical 
characteristics. Hernia. 2011: 1-7.
 229. Hollinsky C, Kolbe T, Walter I, Joachim A, Sandberg S, Koch T, et al. Tensile strength and adhe-
sion formation of mesh fixation systems used in laparoscopic incisional hernia repair. Surgical 
Endoscopy. 2010; 24(6): 1318-24.
 230. Ioannis V, Aliki T, Theodosios T, Constantinos N, Nikolaos A, Nikolaos D, et al. Late polypropylene 
mesh susceptibility to infection during intra-abdominal sepsis. Journal of Investigative Surgery. 
2011; 24(5): 199-204.
 231. Jamry A, Jalynski M, Smigielski J, Brocki M. Shrinkage of Dynamesh IPOM mesh in 6-week follow-
up – an experimental study. Videosurgery and Other Miniinvasive Techniques. 2011; 6(1): 19-23.
 232. Jenkins ED, Melman L, Deeken CR, Greco SC, Frisella MM, Matthews BD. Evaluation of fenestrated 
and non-fenestrated biologic grafts in a porcine model of mature ventral incisional hernia repair. 
Hernia. 2010; 14(6): 599-610.
 233. Jenkins ED, Melman L, Deeken CR, Greco SC, Frisella MM, Matthews BD. Biomechanical and histo-
logic evaluation of fenestrated and nonfenestrated biologic mesh in a porcine model of ventral 
hernia repair. Journal of the American College of Surgeons. 2011; 212(3): 327-39.
 234. Klink CD, Junge K, Binnebösel M, Alizai HP, Otto J, Neumann UP, et al. Comparison of long-term 
biocompability of PVDF and PP meshes. Journal of Investigative Surgery. 2011; 24(6): 292-9.
 235. Konerding MA, Chantereau P, Delventhal V, Holste JL, Ackermann M. Biomechanical and histologi-
cal evaluation of abdominal wall compliance with intraperitoneal onlay mesh implants in rabbits: 
a comparison of six different state-of-the-art meshes. Medical Engineering & Physics. 2011
 236. Lawniczak P, Grobelski B, Pasieka Z. Properties comparison of intraperitoneal hernia meshes in 
reconstruction of the abdominal wall: animal model study. Polish Journal of Surgery. 2011; 83(1): 
19-26.
 237. MacIver AH, McCall MD, Edgar RL, Thiesen AL, Bigam DL, Churchill TA, et al. Sirolimus drug-eluting, 
hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a 
mouse model. Surgery. 2011; 150(5): 907-15.
 238. Mamy L, Letouzey V, Lavigne JP, Garric X, Gondry J, Mares P, et al. Correlation between shrinkage 
and infection of implanted synthetic meshes using an animal model of mesh infection. Interna-
tional Urogynecology Journal and Pelvic Floor Dysfunction. 2011; 22(1): 47-52.
 239. Mandai Y, Naito M, Hayashi T, Asano H, Ino H, Tsukuda K, et al. Impact of endoscopic and histologi-
cal evaluations of two different types of mesh plug for a groin hernia model. Surgery Today. 2011; 
41(11): 1512-8.
 240. Melman L, Jenkins ED, Hamilton NA, Bender LC, Brodt MD, Deeken CR, et al. Early biocompatibility 
of crosslinked and non-crosslinked biologic meshes in a porcine model of ventral hernia repair. 
Hernia. 2011; 15(2): 157-64.
 241. Melman L, Jenkins ED, Hamilton NA, Bender LC, Brodt MD, Deeken CR, et al. Histologic and bio-
mechanical evaluation of a novel macroporous polytetrafluoroethylene knit mesh compared to 
59
Critical overview of all available animal models for abdominal wall hernia research
2
lightweight and heavyweight polypropylene mesh in a porcine model of ventral incisional hernia 
repair. Hernia. 2011; 15(4): 423-31.
 242. Mulier KE, Nguyen AH, Delaney JP, Marquez S. Comparison of Permacol and Strattice for the repair 
of abdominal wall defects. Hernia. 2011; 15(3): 315-9.
 243. Ngo MD, Aberman HM, Hawes ML, Choi B, Gertzman AA. Evaluation of human acellular dermis 
versus porcine acellular dermis in an in vivo model for incisional hernia repair. Cell and Tissue 
Banking. 2011; 12(2): 135-45.
 244. Orenstein SB, Saberski ER, Kreutzer DL, Novitsky YW. Comparative analysis of histopathologic 
effects of synthetic meshes based on material, weight, and pore size in mice. Journal of Surgical 
Research. 2011.
 245. Perko Z, Pogorelic Z, Druzijanic N, Bilan K, Vilovic K. Formation of adhesions at surgical meshes in 
a rat experimental model. Collegium Antropologicum. 2011; 35(3): 911-4.
 246. Petter-Puchner AH, Fortelny RH, Silic K, Brand J, Gruber-Blum S, Redl H. Biologic hernia implants 
in experimental intraperitoneal onlay mesh plasty repair: the impact of proprietary collagen pro-
cessing methods and fibrin sealant application on tissue integration. Surgical Endoscopy. 2011; 
25(10): 3245-52.
 247. Petter-Puchner AH, Fortelny RH, Mika K, Hennerbichler S, Redl H, Gabriel C. Human vital amniotic 
membrane reduces adhesions in experimental intraperitoneal onlay mesh repair. Surgical Endos-
copy. 2011; 25(7): 2125-31.
 248. Potic M, Ignjatovic I, Savic V, Djekic P, Radenkovic G. Mechanical properties and tissue reinforce-
ment of polypropylene grafts used for pelvic floor repair--an experimental study. Hernia. 2011; 
15(6): 685-90.
 249. Raptis DA, Vichova B, Breza J, Skipworth J, Barker S. A comparison of woven versus nonwoven 
polypropylene (PP) and expanded versus condensed polytetrafluoroethylene (PTFE) on their 
intraperitoneal incorporation and adhesion formation. Journal of Surgical Research. 2011; 169(1): 
1-6.
 250. Rodríguez M, Pascual G, Sotomayor S, Perez-Koihler B, Cifuentes A, Bellón JM. Chemical adhesion 
barriers: do they affect the intraperitoneal behavior of a composite mesh? Journal of Investiga-
tive Surgery. 2011; 24(3): 115-22.
 251. Shi CY, Chen W, Zhao YN, Chen B, Xiao ZF, Wei ZL, et al. Regeneration of full-thickness abdominal 
wall defects in rats using collagen scaffolds loaded with collagen-binding basic fibroblast growth 
factor. Biomaterials. 2011; 32(3): 753-9.
 252. Stanwix MG, Nam AJ, Hui-Chou HG, Ferrari JP, Aberman HM, Hawes ML, et al. Abdominal ventral 
hernia repair with current biological prostheses: an experimental large animal model. Annals of 
Plastic Surgery. 2011; 66(4): 403-9.
 253. Steurer JA, Lantz GC, Kazacos EA, Saunders AT, Altizer AM. Chronic hernia repair in a rat model 
using small intestinal submucosa. Journal of Investigative Surgery. 2011; 24(5): 227-35.
 254. Zhang J, Wang GY, Xiao YP, Fan LY, Wang Q. The biomechanical behavior and host response to 
porcine-derived small intestine submucosa, pericardium and dermal matrix acellular grafts in a 
rat abdominal defect model. Biomaterials. 2011; 32(29): 7086-95.
 255. Zhou HY, Zhang JA, Yan RL, Wang QA, Fan LY, Zhang Q, et al. Improving the antibacterial property 
of porcine small intestinal submucosa by nano-silver supplementation: a promising biological 
material to address the need for contaminated defect repair. Annals of Surgery. 2011; 253(5): 
1033-41.
 256. Baktir A, Dogru O, Girgin M, Aygen E, Kanat BH, Dabak DO, et al. The effects of different prosthetic 
materials on the formation of collagen types in incisional hernia. Hernia. 2012: 1-5.
Chapter 2
60
 257. Baracs J, Takacs I, Sajjadi SG, Horvath OP, Weber G. Which mesh is appropriate for laparoscopic 
use? Prevention of adhesions to macroporous mesh, a rabbit model. European Surgery. 2012; 
44(5): 319-24.
 258. Bellón JM, Rodriguez M, Gomez-Gil V, Sotomayor S, Bujan J, Pascual G. Postimplant intraperi-
toneal behavior of collagen-based meshes followed by laparoscopy. Surgical Endoscopy. 2012; 
26(1): 27-35.
 259. Bellows CF, Wheatley B, Moroz K, Rosales S, Morici LA. Histologic and biomechanical evaluation 
of biologic meshes following colonization with Pseudomonas aeruginosa. Journal of Surgical 
Research. 2012; 175(1): E35-E42.
 260. Campbell KT, Burns NK, Ensor J, Butler CE. Metrics of cellular and vascular infiltration of human 
acellular dermal matrix in ventral hernia repairs. Plastic and Reconstructive Surgery. 2012; 129(4): 
888-96.
 261. De Castro Bras LE, Shurey S, Sibbons PD. Evaluation of crosslinked and non-crosslinked biologic 
prostheses for abdominal hernia repair. Hernia. 2012; 16(1): 77-89.
 262. Deeken CR, Matthews BD. Comparison of contracture, adhesion, tissue ingrowth, and histologic 
response characteristics of permanent and absorbable barrier meshes in a porcine model of lapa-
roscopic ventral hernia repair. Hernia. 2012; 16(1): 69-76.
 263. Deerenberg EB, Mulder IM, Grotenhuis N, Ditzel M, Jeekel J, Lange JF. Experimental study on 
synthetic and biological mesh implantation in a contaminated environment. British Journal of 
Surgery. 2012; 99(12): 1734-41.
 264. Dolce CJ, Keller JE, Stefanidis D, Walters KC, Heath JJ, Lincourt AL, et al. Evaluation of soft tissue 
attachments to a novel intra-abdominal prosthetic in a rabbit model. Surgical Innovation. 2012; 
19(3): 295-300.
 265. Hernández-Gascón B, Peña E, Pascual G, Rodríguez M, Bellón JM, Calvo B. Long-term anisotropic 
mechanical response of surgical meshes used to repair abdominal wall defects. Journal of the 
Mechanical Behavior of Biomedical Materials. 2012; 5(1): 257-71.
 266. Huber A, Boruch AV, Nieponice A, Jiang H, Medberry C, Badylak SF. Histopathologic host response 
to polypropylene-based surgical mesh materials in a rat abdominal wall defect model. Journal of 
Biomedical Materials Research Part B: Applied Biomaterials. 2012; 100(3): 709-17.
 267. Jacob DA, Schug-Pass C, Sommerer F, Tannapfel A, Lippert H, Köckerling F. Comparison of a 
lightweight polypropylene mesh (Optilene® LP) and a large-pore knitted PTFE mesh (GORE® 
INFINIT® mesh)--Biocompatibility in a standardized endoscopic extraperitoneal hernia model. 
Langenbeck’s Archives of Surgery. 2012; 397(2): 283-9.
 268. Naufel AM, Czeczko NG, Mafafaia O, Ribas-Filho JM, Naufel-Junior CR, Dietz UA, et al. Comparative 
study between meshes of polyester with collagen and polytetrafluoroethylene in the repair of 
defects produced in abdominal wall of rats. Acta Cirúrgica Brasileira. 2012; 27(7): 454-9.
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ABSTRACT
Introduction
In laparoscopic incisional hernia repair, direct contact between the prosthesis and 
abdominal viscera is inevitable and may lead to adhesions. Despite the large variety 
of mesh prosthesis, little is known about their in vivo behavior. Biological meshes are 
considered to have many advantages, but due to their price they’re rarely used. A rat 
model was used to assess biological and conventional synthetic meshes on their in vivo 
characteristics.
Methods
One-hundred twenty male Wistar rats were randomized into five groups of 24 rats. 
A mesh was implanted intraperitoneally and fixated with non-resorbable sutures. 
The following five meshes were implanted: Parietene™ (polypropylene), Permacol™ 
(cross-linked porcine acellular dermal matrix), Strattice™ (non-cross-linked porcine acel-
lular dermal matrix), XCM Biologic® (non-cross-linked porcine acellular dermal matrix), 
Omyra® Mesh (condensed polytetrafluoroethylene). The rats were sacrificed after 30, 90, 
or 180 days. Incorporation, shrinkage, adhesions, abscess formation, and histology were 
assessed for all meshes.
Results
All animals thrived postoperatively. After 180 days, Permacol™, Parietene™ and Omyra® 
Mesh had a significantly better incorporation than Strattice™ (P = 0.001, P = 0.019, and 
P  =  0.037 respectively). After 180 days, Strattice™ had significantly fewer adhesions 
on the surface of the mesh than Parietene™ (P < 0.001), Omyra® Mesh (P = 0.011), and 
Permacol™ (P  =  0.027). After 30 days, Permacol™ had significantly stronger adhesions 
than Strattice™ (P = 0.030). However, this difference was not significant anymore after 
180 days. After 180 days, there was significantly less shrinkage in Permacol™ than in 
Strattice™ (P = 0.001) and Omyra® Mesh (P = 0.050).
Conclusion
Based on incorporation, adhesions, mesh shrinkage, and histologic parameters Strat-
tice™ performed best in this experimental rat model.
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INTRODUCTION
Incisional hernia is a common postoperative complication. Incidences range from 3 to 
20 percent in the general population with an increased incidence of up to 39 percent 
in patients suffering of obesity or aortic aneurysms [1]. Correction of incisional hernias 
is nowadays most often performed with mesh reinforcement [2]. The use of mesh radi-
cally lowered the 10-year recurrence rates after incisional hernia repair [3]. Meshes are 
produced in a large variety of materials, structures, and shapes, and even composites are 
available [4]. Conventional synthetic meshes are still used most often in general practice 
and polypropylene mesh is the most popular product [5].
In laparoscopic incisional hernia repair, direct contact between the mesh prosthesis and 
the abdominal viscera is inevitable. This may lead to an inflammatory reaction resulting 
in abdominal adhesion formation. Despite the large variety of available mesh prosthesis, 
there is only limited knowledge on their in vivo behavior. Synthetic meshes are used for 
various decades now, however, biological meshes were just recently introduced [6, 7]. 
Biological meshes are matrices made from collagen containing tissues of human, porcine, 
bovine, or equine origin. Tissues such as intestines, heart valves, or skin are processed 
to remove any host debris (cells, cell components, and hairs) as well as various antigens 
present in the tissue [8, 9]. After decellularization and degradation of these tissues, a 
3D structure of collagen and some protein remnants like growth factors remains. After 
completing this step, additional chemical cross-linking can be done with chemicals like 
hexamethylene diisocyanate, carbodiimide, glutaraldehyde, or photo-oxidizing agents 
[10, 11]. Additional cross-linking is performed to increase the strength of the mesh, and 
to slow down the degradation of the mesh after implantation [8, 12]. During this phase 
of degradation, there is incorporation of host fibroblasts into the mesh and collagen 
replacement occurs. This so-called xenograft remodeling begins within a few hours after 
implantation and takes several months to years.
Biological meshes are said to have many advantages, but are also very expensive [6]. 
Consequently, these meshes are only rarely used, which leads to studies with hetero-
geneous populations, mostly short-term follow-up, and little data on long-term results 
[13-15]. Both biological and conventional synthetic meshes were investigated in a 
physiologic, non-contaminated rat model in an intraperitoneal position to assess the in 
vivo characteristics of these prostheses with long-term follow-up. The aim of this study 
was to compare commonly used biological and synthetic meshes in an intraperitoneal 
environment on incorporation, shrinkage, adhesion formation, abscess formation, and 
histology after 30, 90, and 180 days. The working hypothesis for this study is that biologi-
cal meshes behave better than synthetic meshes in an intraperitoneal position.
Chapter 3
68
METHODS
Animals
One-hundred twenty male Wistar rats were obtained from a licensed breeder of labora-
tory animals (Harlan Laboratories, Boxmeer, the Netherlands). The rats were bred under 
specific pathogen-free conditions and kept under standardized laboratory conditions 
(environmental temperature 20–24°C; relative air humidity of 50–60 percent; and 
12-hours light–dark cycles). The rats were housed in pairs in individually ventilated cages. 
All rats were fed ad libitum with standard rat chow and water. The animals weighed 
upon arrival in the experimental facility 250–325 grams each. The rats were acclimatized 
at least for 7 days prior to the start of the experiment. The experimental protocol was ap-
proved by the Ethical Committee on Animal Experimentation of the Erasmus University 
Medical Center, Rotterdam, the Netherlands.
Experimental model
At the start of the experiment, all 120 male Wistar rats were randomly divided into five 
groups of 24 animals each. Prior to operation, the rats were anesthetized with inhala-
tion anesthesia (mixture of isoflurane (Pharmachemie, Haarlem, the Netherlands) and 
oxygen) and they received a single dose of buprenorphine analgesia (0.05 mg/kg 
subcutaneously) (Reckitt Benckiser Healthcare (UK) Limited, Kingston-upon-Thames, 
United Kingdom). The rats were weighed, their abdomen was shaved, and the skin was 
disinfected with 70 percent ethanol. The rats were positioned in supine position. The 
abdominal cavity was opened by a 3-cm midline incision and a sterile mesh of 2.5 × 3.0 
cm was inserted. This mesh was placed intraperitoneally and fixated transmuscularly 
with six non-absorbable nylon sutures (5/0 Ethilon®; Ethicon, Somerville, NJ, USA). The 
fascia and skin were closed separately with a running absorbable suture of polyglycolic 
acid (5/0 Safil®; B. Braun, Melsungen, Germany). After mesh implantation, all animals 
received a single dose of gentamicin (6 mg/kg intramuscularly) and a dose of 5 ml so-
dium chlorine 0.9 percent subcutaneously. Postoperatively, the rats were placed under a 
heating lamp to recover from anesthesia in the immediate postoperative phase.
Physiologic rat model
In this rat model, all meshes were placed in a physiologic, non-contaminated intra-
peritoneal environment to assess their characteristics in the absence of an infection. 
Contrary to a previous study from this research group in which the same meshes were 
examined in a contaminated intraperitoneal environment to assess their characteristics 
in the presence of a fulminant infection [16].
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Mesh material
Five different meshes were implanted: polypropylene (Parietene™, Sofradim, Trévoux, 
France; part of Covidien–Medtronic, New Haven, Connecticut, USA), cross-linked por-
cine acellular dermal matrix (Permacol™; Sofradim), non-cross-linked porcine acellular 
dermal matrix (Strattice™; LifeCell Corporation, Branchburg, New Jersey, USA), another 
non-cross-linked porcine acellular dermal matrix (XCM Biologic®; Kensey Nash Corpora-
tion, Exton, Pennsylvania, USA, distributed by DePuy Synthes, Oberdorf, Switzerland), 
and condensed polytetrafluoroethylene (c-PTFE; Omyra® Mesh, B. Braun). Prior to im-
plantation, all meshes were prepared in a sterile environment to create smaller meshes 
of 2.5 × 3 cm. All meshes were handled according to the Instructions for Use of their 
manufacturers.
Postoperative outcomes
Wellness and survival of the animals
Postoperatively, all animals were weighed on a daily base in the first week and thereafter 
on a weekly base. Based on the weighing results mean weight loss was calculated by 
subtracting the rat’s weight at the start of the experiment and the maximum amount of 
weight loss during the first 7 days of the experiment. During weighing, the animals were 
assessed for signs of discomfort. To objectify these signs of discomfort, the rat’s behavior 
was assessed with a 12-point wellness scoring system [17]. Rats reached the humane 
endpoint if they suffered from at least 20 percent weight loss or a wellness score less 
than 5 points. All rats that reached the humane endpoint were euthanized. Euthanized 
or deceased animals underwent a necropsy. The data of euthanized or deceased animals 
were included for analyses.
Sacrifice
The experimental endpoints were 30 days, 90 days, and 180 days after mesh placement. 
During sacrifice, a photograph was taken from the inner abdominal wall and the mesh 
site. Figure 1 shows a photograph taken at time of sacrifice showing inner abdominal 
wall and mesh site (non-cross-linked biological mesh). The black box in Figure 1 shows 
a schematic representation of the tissue sampling for histopathology. The following 
parameters were assessed: incorporation and shrinkage of the mesh, and adhesion 
formation (coverage, and strength).
Incorporation of the mesh
Incorporation of the mesh was assessed with a slide calliper. The number of millimeters 
of all sides of the remaining mesh were measured. The standard length and width of the 
implanted mesh were 30 × 25 mm. Thereafter, the number of millimeters of each side 
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of the mesh that showed incorporation were measured. Both measures resulted in a 
percentage of incorporation. Full incorporation was incorporation of all sides taking any 
shrinkage of the mesh into account.
Shrinkage of the mesh
Shrinkage of the mesh was assessed by measurement of the surface of mesh that was 
present during sacrifice. The measurement was performed with a standardized calliper 
and the mesh surface found during sacrifice was compared with the standardized im-
plant size (7.5 cm²) and expressed in a percentage of this standardized implant.
Adhesion formation
Adhesion formation was assessed in two ways. Firstly, a qualitative analysis was per-
formed using the Zühlke score [18]. The Zühlke score was used to assess the strength 
and tenacity of adhesions. The score ranges from 0 (no adhesions) to 4 (very strong 
adhesions) (Supplementary data, Table S1). Table S1 shows the Zühlke scoring system 
for adhesions that was used to assess adhesions in this study. Secondly, the quantity 
of adhesions was assessed and expressed in a percentage of adhesions on the surface 
of the mesh. Two independent investigators assessed both parameters. Discrepancies 
were discussed amongst the two investigators and resolved together.
Figure 1. Photograph taken at time of sacrifice showing the inner abdominal wall and mesh site
The depicted mesh is a non-crosslinked biological mesh. The black box is a schematic representation of 
tissue sampling for histopathology.
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Abscesses
The presence of mesh abscesses was regarded as an expression of an ongoing intra-
abdominal infection. The presence of abscesses was assessed with a standardized visual 
inspection and examination of the abdominal cavity of all rats. If abscesses were present, 
their size was scored with the Abscess Scoring System [19] (Supplementary data, Table 
S2). Table S2 shows the abscess scoring system.
Scoring system for the ranking of all meshes
The characteristics that were assessed in this study were incorporation of the mesh, 
shrinkage of the mesh, adhesion formation, abscess formation, and histologic pa-
rameters. To assess the ranking of the meshes, all meshes received a score of 1 (worst 
performing mesh) to 5 (best performing mesh) for each individual parameter. Adhesions 
were considered to be the decisive factor, because of the intra-abdominal position of 
the mesh.
Histologic evaluation
After sacrifice, a full-thickness abdominal wall sample of 1.0 by 0.5 cm was harvested 
from each rat. This sample was taken from one of the long sides in between the sutures 
and contained both abdominal wall and mesh (Figure 1). Figure 1 shows a schematic 
representation of the tissue sampling for histopathology. All samples were fixated in 
4 percent formalin and embedded in paraffin. Samples were cut into 4 µmeter thick 
slices, and stained with either hematoxylin and eosin (HE) or sirius red (SR) according to 
standard diagnostic procedure.
The histologic evaluation of all slides was performed in a blind fashion by an experienced 
pathologist (MC-vG). HE slides were analyzed by a scoring system described by Peeters 
and colleagues [20] (adapted from Jenkins and colleagues [21]). All cells were assessed 
under the microscope under a 40 × magnification and the number of cells per high-
power field (40 × magnification) was counted. No additional stains were performed. SR 
slides were assessed with the scoring system described by Deeken and Matthews [22]. 
The histological analysis of the biological meshes focused on the periprosthetic area. 
The histological analysis of Parietene™ and Omyra® Mesh focused on both the perifila-
mentary areas and the pores. Both areas were assessed and a grade was given for the 
overall number of cells per sample. In the SR slides the amount of fibrous encapsulation 
around each mesh was assessed. The histologic scoring systems can be found in Supple-
mentary data, Table S3, Table S4 and Table S5. Table S3 shows the histologic scoring 
system for inflammatory cell reaction. Table S4 shows the histologic scoring system for 
mesh-specific parameters. Table S5 shows the histologic scoring system for collagen 
deposition.
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Statistical analysis
Prior to the start of the experiment, a sample size calculation was performed. The sample 
size calculation was made regarding an expected decrease in amount of adhesions of 25 
to 30 percent. The expected mortality of the mesh model was 10 percent. Aiming for a 
power of 80 percent and a P value of 0.05, the necessary number of animals was 24 per 
group. All meshes were included in the experiment as equal study groups. None of the 
study groups served as a control group only.
In this experiment, only the data of incorporation of the mesh showed a normal distribu-
tion. All other parameters did not show a normal distribution, thus statistical analyses 
were performed using non-parametrical Kruskal–Wallis tests for independent samples. 
If the overall statistical test showed significant differences, pairwise tests were done to 
determine the groups causing the overall statistical significance.
Baseline characteristics like weight loss were summarized in percentages, continuous 
variables using means and standard errors of the mean, categorical values were summa-
rized with medians and interquartile ranges. All P values were tested with a two-tailed 
test of significance, a P  value of <  0.05 was considered statistically significant and all 
P values were adjusted for multiple testing using Dunn’s post-test. The statistical analy-
ses were performed using SPSS version 21.0.
RESULTS
Animals
All 120 rats survived the operation and thrived afterwards. None of the rats reached 
the humane endpoint. The maximum postoperative weight loss varied between 0 to 
7 percent among the five groups and was more pronounced in the Parietene™ group 
(P = 0.001), and the Permacol™ group (P < 0.001). There were no differences observed in 
weight change or wellness score among the five groups. Table 1 shows an overview of 
the experimental groups in this experiment. In this table, the distribution of the animals 
per study group and per study time point can be found.
Incorporation of the mesh
There was a fluctuating amount of incorporation in all meshes with most often first a 
decrease in ingrowth at 90 days compared with 30 days, followed by an increase after 
180 days compared with 90 days. The amount of incorporation strongly varied between 
the mesh groups. One-hundred and eighty days after implantation, incorporation was 
most superior in Permacol™ (62 ± 11 percent), followed by Omyra® Mesh (58 ± 20 per-
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cent), Parietene™ (56 ± 9 percent), XCM Biologic® (43 ± 12 percent), and most inferior 
in Strattice™ (23 ± 13 percent). After 180 days, mesh incorporation was significantly 
lower in Strattice™ compared with Omyra® Mesh (P = 0.037), Parietene™ (P = 0.019), and 
Table 1. Overview of the experimental groups in this experiment
Parietene™ Permacol™ Strattice™ XCM Biologic® Omyra® Mesh
Mesh material Polypropylene Cross-linked 
collagen of 
porcine dermis
Non-cross-linked 
collagen of 
porcine dermis
Non-cross-linked 
collagen of 
porcine dermis
Condensed 
PTFE
Weight (g/m²) 78 n.a. n.a. n.a. 90
Pore size (mm) 1.0–1.6 n.a. n.a. n.a. 2.4
No. of animals 24 24 24 24 24
Postoperative deaths 0 0 0 0 0
No. analyzed
30 days 8 8 8 7 8
90 days 8 8 8 9 8
180 days 8 8 8 8 8
n.a. = not applicable
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Figure 2. Mean percentage incorporation of each mesh at 30, 90 and 180 days
Chapter 3
74
Permacol™ (P = 0.001) (Figure 2, and Table 2). Figure 2 shows the incorporation of the 
mesh after 30, 90, and 180 days. The mean incorporation is expressed in percentage. 
Table 2 shows the results of macroscopic mesh-specific parameters after sacrifice.
Table 2. Results of macroscopic mesh-specific parameters after sacrifice
n Incorporation of 
mesh (%)
Shrinkage of mesh 
(%)
Adhesions on 
mesh (%)
Tenacity of 
adhesions
Parietene™
30 days 8 49 ± 13 8 (5–13) 83 (78–90) 3 (3–3)
90 days 8 36 ± 12 7 (5–14) 88 (85–93) 3 (3–3)
180 days 8 56 ± 9 9 (5–13) 85 (70–90) 3 (3–3)
Permacol™
30 days 8 47 ± 18 11 (3–23) 75 (60–85) 4 (3–4) A
90 days 8 42 ± 15 7 (3–11) 75 (70–78) 4 (3–4)
180 days 8 62 ± 11 0 (0–4) B 68 (63–73) 4 (3–4)
Strattice™
30 days 8 35 ± 14 13 (7–18) 5 (5–10) C 3 (3–3)
90 days 8 22 ± 11 15 (6–18) 5 (5–5) D 3 (3–3)
180 days 8 23 ± 13 E 18 (15–22) 5 (0–5) F 3 (3–3)
XCM Biologic®
30 days 7 38 ± 6 7 (0–7) 30 (25–55) 3 (3–3)
90 days 9 35 ± 13 12 (8–14) 40 (35–45) 3 (3–3)
180 days 8 43 ± 12 10 (5–16) 35 (28–35) 3 (3–3)
Omyra® Mesh
30 days 8 61 ± 11 16 (13–17) 53 (45–80) 3 (3–3)
90 days 8 48 ± 21 17 (14–31) 63 (45–85) 3 (3–3)
180 days 8 58 ± 20 13 (8–30) 75 (60–75) 3 (3–4)
Incorporation of mesh values are mean ± SD
All other values are median (IQR).
Significant differences between:
A  Permacol™ 30 days and Strattice™ 30 days (P = 0.030)
B  Permacol™ 180 days and Omyra® Mesh 180 days (P = 0.050), and Strattice™ 180 days (P = 0.001)
C  Strattice™ 30 days and Permacol™ 30 days (P = 0.023), and Parietene™ 30 days (P < 0.001)
D  Strattice™ 90 days and Permacol™ 90 days (P = 0.011), and Parietene™ 90 days (P < 0.001)
E  Strattice™ 180 days and Omyra® Mesh 180 days (P = 0.037), Parietene™ 180 days (P = 0.019), and Perma-
col™ 180 days (P = 0.001)
F  Strattice™ 180 days and Permacol™ 180 days (P = 0.027), Omyra® Mesh 180 days (P = 0.011), Parietene™ 
180 days (P < 0.001)
Shrinkage of the mesh
All meshes shrunk after implantation, however the amount of shrinkage varied strongly: 0 
to 18 percent on different time points in different meshes (Figure 3, and Table 2). Figure 3 
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shows the shrinkage of each mesh after 30, 90, and 180 days. Median shrinkage is expressed 
in percentage. Table 2 shows the results of macroscopic mesh-specific parameters after 
sacrifice. After 180 days, shrinkage was most evident in Strattice™ (18 (IQR 15–22) percent), 
followed by Omyra® Mesh (13 (8–30) percent), XCM Biologic® (10 (5–16) percent), and Pa-
rietene™ (9 (5–13) percent). Shrinkage was least prominent in Permacol™ (0 (0–4) percent 
at 180 days). After 180 days, there was significantly less shrinkage in Permacol™ than in 
Strattice™ (P = 0.001) and Omyra® Mesh (P = 0.050).
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Figure 3. Median shrinkage of each mesh at 30, 90 and 180 days
Adhesions
One-hundred and eighty days after implantation, the percentage adhesions on the mesh 
surface was highest in Parietene™ (85 (IQR 70–90) percent), followed by Omyra® Mesh 
(75 (60–75) percent), Permacol™ (68 (63–73) percent), XCM Biologic® (35 (28–35) per-
cent), and lowest in Strattice™ (5 (0–5) percent) (Figure 4). Figure 4 shows the adhesions 
on each mesh after 30, 90, and 180 days. The median value of adhesions is expressed 
in percentage. Strattice™ had significantly fewer adhesions on the surface of the mesh 
than Parietene™ (P < 0.001), Omyra® Mesh (P = 0.011) and Permacol™ (P = 0.027) after 
180 days.
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The tenacity of adhesions, expressed in the Zühlke score, was median 3 in Parietene™, 
Strattice™, XCM Biologic®, and Omyra® Mesh, and median 4 in Permacol™ at all time 
points. After 30 days, Permacol™ had significantly stronger adhesions than Strattice™ 
(P = 0.03). However, this difference was not significant anymore after 180 days (Table 2). 
Table 2 shows the results of macroscopic mesh-specific parameters after sacrifice.
Abscesses
There were no abscesses found on either of the meshes or in the intra-abdominal cavity 
at all time points.
Histological evaluation
In one of the rats that had Permacol™ implanted, there was no mesh left 180 days after 
implantation. In all other samples, meshes were still present after sacrifice and histologic 
evaluation was performed. H&E staining of the samples revealed no significant difference 
in the total count of inflammatory cells between all meshes. There were however sig-
nificant differences in the number of eosinophils, macrophages, mononuclear cells, and 
extracellular matrix deposition between the different mesh groups (Supplementary data, 
Table S6 and Table S7). Table S6 shows the results of histologic evaluation after sacrifice. 
The results are presented as median (interquartile ranges). Table S7 shows the results of 
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Figure 4. Median percentage of adhesions on each mesh at 30, 90 and 180 days
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mesh-specific parameters after sacrifice. The results are presented as median (interquar-
tile ranges). All histological findings will be discussed individually. Examples of the histo-
logical slides can be found in the Supplementary data, Figure S1 to S10. The hematoxylin 
and eosin slides show samples of 180 days after implantation (10 × magnification). The 
sirius red slides show samples of 180 days after implantation (5 × magnification).
Parietene™
Parietene™ mesh had a significantly higher number of eosinophils, neutrophils, and 
macrophages on various time points when compared with Permacol™, Strattice™, and 
XCM Biologic® (Supplementary data, Table S6). Table S6 shows the results of histologic 
evaluation after sacrifice. The results are presented as median (interquartile ranges). Af-
ter 30 days of follow-up, there was a significantly lower number of mononuclear cells in 
the Parietene™ samples compared with XCM Biologic® (P = 0.019). Collagen deposition 
was higher than in the other meshes, however, there was no significant difference when 
compared with other meshes.
The mesh-specific histological parameters revealed statistically higher scaffold degra-
dation in the non-cross-linked biological meshes XCM Biologic® (P = 0.049) and Strat-
tice™ (P = 0.018) when compared with Parietene™ 30 days after implantation. Fibrous 
encapsulation was significantly lower in Parietene™ than in XCM Biologic® after 90 
days (P = 0.024). Cellular infiltration, and neovascularization were significantly lower in 
Parietene™ than in Strattice™ 90 and 180 days after implantation. Extracellular matrix 
deposition was low to moderate present in all samples and showed no significant differ-
ences with other meshes.
Permacol™
Permacol™ contained only very few eosinophils and neutrophils, significantly less than in 
Parietene™ (at all time points). The number of macrophages and mononuclear cells was 
low to moderate, but there were no significant differences with other meshes. Collagen 
deposition was moderate, but significantly lower than in Omyra® Mesh after 180 days.
The mesh-specific histological parameters revealed that fibrous encapsulation was very 
low and showed no significant differences with other meshes. Scaffold degradation, 
neovascularization, and extracellular matrix deposition were significantly lower in Per-
macol™ than in Strattice™ after 90 days. Cellular infiltration was significantly lower than 
in Strattice™ after both 90 and 180 days.
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Strattice™
Strattice™ mesh contained only very few eosinophils and neutrophils, significantly less 
than in Parietene™ (at all time points). After 180 days, only few macrophages were found 
in Strattice™, significantly less than in Parietene™ (P  =  0.004). The number of mono-
nuclear cells and the amount of collagen deposition was quite high, but diminished over 
time. After 180 days, the amount of collagen deposition was significantly lower than in 
Omyra® Mesh (P = 0.003).
Scaffold degradation was significantly higher in Strattice™ at all time points. Fibrous en-
capsulation was low and showed no significant differences with other meshes. Cellular 
infiltration and neovascularization were significantly higher in Strattice™ after 90 and 
180 days, when compared with Parietene™, Omyra® Mesh, and Permacol™. Extracellular 
matrix deposition was significantly higher than in Permacol™ after 180 days (P = 0.020).
XCM Biologic®
XCM Biologic® contained only very few eosinophils and neutrophils, significantly less 
than in Parietene™ after 30 days (P  =  0.001). After 90 and 180 days, the number of 
macrophages was significantly lower in XCM Biologic® than in Parietene™ (P  =  0.003, 
and P = 0.010 respectively). After 30 days of follow-up, there was a significantly higher 
number of mononuclear cells in the XCM Biologic® samples compared with Parietene™ 
(P = 0.019). After 90 and 180 days, collagen deposition was significantly lower in XCM 
Biologic®.
After 30 days, scaffold degradation was significantly higher in XCM Biologic® than in 
Omyra® Mesh (P = 0.049). After 90 days, fibrous encapsulation was significantly higher 
in XCM Biologic® than in Parietene™ and Omyra® Mesh (P = 0.024, and P = 0.024 respec-
tively). Cellular infiltration, neovascularization, and extracellular matrix deposition were 
moderate and did not show significant differences when compared with other meshes.
Omyra® Mesh
Omyra® Mesh contained only few eosinophils and neutrophils, but no significant dif-
ferences were found with other meshes. After 90 days, significantly more macrophages 
were found in the Omyra® Mesh samples than in the XCM Biologic® samples (P = 0.003). 
Mononuclear cells were present in moderate amounts, there were no significant differ-
ences with other meshes. After 90 and 180 days, there was a significantly higher amount 
of collagen deposition in Omyra® Mesh than in XCM Biologic® (P = 0.007, and P = 0.014 
respectively).
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Scaffold degradation was significantly higher in most other meshes at all time points 
after implantation, when compared with Omyra® Mesh. After 90 days, also fibrous en-
capsulation was significantly lower in Omyra® Mesh than in XCM Biologic® (P = 0.024). 
After 90 and 180 days, both cellular infiltration and neovascularization were significantly 
lower in Omyra® Mesh when compared with XCM Biologic®. Extracellular matrix deposi-
tion was moderate at all time points and no significant differences were found compared 
with other meshes.
DISCUSSION
This experimental study in a physiologic, non-contaminated rat model revealed that the 
use of biological meshes in an intra-abdominal position is feasible. Based on incorpora-
tion, adhesions on the surface of the mesh, adhesion strength, mesh shrinkage, and 
the histologic parameters scaffold degradation, cellular infiltration, neovascularization, 
and extracellular matrix deposition, Strattice™ performed best in this experimental rat 
model with intraperitoneal mesh placement.
Ever since the introduction of mesh-assisted abdominal wall hernia repair, there has 
been a search for the “ideal mesh” [23, 24]. The ideal mesh must be tailored to each 
patient’s needs in the current clinical situation [25]. In case of abdominal wall hernia 
repair in the intraperitoneal plane, one needs a high incorporation of the mesh, little 
to no shrinkage of the mesh, few to no adhesions on the mesh, and if adhesions are 
formed, preferably adhesions of a low tenacity [23-25]. None of the examined meshes in 
this study showed all the requested characteristics within one product.
In this study, the incorporation of the mesh was best in Permacol™ (62 ± 11 percent) and 
worst in Strattice™ (23 ± 13 percent) after 180 days. A previous study from this research 
group with the same mesh materials in a contaminated environment showed similar re-
sults for mesh incorporation in Permacol™ and Strattice™ [16]. XCM Biologic®, however, 
had a much higher incorporation of the mesh in a contaminated environment than in 
a physiologic, non-contaminated environment (88 (IQR: 72–100) percent versus 43 ± 
12 SD percent after 180 days). The other meshes showed a comparable incorporation 
after 180 days in both the contaminated environment (median (IQR)) and the physi-
ologic, non-contaminated environment (mean ± SD) (Parietene™ 57 (32–87) percent 
versus 56 ± 9 percent, Permacol™ 62 (58–67) percent versus 62 ± 11 percent, Strattice™ 
21 (10–30) percent versus 23 ± 13 percent, and Omyra® Mesh 54 (40–66) percent versus 
58 ± 20 percent) [16]. When reviewing the histological parameters of XCM Biologic® in a 
contaminated environment versus a non-contaminated environment, all the following 
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parameters scored much higher values in the contaminated environment: the total 
number of inflammatory cells, macrophages and foreign body giant cells, mononuclear 
cells, and the amount of collagen deposition. It is possible that a more fulminant in-
flammatory response led to a better incorporation of XCM Biologic® in a contaminated 
environment. All other meshes didn’t follow this pattern and didn’t show an increase in 
total number of inflammatory cells, macrophages and foreign body giant cells, mono-
nuclear cells, and the amount of collagen deposition. As far as currently known, there is 
no literature on the head-to-head comparison of mesh incorporation between meshes 
in a contaminated environment versus a non-contaminated situation.
There was a large variety in shrinkage of the mesh in this study: 0 to 18 percent of 
shrinkage on various time points. After 180 days, Permacol™ was shrunken significantly 
less than Strattice™ and Omyra® Mesh (0 percent versus 18 percent and 13 percent 
respectively). In a previous experimental study of Mulier and colleagues, Strattice™ 
and Permacol™ were compared alongside. In that study, the surface area of Permacol™ 
remained stable, but Strattice™ mesh expanded in size 12 months after implantation 
[26]. This finding might be explained by the growth of the animals; however, it was only 
found in Strattice™, not in Permacol™. In this current study, no expansion of Strattice™ 
was found, however, this study only had a maximum of 6 months follow-up. Parietene™ 
and XCM Biologic® showed a moderate amount of shrinkage (9 percent and 10 percent 
after 180 days) in this study. This in contrary to a previous study, in which a very high 
percentage of shrinkage was found in XCM Biologic® (21 (4–36) percent at 30 days, 
43 (38–66) percent at 90 days, and 36 (34–51) percent at 180 days) [16]. It is unclear 
why XCM Biologic® shrunk excessively in the presence of infection and shrunk less in a 
physiologic, non-contaminated environment. This finding could again be explained by a 
more fulminant foreign body response in XCM Biologic® in a contaminated environment 
versus a non-contaminated environment. In the contaminated environment, a higher 
total number of inflammatory cells, macrophages, foreign body giant cells, mononuclear 
cells, and a higher amount of collagen deposition was found. Other meshes that were 
examined in both a contaminated and a physiologic, non-contaminated environment 
did not show the same pattern of shrinkage neither did they show the same pattern of 
foreign body response.
All meshes that were investigated in this study formed strong adhesions. The adhesions 
formed by Permacol™ were significantly stronger compared to Strattice™ after 30 days. 
The amount of adhesions varied significantly amongst all groups and varied between 
5 percent and 88 percent of the surface of the mesh. Strattice™ had significantly the 
lowest amount of adhesions and Parietene™ had significantly the highest amount of 
adhesions. The amount of adhesions per mesh are comparable to results from previous 
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studies from this group [14, 27, 28]. No comparable studies of other research groups 
were found.
To summarize the findings of this study: when comparing all meshes head-to-head, 
Permacol™ and Strattice™ showed most often desired characteristics for intraperito-
neal mesh placement, but also some characteristics that are less eligible for use in the 
intra-abdominal cavity. Permacol™ had a better mesh incorporation than Strattice™, 
less shrinkage than Strattice™, but a much higher adhesion percentage compared with 
Strattice™. After 30 days, significantly higher adhesion tenacity was observed in Perma-
col™ compared with Strattice™. Strattice™ however, had less mesh incorporation than 
Permacol™, higher shrinkage than Permacol™, but a much lower adhesion percentage.
Since adhesions can lead to serious complaints and complications in patients, the 
surgeon’s aim should be to place a mesh that leads to the least possible amount of 
adhesions, when placed intraperitoneally. This mesh could be suitable for laparoscopic 
mesh placement in an intraperitoneal onlay mesh (IPOM) technique, or for patient 
with a giant abdominal wall hernia, in which closure of the fascia is not always possible 
and in which there could be an eminent risk for direct contact between the mesh and 
the viscera. Further studies are surgically relevant, because this study only assessed 
feasibility and in vivo characteristics like incorporation, shrinkage, adhesion formation, 
and histology. In this study, no analyses were performed regarding the biomechanical 
properties of the meshes. Properties like tensile strength, ball burst strength, and tear 
resistance, resemble clinical parameters that are important for the patients’ abdominal 
wall hernia repair [29]. Future investigations could target the assessment of biomechani-
cal characteristics of the meshes, but moreover postoperative assessment of patients 
that have undergone abdominal wall hernia repair with a biological mesh. This type of 
mesh seems feasible for different indications in patients, but a careful selection should 
be done preoperatively, to select the right indication for the right mesh.
The rat model in this study is suitable to assess the behavior of synthetic and biologi-
cal meshes experimentally in a physiologic, non-contaminated environment. There are 
however some limitations to this study. Firstly, only the surface of the mesh could be 
adjusted, proportionally the mesh implants were much thicker in the rats than that they 
would be in humans. This may lead to a decreased incorporation of the mesh in the ab-
dominal wall. Secondly, in this model all meshes were placed intraperitoneally, whereas 
in the clinical situation one would be cautious to implant Parietene™ into the abdominal 
cavity without an anti-adhesive layer. Previous studies showed a more pronounced in-
flammatory response and adhesion formation after intraperitoneal placement of these 
meshes compared with extraperitoneal placement [27, 28, 30]. However, closure of the 
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peritoneum is not always possible in patients with large hernias, and contact between 
viscera and mesh might still occur. It is therefore important to assess in vivo mesh 
behavior of synthetic and cross-linked meshes in an intra-abdominal environment. The 
translation of experimental results to the clinical situation should however be done with 
caution.
CONCLUSION
Based on incorporation, adhesion surface, adhesion strength, mesh shrinkage, and the 
histologic parameters scaffold degradation, cellular infiltration, neovascularization, and 
extracellular matrix deposition, Strattice™ performed best in this experiment in a physi-
ologic, non-contaminated rat model with intraperitoneal mesh placement.
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SUPPLEMENTARY DATA
Table S1. Zühlke Scoring System for Adhesions [18]
Score Definition
0 No adhesions
1 Minimal, filmy adhesions requiring little blunt dissection
2 Moderate adhesions requiring blunt and partly sharp dissection; beginning of vascularization
3 Strong adhesions; lysis possible by sharp dissection only; clear vascularization
4 Very strong adhesions; lysis possible by sharp dissection only; organs attached (damage to organs 
difficult to prevent)
Table S2. Abscess Scoring System [19]
Score Definition
0 No abscess present at the site
0.5 One small abscess present at the site
1 Several small abscesses present at the site
2 Medium abscess present at the site
3 Large or several medium abscesses present at the site
4 One very large or several large abscesses present at the site
Table S3. Histologic scoring system for inflammatory cell reaction [20, 21]
Score
0 1 2 3
Inflammatory cell reaction (no. of cells per HPF) 0–50 51–100 101–150 > 150
Eosinophils–neutrophils (no. of cells per HPF) 0 1–5 6–10 > 10
Macrophages–foreign body giant cells (no. of cells per HPF) 0 1–5 6–10 > 10
Mononuclear cells (no. of cells per HPF) 0–10 11–50 51–100 > 100
Number of cells per high-power field (HPF) was determined at 40 × magnification.
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Table S4. Histologic scoring system for mesh-specific parameters [20]
Score
0 1 2
Scaffold 
degradation
–
Original scaffold intact, 
borders clearly demarcated
±
Scaffold partially degraded, 
layers separated by cells, 
blood vessels, host tissue, etc.
+
Scaffold completely 
degraded, no evidence of 
original scaffold
Fibrous 
encapsulation
+
Extensive encapsulation 
(50–100%) of periphery)
±
Moderate encapsulation 
(>0–50% of periphery)
–
No fibrous encapsulation
Cellular 
infiltration* 
–
No cells in contact with 
scaffold
Periphery
Cells infiltrate scaffold, but 
none reach center
Center
Cells penetrate into center 
of scaffold
Neovasculariza-
tion
–
No blood vessels
present
Periphery
Vessels infiltrate scaffold but 
none reach center of scaffold
Center
Vessels penetrate into 
center of scaffold
ECM deposition
–
No host ECM deposition
Periphery
Host ECM deposited inside 
scaffold, but not at center
Center
Host ECM deposited inside 
scaffold, including center
*Inflammatory and connective tissue cells. ECM = extracellular matrix.
Table S5. Collagen deposition [22]
Score Definition
0 No response
1 Minimal/barely detectable
2 Mild/slightly detectable
3 Moderate/easily detectable
4 Marked/very evident
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Table S6. Results of histologic evaluation after sacrifice
n
Inflammatory 
cells total
Eosinophils–
neutrophils
Macrophages–
FBGC
Mononuclear 
cells
Collagen 
deposition SR
Parietene™
30 days 8 3 (2–3) 3 (3–3) A 3 (3–3) 1 (1–1) E 3 (3–4)
90 days 8 2 (1–2) 1 (1–3) B 3 (3–3) 1 (1–2) 3 (2–3)
180 days 8 1 (1–1) 1 (1–2) C 3 (3–3) D 1 (1–2) 3 (1–3)
Permacol™
30 days 8 1 (1–2) 0 (0–0) 1 (1–3) 1 (1–2) 2 (1–2)
90 days 8 0 (0–1) 0 (0–0) 3 (3–3) 1 (1–1) 2 (1–3)
180 days 8 0 (0–1) 0 (0–0) 2 (1–3) 1 (1–1) 1 (0–1)
Strattice™
30 days 8 2 (1–2) 0 (0–1) 1 (1–2) 3 (2–3) 4 (2–4)
90 days 8 2 (0–3) 0 (0–0) 1 (1–2) 3 (1–3) 3 (2–3)
180 days 8 0 (0–1) 0 (0–0) 1 (1–1) 1 (1–2) 1 (1–2)
XCM Biologic®
30 days 7 3 (2–3) 0 (0–0) 3 (2–3) 3 (2–3) 3 (2–3)
90 days 9 0 (0–1) 0 (0–0) 1 (1–1) F 1 (1–2) 1 (1–2) G
180 days 8 1 (0–2) 0 (0–0) 1 (0–2) 2 (1–3) 1 (1–2)
Omyra® Mesh
30 days 8 2 (2–2) 1 (0–1) 3 (3–3) 2 (1–2) 2 (2–3)
90 days 8 1 (1–2) 0 (0–1) 3 (3–3) 1 (1–2) 4 (4–4)
180 days 8 1 (0–1) 0 (0–1) 3 (3–3) 1 (1–1) 4 (4–4) H
Results are presented as median (interquartile ranges). FBGC = foreign body giant cells.
Significant differences between:
A  Parietene™ 30 days and Permacol™ 30 days (P < 0.001), XCM Biologic® 30 days (P = 0.001), and Strattice™ 
30 days (P = 0.033)
B  Parietene™ 90 days and Strattice™ 90 days (P = 0.004) and Permacol™ 90 days (P = 0.023)
C  Parietene™ 180 days and Strattice™ 180 days (P = 0.010) and Permacol™ 180 days (P = 0.018)
D  Parietene™ 180 days and Strattice™ 180 days (P = 0.004) and XCM Biologic® 180 days (P = 0.010)
E  Parietene™ 30 days and XCM Biologic® 30 days (P = 0.019)
F  XCM Biologic® 90 days and Parietene™ 90 days (P = 0.003) and Omyra® Mesh 90 days (P = 0.003)
G  XCM Biologic® 90 days and Omyra® Mesh 90 days (P = 0.007)
H  Omyra® Mesh 180 days and Permacol™ 180 days (P < 0.001), Strattice™ 180 days (P = 0.003), and XCM 
Biologic® 180 days (P = 0.014)
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Table S7. Results of mesh-specific parameters after sacrifice
n Scaffold 
degradation
Fibrous 
encapsulation
Cellular 
infiltrationX
Neovasculariza-
tion
ECM depositionY
Parietene™
30 days 8 0 (0–0) A 0 (0–1) 1 (1–1) 1 (1–1) 1 (1–1)
90 days 8 0 (0–0) 0 (0–0) 1 (1–1) 1 (1–1) 1 (1–1)
180 days 8 0 (0–0) 0 (0–0) 1 (1–1) 1 (1–1) 1 (1–1)
Permacol™
30 days 8 1 (1–2) 0 (0–1) 1 (1–1) 1 (1–1) 1 (1–2)
90 days 8 0 (0–0) 0 (0–2) 1 (1–1) 1 (1–1) 1 (0–1) B
180 days 8 1 (0–2) 1 (0–2) 1 (1–1) 1 (1–2) 1 (0–2)
Strattice™
30 days 8 1 (1–2) 1 (1–1) 2 (2–2) 2 (2–2) 2 (2–2)
90 days 8 2 (1–2) C 1 (1–1) 2 (2–2) D 2 (2–2) E 2 (2–2)
180 days 8 2 (1–2) F 1 (1–1) 2 (2–2) G 2 (2–2) H 2 (0–2)
XCM Biologic®
30 days 7 2 (1–2) 0 (0–0) 1 (1–1) 1 (1–2) 1 (1–2)
90 days 9 0 (0–1) 1 (1–2) I 2 (1–2) 2 (2–2) 1 (1–2)
180 days 8 1 (0–2) 2 (1–2) 2 (1–2) 2 (1–2) 1 (0–2)
Omyra® Mesh
30 days 8 0 (0–0) J 0 (0–1) 1 (1–1) 1 (1–1) 1 (1–1)
90 days 8 0 (0–0) 0 (0–0) 1 (1–1) 1 (1–1) 1 (1–1)
180 days 8 0 (0–0) 0 (0–1) 1 (1–1) 1 (1–1) 1 (1–1)
Results are presented as median (interquartile ranges).
X Cellular infiltration = inflammatory and connective tissue cells
Y ECM = extracellular matrix
Significant differences between:
A  Parietene™ 30 days and XCM Biologic® 30 days (P = 0.049), and Strattice™ 30 days (P = 0.018)
B  Permacol™ 90 days and Strattice™ 90 days (P = 0.020)
C  Strattice™ 90 days and Parietene™ 90 days (P = 0.003), Permacol™ 90 days (P = 0.017), and Omyra® Mesh 
90 days (P = 0.003)
D  Strattice™ 90 days and Parietene™ 90 days (P = 0.019), Omyra® Mesh 90 days (P = 0.019), and Permacol™ 
90 days (P = 0.019)
E  Strattice™ 90 days and Parietene™ 90 days (P = 0.030), Omyra® Mesh 90 days (P = 0.030), and Permacol™ 
90 days (P = 0.030)
F  Strattice™ 180 days and Parietene™ 180 days (P = 0.008), and Omyra® Mesh 180 days (P = 0.008)
G  Strattice™ 180 days and Omyra® Mesh 180 days (P = 0.002), Parietene™ 180 days (P = 0.002), and Perma-
col™ 180 days (P = 0.004)
H  Strattice™ 180 days and Omyra® Mesh 180 days (P = 0.001), and Parietene™ 180 days (P = 0.004)
I  XCM Biologic® 90 days and Parietene™ 90 days (P = 0.024), and Omyra® Mesh 90 days (P = 0.024)
J  Omyra® Mesh 30 days and XCM Biologic® 30 days (P = 0.049) and Strattice™ 30 days (P = 0.018)
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Figure S1. Hematoxylin and eosin staining of Parietene™ (180 days postoperative; 10 × magnification)
Figure S2. Sirius red staining of Parietene™ (180 days postoperative; 5 × magnification)
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Figure S3. Hematoxylin and eosin staining of Permacol™ (180 days postoperative; 10 × magnification)
Figure S4. Sirius red staining of Permacol™ (180 days postoperative; 5 × magnification)
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Figure S5. Hematoxylin and eosin staining of Strattice™ (180 days postoperative; 10 × magnification)
Figure S6. Sirius red staining of Strattice™ (180 days postoperative; 5 × magnification)
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Figure S7. Hematoxylin and eosin staining of XCM Biologic® (180 days postoperative; 10 × magnification)
Figure S8. Sirius red staining of XCM Biologic® (180 days postoperative; 5 × magnification)
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Figure S9. Hematoxylin and eosin staining of Omyra® Mesh (180 days postoperative; 10 × magnification)
Figure S10. Sirius red staining of Omyra® Mesh (180 days postoperative; 5 × magnification)
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ABSTRACT
Introduction
The use of synthetic mesh to repair a potentially contaminated incisional hernia may 
lead to higher failure rates. A biological mesh might be considered, but little is known 
about long-term results. Both biological and synthetic meshes were investigated in an 
experimental model of peritonitis to assess their characteristics in vivo.
Methods
Male Wistar rats were randomized into five groups and peritonitis was induced. A 
mesh was implanted after 24 hours. Five meshes were investigated: Permacol™ (cross-
linked collagen), Strattice™ (non-cross-linked collagen), XCM Biologic® (non-cross-
linked collagen), Omyra® Mesh (condensed polytetrafluoroethylene) and Parietene™ 
(polypropylene). The rats were killed after either 30, 90 or 180 days. Incorporation and 
shrinkage of the mesh, adhesion coverage, strength of adhesions and histology were 
analyzed.
Results
Of 135 rats randomized, 18 died from peritonitis. Some 180 days after implantation, 
both XCM Biologic® and Permacol™ had significantly better incorporation than Strat-
tice™ (P = 0.003 and P = 0.009 respectively). Strattice™ had significantly fewer adhesions 
than XCM Biologic® (P = 0.001) and Permacol™ (P = 0.020). Thirty days after implantation, 
Permacol™ had significantly stronger adhesions than Strattice™ (P < 0.001). Shrinkage 
was most prominent in XCM Biologic®, but no significant difference was found com-
pared with other meshes. Histological analysis revealed marked differences in foreign 
body response among all meshes.
Conclusion
This experimental study suggested that XCM Biologic® was superior in terms of incor-
poration, macroscopic mesh infection, and histological parameters such as collagen 
deposition and neovascularization. There must be sufficient overlap of mesh during 
placement, as XCM Biologic® showed a high rate of shrinkage.
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Surgical relevance
The use of synthetic mesh to repair a potentially contaminated incisional hernia is 
not supported unequivocally, and may lead to a higher failure rate. A biological mesh 
might be considered as an alternative. There are few long-term studies, as these 
meshes are expensive and rarely used.
This study evaluated the use of biological mesh in a contaminated environment, and 
investigated whether there is an ideal mesh for this environment. A new non-cross-
linked biological mesh (XCM Biologic®) was evaluated in this experiment.
The new non-cross-linked biological mesh XCM Biologic® performed best and may be 
useful in patients with a potentially contaminated incisional hernia.
INTRODUCTION
Incisional hernia is a common postoperative complication, with an incidence ranging 
from 11 to 20 percent [1, 2]. Currently, incisional hernias are most often repaired with 
mesh material [3]. The use of mesh significantly decreases 10-year recurrence rates [4]. 
There are various mesh types available; polypropylene mesh is the most widely used 
[5, 6].
The use of synthetic meshes to repair potentially contaminated or contaminated inci-
sional hernias is not supported unequivocally and may lead to complications (wound 
healing problems, adhesions and fistula formation) and even death [6, 7]. A biological 
mesh might be considered as an alternative [8]. These meshes are made from collagen-
containing tissues of human or animal origin [9]. They are composed of tissue such as 
intestine, heart valves or skin, and are processed to remove cells, cell components and 
hair (if present) as well as other antigens present in the tissue [10, 11]. After decellular-
ization and degradation of these tissues, a three-dimensional structure of collagen and 
some protein remnants remains. Additional chemical cross-linking of the mesh can be 
done to increase its strength and to slow down its degradation [10, 12, 13]. Degradation 
takes place after implantation of the mesh. During this phase, there is incorporation of 
host fibroblasts and collagen replacement occurs. This so-called xenograft remodeling 
begins within a few hours after implantation and continues for several months to years. 
Two experimental studies [14, 15] have assessed the efficacy of biological meshes in the 
short term. There are few long-term studies [16, 17], as these meshes are expensive and 
rarely used [16, 17].
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In this study, both biological and synthetic meshes were investigated in an experimental 
peritonitis model. They were all compared in several aspects: incorporation, shrinkage, 
adhesion formation and abscess formation 30, 90 and 180 days after implantation. The 
aim of this study was to evaluate the feasibility of using a biological mesh in a con-
taminated environment, and to investigate whether there is an ideal mesh. The working 
hypothesis for this study was that biological meshes would be better than synthetic 
mesh in a contaminated field.
METHODS
Some 135 male Wistar rats were obtained from a licensed breeder (Harlan Laboratories, 
Boxmeer, The  Netherlands). They were bred under specific pathogen-free conditions 
and were kept under standard laboratory conditions. This included a temperature of 
20–24°C, a relative humidity of 50–60 percent, and 12-hours light–dark cycles. The rats 
were housed in pairs in individually ventilated cages, and fed freely with standard rat 
chow and water throughout the experiment. On arrival, the animals weighed 250–325 
grams and were acclimatized for at least 7 days before the experiment. The study pro-
tocol was approved by the Ethical Committee on Animal Experimentation of Erasmus 
University (Rotterdam, The Netherlands).
Peritonitis model
The rats were divided randomly into five groups of 27 animals each before the start of 
the experiment. All rats were anesthetized with a mixture of isoflurane and oxygen, and 
received a single preoperative dose of 0.05 mg/kg buprenorphine analgesia subcutane-
ously. Before operation, all animals were weighed, the abdomen was shaved, and the 
skin disinfected with 70 percent ethanol. The abdominal cavity was opened via a 3-cm 
midline incision. To induce peritonitis, the cecum ligation puncture model (CLP) was 
used [18]. The cecum was ligated just distal to the ileocecal valve (maintaining bowel 
continuity) and punctured beyond the ligature with an 18-G needle. The fascia and skin 
were closed separately with a running absorbable suture of polyglycolic acid (5/0 Safil®; 
B. Braun, Melsungen, Germany). All animals received 5 ml sodium chlorine 0.9 percent 
and were placed under a heating lamp to recover from anesthesia.
After 24 hours, all rats were again anesthetized with a mixture of isoflurane and oxygen. 
They received a single dose of buprenorphine (0.05 mg/kg subcutaneously). The skin was 
disinfected with 70 percent ethanol, the abdomen was reopened, and a bacterial culture 
swab taken to confirm fecal peritonitis. The necrotic or ischemic part of the cecum was 
removed. The abdominal cavity was rinsed with 20 ml warmed phosphate buffer and 
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gentamicin was administered (6 mg/kg intramuscularly). A sterile mesh of 2.5 × 3 cm 
was implanted intraperitoneally and fixed transmuscularly with six non-absorbable 
nylon sutures (5/0 Ethilon®; Ethicon, Somerville, New Jersey, USA). The fascia and skin 
were closed separately with a running absorbable suture of polyglycolic acid (5/0 Safil®). 
All animals received 5 ml sodium chlorine 0.9 percent and were placed under a heating 
lamp to recover from anesthesia.
Mesh material
Five different meshes were analyzed in this experiment. Two non-cross-linked collagen 
matrices of porcine dermis (Strattice™, LifeCell Corporation, Branchburg, New Jersey, 
USA; XCM Biologic®, Kensey Nash Corporation, Exton, Pennsylvania, USA, distributed 
by DePuy Synthes, Oberdorf, Switzerland), one cross-linked collagen matrix of porcine 
dermis (Permacol™; Sofradim, Trévoux, France, part of Covidien–Medtronic, New Haven, 
Connecticut, USA), one mesh of condensed polytetrafluoroethylene (Omyra® Mesh; B. 
Braun), and one polypropylene mesh (Parietene™; Sofradim). In a sterile environment, 
all meshes were cut to 2.5 × 3 cm. Each mesh was handled according to the instructions 
for use provided by the manufacturer.
Wellness and survival
All animals were weighed on a daily basis in the first week after surgery and weekly 
thereafter. Maximum weight loss within the first 7 days was expressed as a percentage 
of the weight at the start of the experiment. Wellness and behavior were assessed using 
a 12-point wellness scoring system [19]. Animals were killed if they reached the humane 
endpoint (at least 20 percent weight loss or a wellness score less than 5 points). All 
animals that died underwent autopsy.
Macroscopic assessment of mesh-specific parameters
Animals were killed 30, 90 or 180 days after mesh placement. They were anesthetized 
with a mixture of isoflurane and oxygen, the abdomen was shaved, and the skin disin-
fected with 70 percent ethanol. The abdominal wall was opened via a U-shaped incision 
in the ventral abdominal wall. A photograph was taken of the inner abdominal wall and 
mesh site (Figure 1). Incorporation and shrinkage of the mesh, adhesion coverage and 
strength of adhesions were assessed. All parameters were evaluated by two indepen-
dent investigators. Discrepancies were discussed and resolved. The rat was killed by 
cardiac cut.
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Figure 1. Photograph taken at time of death showing inner abdominal wall and mesh site (cross-linked 
biological mesh)
Incorporation of mesh
First, the remaining mesh was measured using a calliper and the perimeter calculated. 
Second, the incorporation of the mesh was assessed by lifting its edges; if the mesh could 
be lifted from the abdominal wall without adhering tissue, it had not been incorporated. 
The percentage incorporation was calculated as the length of incorporated mesh as a 
percentage of the perimeter of remaining mesh. Full incorporation was represented by 
incorporation of all sides, taking any shrinkage of the mesh into account.
Shrinkage of mesh
Shrinkage of the mesh was assessed by measurement of the surface of the remaining 
mesh using a calliper. The mesh surface at the time of death was expressed as a percent-
age of the standard implant size (7.5 cm²).
Adhesions
Adhesions were evaluated in two ways. First, a qualitative analysis was done to as-
sess strength and tenacity of adhesions using the Zühlke score (Table S1, supporting 
information) [20]. Second, the quantity of adhesions was assessed and expressed as a 
percentage of adhesions on the mesh surface.
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Abscesses
Abscesses were regarded as an expression of an ongoing intra-abdominal infection. 
The presence of abscesses was assessed by visual inspection and examination of the 
abdominal cavity. The size of all abscesses was scored using an abscess scoring system 
(Table S1, supporting information) [21].
Histological evaluation
Full-thickness abdominal wall samples were harvested from each animal. This sample 
measured 1.0 × 0.5 cm, was taken from one of the long sides in between the sutures, 
and contained both abdominal wall and mesh (Figure S1, supporting information). The 
samples were fixed for 24 hours in 4 percent formalin and subsequently embedded in 
paraffin. Two 4-µm sections were cut and stained with either hematoxylin and eosin or 
sirius red, according to standard diagnostic procedure in the pathology department.
All slides were analyzed blind by an experienced pathologist. Hematoxylin and eosin-
stained slides were evaluated by means of a scoring system described by Peeters and 
colleagues [22]. All cells were assessed under the microscope and the number of cells 
per high-power field (40 × magnification) was counted. No additional stains were 
performed. Sirius red-stained slides were assessed using an adapted scoring system 
described by Deeken and Matthews [23]. Histological analysis of the biological meshes 
focused on the periprosthetic area, whereas analysis of Parietene™ and Omyra® Mesh 
focused on both the perifilamentary areas and the pores. Both areas were assessed and 
a grade was given for the overall number of cells per sample. In addition, the extent of 
fibrous encapsulation around each mesh was assessed. The histological scoring systems 
used are described in Tables S3–S5 (supporting information).
Statistical analysis
A power calculation was done before the experiment. The calculation was based on an 
expected difference of 25–30 percent in amount of adhesions between the meshes. The 
expected mortality of the CLP model was 25 percent. Aiming for a power of 80 percent 
and P < 0.050, the number of animals needed was 27 per group. All meshes were in-
cluded in the experiment as equal study groups. None of the study groups served as a 
control group only.
Continuous variables are expressed as median (IQR). As the data did not show a normal 
distribution for incorporation and shrinkage of the mesh, quantity and tenacity of adhe-
sions, abscess formation and histological scores, statistical analyses were done using 
non-parametric Kruskal–Wallis tests for independent samples. If the overall test showed 
significant differences, pairwise tests were carried out to determine which groups 
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caused these. P values were adjusted for multiple testing using Dunn’s post-test. P < 
0.050 was considered statistically significant. All statistical analyses were undertaken in 
SPSS® version 21.0 (IBM, Armonk, New York, USA).
RESULTS
All 135 rats survived the initial operation to induce peritonitis, but five died within 
24 hours after induction of peritonitis and another 13 died in the next 24 hours after 
implantation of the mesh (overall mortality rate 13.3 percent). There were no significant 
differences between the groups. None of the rats reached the humane endpoint. Au-
topsy in all animals showed that the cause of early death was abdominal sepsis second-
ary to fecal peritonitis. In addition, one rat in the XCM Biologic® group died 14 days after 
implantation from bowel obstruction caused either by intestinal adhesions or volvulus 
(adhesion between cecum and mesentery; no adhesions between bowel and mesh). 
The remaining 117 rats survived and could be analyzed at the intended endpoint. The 
distribution of the surviving animals per study group is shown in Table 1.
Table 1. Overview of experimental groups
Parietene™ Permacol™ Strattice™ XCM Biologic® Omyra® Mesh
Mesh material Polypropylene Cross-linked 
collagen of 
porcine dermis
Non-cross-
linked collagen 
of porcine 
dermis
Non-cross-
linked collagen 
of porcine 
dermis
Condensed 
PTFE
Weight (g/m²) 78 n.a. n.a. n.a. 90
Pore size (mm) 1.0–1.6 n.a. n.a. n.a. 2.4
No. of animals 27 27 27 27 27
Postoperative deaths 3 2 2 3* 9
No. analyzed
30 days 8 9 9 10 6
90 days 9 8 9 7 6
180 days 7 8 7 7 6
* One rat died from bowel obstruction on day 14; results for this animal were not used for analysis. n.a. = 
not applicable.
Peritonitis model
The bacterial culture swab on day one confirmed intraperitoneal bacterial contamina-
tion with Gram-positive (Enterococcus, Staphylococcus) and Gram-negative (Escherichia 
coli) microorganisms in all rats. All animals suffered from symptoms of sepsis, including 
apathetic behavior, piloerection, ocular exudates, abnormal posture, shivering, diarrhea 
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and weight loss. Mean weight loss varied from 9.0 to 11.2 percent, and was significantly 
greater in the Omyra® Mesh group than in the XCM Biologic® group (P = 0.005) and the 
Permacol™ group (P = 0.013). There were no differences in wellness score among the five 
groups. The removed part of the cecum was macroscopically ischemic in 89 percent of 
the animals, necrotic in 4 percent, and both ischemic and necrotic in 7 percent of the 
animals.
Incorporation of mesh
The percentage incorporation varied greatly between the mesh groups (Table 2 and 
Figure 2). At 180 days after implantation, it was highest for XCM Biologic® (88 (IQR 72–100) 
percent), followed by Permacol™ (62 (58–67) percent), Parietene™ (57 (32–87) percent), 
Omyra® Mesh (54 (40–66) percent) and lowest for Strattice™ (21 (10–30) percent). Both 
XCM Biologic® and Permacol™ showed significantly better incorporation than Strattice™ 
Table 2. Results for macroscopic mesh-specific parameters
n Incorpora-
tion of mesh 
(%)
Shrinkage 
of mesh 
(%)
Adhesions 
on mesh (%)
Tenacity of 
adhesions
No. of 
animals with 
abscess 
Total 
no. of 
abscesses
Abscess 
score 
(highest)
Parietene™
30 days 8 52 (40–60)  8 (1–25) 63 (50–75) 3 (3–3) 0 0 n.a.
90 days 9 55 (30–71) 19 (8–29) 58 (48–70) 3 (3–4) 1 2 4
180 days 7 57 (32–87) 14 (5–20) 70 (60–80) 3 (3–3) 0 0 n.a.
Permacol™
30 days 9 57 (50–60)* 22 (7–26) 70 (55–85)* 3 (3–4)* 0 0 n.a.
90 days 8 47 (43–54) 23 (19–28) 83 (70–93)† 3 (3–4) 1 1 0.5
180 days 8 62 (58–67)‡ 20 (17–24) 73 (63–83)‡ 3 (3–3) 0 0 n.a.
Strattice™
30 days 9 16 (12–22) 18 (12–25) 0 (0–5) 0 (0–2) 0 0 n.a.
90 days 9 18 (13–27) 15 (13–20) 0 (0–5) 3 (2–3) 0 0 n.a.
180 days 7 21 (10–30) 13 (5–17) 0 (0–0) 0 (0–3) 0 0 n.a.
XCM™ Biologic
30 days 10 38 (34–44) 21 (4–36) 25 (5–70) 3 (3–3) 0 0 n.a.
90 days 7 46 (42–75) 43 (38–66) 95 (50–100)† 3 (3–3) 0 0 n.a.
180 days 7 88 (72–100)‡ 36 (34–51) 100 (70–100)‡ 3 (3–3) 0 0 n.a.
Omyra® Mesh
30 days 6 59 (43–73) 14 (12–16) 38 (20–55) 3 (3–3) 0 0 n.a.
90 days 6 40 (25–62) 15 (9–20) 48 (30–60) 3 (3–3) 0 0 n.a.
180 days 6 54 (40–66) 27 (3–33) 63 (60–70) 3 (3–3) 0 0 n.a.
Values are median (IQR). n.a. = not applicable. *P < 0.050 versus Strattice™ at 30 days, †P < 0.050 versus 
Strattice™ at 90 days, ‡P < 0.050 versus Strattice™ at 180 days (Kruskal–Wallis test with Dunn’s post-test).
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Figure 2. Median percentage of incorporation of each mesh at 30, 90 and 180 days
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Figure 3. Median shrinkage of each mesh at 30, 90 and 180 days
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180 days after implantation (P = 0.003 and P = 0.009). There were no significant differ-
ences in incorporation between the synthetic and biological meshes.
Shrinkage of mesh
All meshes shrank; however, the amount of shrinkage varied widely from 8 to 43 percent 
at different time points for different meshes (Table 2 and Figure 3). Shrinkage was most 
evident in XCM Biologic®: 21 (IQR 4–36) percent at 30 days, 43 (38–66) percent at 90 
days and 36 (34–51) percent at 180 days. Parietene™ showed the least shrinkage at 30 
days after implantation (8 (1–25) percent). Strattice™ and Omyra® Mesh showed the 
least shrinkage 90 days after implantation (15 (13–20) percent and 15 (9–20) percent 
respectively). Strattice™ showed the least shrinkage 180 days after implantation (13 
(5–17) percent). Although there were considerable differences in shrinkage between the 
various groups, no significant difference was found.
Adhesions
The percentage of adhesions was relatively high in all mesh groups, except Strattice™ 
(Table 2). The percentage of adhesions increased over time in the XCM Biologic® and 
Omyra® Mesh groups. The percentage of adhesions 180 days after implantation was 
highest in XCM Biologic® (100 (70–100) percent), followed by Permacol™ (73 (63–83) 
percent), Parietene™ (70 (60–80) percent) and Omyra® Mesh (63 (60–70) percent), and 
lowest in Strattice™ (0 (0–0) percent). Strattice™ had a significantly lower percentage of 
adhesions than Permacol™ at all time points (P = 0.007, P = 0.002 and P = 0.020, respec-
tively). The quantity of adhesions in Strattice™ was also significantly lower than in XCM 
Biologic® 90 and 180 days after implantation (P = 0.009 and P = 0.001 respectively).
The tenacity of adhesions was strong to very strong at all time points in all mesh groups, 
except for Strattice™. In the Strattice™ group, there was variation in median tenacity: no 
adhesions 30 days after implantation, strong adhesions at 90 days, and again no adhe-
sions 180 days after implantation. Permacol™ was the only mesh that had significantly 
stronger adhesions than Strattice™ 30 days after implantation (P < 0.001). All other com-
parisons between the groups were not significant.
Abscesses
Abscess formation was rare; only two animals developed abscesses (Table 2). Both 
animals were killed after 90 days: one in the Parietene™ and the other in the Permacol™ 
group. The animal in the Parietene™ group had a small abscess on the bowel (not in 
proximity to the cecal ligation site) and a large macroscopic abscess alongside the mesh. 
The animal in the Permacol™ group had a very small macroscopic abscess alongside the 
mesh.
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Histological evaluation
Four slides from the XCM Biologic® group did not contain mesh material and could not 
therefore be analyzed. One of these incomplete samples was harvested 30 days after 
implantation, two samples were harvested 90 days after implantation and the fourth 
180 days after implantation.
In general, the hematoxylin and eosin staining revealed no significant differences in the 
total count of inflammatory cells, mononuclear cells and extracellular matrix deposition 
between the different mesh groups (Tables S6 and S7, Figures S2–S11, supporting in-
formation). The histological findings of all meshes are discussed individually as follows.
Parietene™
Parietene™ mesh had a large number of macrophages, foreign body giant cells, eo-
sinophils and neutrophils at all time points. The number of macrophages and foreign 
body giant cells was significantly higher after 180 days in Parietene™ than in Strattice™ 
(P = 0.022). Numbers of eosinophils and neutrophils, on the other hand, were significant-
ly higher in Parietene™ mesh than in the non-cross-linked biological mesh at 30 and 90 
days. Sirius red staining revealed significantly greater collagen deposition in Parietene™ 
compared with Strattice™ 30 and 180 days after implantation.
Permacol™
Slides of the Permacol™ meshes showed a moderate amount of macrophages, but only 
scanty eosinophils and neutrophils. There were no significant differences compared with 
other mesh groups. There was a significantly greater amount of collagen encapsulation 
in the Permacol™ group than in the Strattice™ group at 30 days (P = 0.029) and 180 days 
(P = 0.031) after implantation.
Evaluation of mesh-specific histological parameters revealed moderate to pronounced 
scaffold degradation, pronounced fibrous encapsulation, and peripheral cellular infiltra-
tion and neovascularization. There were no significant differences between Permacol™ 
and other mesh groups.
Strattice™
Compared with Parietene™ mesh, Strattice™ had significantly fewer neutrophils and 
eosinophils 30 and 90 days after implantation, and significantly fewer macrophages 180 
days after implantation. In addition, Strattice™ had significantly less collagen encapsula-
tion than Parietene™ and Permacol™ 30 and 180 days after implantation.
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Assessment of the mesh-specific histological parameters revealed a significantly in-
creased amount of scaffold degradation in Strattice™ than in Parietene™ and Omyra® 
Mesh 90 days after implantation.
XCM Biologic®
XCM Biologic® had large numbers of macrophages and foreign body giant cells present 
30 and 90 days after implantation (more than 10 cells per high-power field). In contrast, 
eosinophils and neutrophils were almost absent, and their numbers were therefore sig-
nificantly lower than in Parietene™ at 90 days (P = 0.029). XCM Biologic® had significantly 
more collagen encapsulation than Strattice™ 30 days after implantation. There were no 
significant differences at other time points.
Analysis of mesh-specific histological parameters revealed an increased amount of scaf-
fold degradation at all time points compared with other meshes, but this difference was 
only significant compared with Parietene™ at 30 days after implantation (P = 0.025).
Omyra® Mesh
Omyra® Mesh had large numbers of macrophages and foreign body giant cells at all time 
points (more than 10 cells per high-power field). Thirty days after implantation, there 
was a large number of eosinophils and neutrophils, but these were absent at 90 and 
180 days. At 90 days after implantation, collagen encapsulation was significantly more 
prominent around the Omyra® Mesh than around Strattice™ (P = 0.002).
Assessment of mesh-specific histological parameters revealed the absence of scaffold 
degradation with an increased amount of fibrous encapsulation at all time points.
DISCUSSION
This experimental study in a peritonitis model revealed that the use of biological mesh 
is feasible in a contaminated environment. Overall, XCM Biologic® appeared superior in 
this model; however, adhesions and shrinkage of the mesh were evident.
Regarding the individual meshes, Strattice™ had inferior incorporation, whereas the 
other meshes incorporated well. This agrees with previous studies [14, 24] using Strat-
tice™ mesh. Even 180 days after implantation, there was little incorporation of this mesh 
into the abdominal wall. In addition, it was found that collagen deposition was less in 
Strattice™ than in the other meshes.
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Overall, there was a large, but non-significant variation in shrinkage, ranging from 8 to 
43 percent at various time points. XCM Biologic® shrank excessively, by 21–43 percent. 
Structural resistance might be influential with regard to mesh shrinkage. Resistance is a 
function of the volume of the material used in the mesh. Large-pore, low-weight meshes 
show less resistance, and thus less shrinkage. No previous studies of XCM Biologic® have 
assessed shrinkage rates in an experimental model. The other meshes studied shrank 
between 8 and 27 percent at various time points. This finding highlights the importance 
of implanting mesh materials with sufficient overlap around a hernia defect.
All meshes, except for Strattice™, formed strong adhesions; those formed by Permacol™ 
were significantly stronger than those on all other meshes. The tenacity of adhesions is 
linked to the percentage adhesion on the surface of the mesh.
Although all meshes were assessed in a peritonitis model, active inflammation with 
abscess formation was found in only two animals at the time of death. Previous studies 
[14, 24] revealed abscesses in 42–62 percent of animals at the time of death [14, 24]. 
Both Deerenberg and colleagues [14] and the present study group studied Strattice™, 
Parietene™ and Omyra® Mesh. In the study of Deerenberg and colleagues [14], these 
three meshes showed little abscess formation. There were significantly larger numbers of 
abscesses surrounding the mesh in C-Qur™ (omega-3-fatty acid-coated polypropylene; 
Atrium, Hudson, New York, USA), and DualMesh® (expanded polytetrafluoroethylene; 
Gore, Flagstaff, Arizona, USA). Mulder and colleagues [24] reported abscesses on more 
than 50 percent of Permacol™ meshes. Many abscesses were also found in Surgisis® 
(non-cross-linked porcine submucosa; Cook Medical, Bloomington, Indiana, USA) and 
CollaMend™ FM (cross-linked porcine dermis; C.R. Bard (Davol), Warwick, Rhode Island, 
USA), meshes that were not investigated here. Aside from the mesh materials, another 
reason for the lack of abscesses could be the fact that the substrain of Wistar rats used in 
the present study is more resistant to infection.
In this study, the synthetic meshes Parietene™ and Omyra® Mesh and the biological 
cross-linked mesh Permacol™ incorporated well and had only moderate shrinkage. 
Although the three meshes are made of different materials, their in vivo response was 
similar. Interestingly, Permacol™ is the only biological mesh in this study that mimicked 
the behavior of the synthetic meshes. Permacol™ is of porcine origin and is additionally 
cross-linked with hexamethylene di-isocyanate [25]. These additional cross-links give 
a more synthetic-like behavior to the biological mesh compared with the non-cross-
linked biological meshes. The foreign body reaction against Permacol™ may therefore 
be comparable to that of the synthetic meshes, but not to that of the non-cross-linked 
biological meshes.
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Two distinct patterns were identified when the histological mesh-specific parameters 
were evaluated. First, the synthetic meshes Parietene™ and Omyra® Mesh, and the 
cross-linked biological mesh Permacol™, showed almost no scaffold degradation, a large 
amount of fibrous encapsulation, and little or no cellular infiltration, neovascularization 
and extracellular matrix deposition. Second, the non-cross-linked meshes Strattice™ 
and XCM Biologic® showed a large amount of scaffold degradation, little to no fibrous 
encapsulation, and considerable cellular infiltration, neovascularization and extracel-
lular matrix deposition. These two patterns could be explained by the respective mesh 
materials. If high biocompatibility is desirable, a non-cross-linked biological mesh is 
optimal. However, slower mesh incorporation and quicker mesh degradation should be 
taken into account.
There are several limitations to this study that do not allow direct translation to a clinical 
setting. There are three differences between the human situation and this experimental 
study. First, there is a difference in the treatment of abdominal sepsis. The rats received 
a single dose of antibiotics and one abdominal cavity rinse, whereas humans receive 
long-term intravenous antibiotics and undergo extensive debridement with or without 
open abdomen treatment. Second, there are differences in the dimension of the mesh. 
The mesh is proportionally much thicker in rats than in humans, in comparison with 
the thickness of the abdominal wall. This could lead to decreased incorporation of the 
mesh in the rat model. Third, all meshes were placed intraperitoneally in this study. This 
includes non-coated or non-composite synthetic meshes, whereas previous studies [14, 
24, 26-28] showed high cellular reactivity and adhesion formation after intraperitoneal 
placement of these meshes compared with extraperitoneal placement [14, 24, 26-28]. 
The same applies to the cross-linked mesh Permacol™, which was placed intraperito-
neally in the rat model, whereas in humans results of placement in the intraperitoneal 
plane have been variable [10, 29, 30]. However, closure of the peritoneum is not always 
possible in patients, and contact between the viscera and mesh could be occurring. 
Therefore, it is important to assess mesh behavior of synthetic and cross-linked meshes 
in an intra-abdominal environment in vivo.
In this experimental study, XCM Biologic® appeared superior, in terms of incorporation, 
macroscopic mesh infection, and histological parameters such as collagen deposition 
and neovascularization. It is important, however, that there is a sufficient overlap of the 
mesh during placement, as XCM Biologic® showed a high rate of shrinkage.
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SUPPORTING INFORMATION
Table S1. Zühlke scoring system for adhesions [20]
Score Definition
0 No adhesions
1 Minimal, filmy adhesions requiring little blunt dissection
2 Moderate adhesions requiring blunt and partly sharp dissection; beginning of vascularization
3 Strong adhesions; lysis possible by sharp dissection only; clear vascularization
4 Very strong adhesions; lysis possible by sharp dissection only; organs attached (damage to 
organs difficult to prevent)
Table S2. Abscess scoring system [21]
Score Definition
0 No abscess present at the site
0.5 One small abscess present at the site
1 Several small abscesses present at the site
2 Medium abscess present at the site
3 Large or several medium abscesses present at the site
4 One very large or several large abscesses present at the site
Table S3. Histological scoring system for inflammatory cell reaction [22]
Score
0 1 2 3
Inflammatory cell reaction (no. of cells per HPF) 0–50 51–100 101–150 > 150
Eosinophils–neutrophils (no. of cells per HPF) 0 1–5 6–10 > 10
Macrophages–foreign body giant cells (no. of cells per HPF) 0 1–5 6–10 > 10
Mononuclear cells (no. of cells per HPF) 0–10 11–50 51–100 > 100
Number of cells per high-power field (HPF) was determined at 40 × magnification.
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Table S4. Histological scoring system for mesh-specific parameters [22]
Score
0 1 2
Scaffold degradation
–
Original scaffold 
intact, borders clearly 
demarcated
±
Scaffold partially 
degraded, layers 
separated by cells, blood 
vessels, host tissue, etc.
+
Scaffold completely 
degraded, no evidence of 
original scaffold
Fibrous encapsulation
+
Extensive encapsulation 
(50–100%) of periphery)
±
Moderate encapsulation 
(>0–50% of periphery)
–
No fibrous encapsulation
Cellular infiltration* 
–
No cells in contact with 
scaffold
Periphery
Cells infiltrate scaffold, but 
none reach center
Center
Cells penetrate into center 
of scaffold
Neovascularization
–
No blood vessels
present
Periphery
Vessels infiltrate scaffold 
but none reach center of 
scaffold
Center
Vessels penetrate into 
center of scaffold
ECM deposition
–
No host ECM deposition
Periphery
Host ECM deposited inside 
scaffold, but not at center
Center
Host ECM deposited inside 
scaffold, including center
*Inflammatory and connective tissue cells. ECM = extracellular matrix.
Table S5. Collagen deposition [23]
Score Definition
0 No response
1 Minimal/barely detectable
2 Mild/slightly detectable
3 Moderate/easily detectable
4 Marked/very evident
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Table S6. Results of histological evaluation
n Inflammatory 
cells total
Eosinophils–
neutrophils
Macrophages–
FBGC
Mononuclear 
cells
Collagen 
deposition*
Parietene™
30 days 8 2 (2–2) 3 (3–3)† 3 (3–3) 2 (1–2) 3 (3–3)†
90 days 9 2 (1–2) 3 (2–3)‡ 3 (3–3) 2 (1–2) 3 (2–3)
180 days 7 1 (1–2) 1 (1–3) 3 (3–3)§ 1 (1–1) 3 (2–4)§
Permacol™
30 days 9 1 (1–2) 0 (0–3) 1 (1–2) 2 (1–2) 3 (2–3)†
90 days 8 1 (1–2) 0 (0–2) 2 (2–3) 2 (2–3) 2 (1–3)
180 days 8 1 (1–1) 0 (0–0) 2 (1–3) 1 (1–2) 3 (2–4)§
Strattice™
30 days 9 1 (0–2) 0 (0–0) 1 (1–3) 1 (1–3) 0 (0–0)
90 days 9 2 (1–3) 0 (0–0) 3 (2–3) 2 (1–3) 0 (0–0)
180 days 7 0 (0–1) 0 (0–0) 1 (0–1) 1 (0–1) 0 (0–0)
XCM Biologic®
30 days 9 2 (2–3) 0 (0–1) 3 (2–3) 3 (2–3) 3 (2–3)†
90 days 5 3 (2–3) 0 (0–0)¶ 3 (1–3) 3 (3–3) 2 (1–2)
180 days 6 1 (1–2) 0 (0–0) 1 (1–1) 3 (1–3) 2 (1–2)
Omyra Mesh®
30 days 6 2 (2–3) 3 (1–3) 3 (3–3) 3 (2–3) 3 (2–3)
90 days 6 2 (1–2) 0 (0–1) 3 (3–3) 2 (1–2) 3 (3–4)‡
180 days 6 1 (1–1) 0 (0–1) 3 (3–3) 1 (1–2) 3 (2–3)
Values are median (IQR). *Based on sirius red staining. FBGC = foreign body giant cells. †P < 0.050 versus 
Strattice™ at 30 days, ‡P < 0.050 versus Strattice™ at 90 days, §P < 0.050 versus Strattice™ at 180 days, 
¶P < 0.050 versus Parietene™ at 90 days (Kruskal–Wallis test with Dunn’s post-test).
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Table S7. Results for mesh-specific parameters
n Scaffold 
degradation
Fibrous 
encapsulation
Cellular 
infiltration*
Neovasculariza-
tion
ECM deposition
Parietene™
30 days 8 0 (0–0) 0 (0–0) 1 (1–1) 1 (1–1) 1 (1–1)
90 days 9 0 (0–0) 1 (0–1) 1 (1–1) 1 (1–1) 1 (1–1)
180 days 7 0 (0–0) 1 (0–1) 1 (1–1) 1 (1–1) 1 (1–1)
Permacol™
30 days 9 1 (1–2) 0 (0–1) 1 (1–1) 1 (1–1) 1 (1–1)
90 days 8 2 (1–2) 0 (0–1) 1 (1–1) 1 (1–1) 1 (1–1)
180 days 8 2 (1–2) 0 (0–1) 1 (1–2) 1 (1–2) 2 (1–2)
Strattice™
30 days 9 1 (1–2) 2 (1–2)† 1 (1–1) 1 (1–2) 0 (0–2)
90 days 9 2 (2–2)‡ 2 (0–2) 2 (2–2)‡ 2 (2–2)‡ 2 (2–2)
180 days 7 2 (0–2) 2 (2–2) 2 (2–2) 2 (2–2)§ 2 (0–2)
XCM Biologic®
30 days 9 2 (1–2)† 1 (0–1) 1 (1–2) 1 (1–2) 1 (1–2)
90 days 5 2 (1–2) 1 (1–1) 2 (2–2) 2 (2–2)‡ 2 (2–2)
180 days 6 1 (1–2) 2 (1–2) 2 (2–2)§ 2 (2–2)§ 1 (0–1)
Omyra Mesh®
30 days 6 0 (0–0) 0 (0–0)¶ 1 (1–1) 1 (1–1) 1 (1–1)
90 days 6 0 (0–0)# 0 (0–0) 1 (1–1) 1 (1–1)# 1 (1–1)
180 days 6 0 (0–0) 0 (0–0) 1 (1–1)** 1 (1–1) 1 (1–1)
Values are median (IQR). *Inflammatory and connective tissue cells. ECM = extracellular matrix. †P < 0.050 
versus Parietene™ at 30 days, ‡P < 0.050 versus Parietene™ at 90 days, §P < 0.050 versus Parietene™ at 180 
days, ¶P < 0.050 versus Strattice™ at 30 days, #P < 0.050 versus Strattice™ at 90 days, **P < 0.050 versus 
XCM™ Biologic at 180 days (Kruskal–Wallis test with Dunn’s post-test).
Figure S1. Schematic representation of tissue sampling for histopathology
Drawing depicted in an anteroposterior projection. Full-thickness abdominal wall samples measuring 1.0 × 
0.5 cm were taken from one of the long sides in between the sutures, and contained both abdominal wall 
and mesh.
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Figure S2. Hematoxylin and eosin staining of cross-linked biological mesh, without abscess (original mag-
nification × 10)
Figure S3. Hematoxylin and eosin staining of cross-linked biological mesh, without abscess (original mag-
nification × 20)
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Figure S4. Sirius red staining of cross-linked biological mesh, without abscess (original magnification × 5)
Figure S5. Hematoxylin and eosin staining of cross-linked biological mesh, with abscess (original magni-
fication × 2.5)
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Figure S6. Hematoxylin and eosin staining of cross-linked biological mesh, with abscess (original magni-
fication × 10)
Figure S7. Hematoxylin and eosin staining of cross-linked biological mesh, with abscess (original magni-
fication × 20)
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Figure S8. Sirius red staining of cross-linked biological mesh, with abscess (original magnification × 5)
Figure S9. Hematoxylin and eosin staining of non-cross-linked biological mesh (XCM Biologic®), without 
abscess (original magnification × 10)
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Figure S10. Hematoxylin and eosin staining of non-cross-linked biological mesh (XCM Biologic®), without 
abscess (original magnification × 20)
Figure S11. Sirius red staining of non-cross-linked biological mesh (XCM Biologic®), without abscess (origi-
nal magnification × 5)
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ABSTRACT
Introduction
Both mesh and suture repair are used for the treatment of umbilical hernias, but for 
smaller umbilical hernias (diameter 1–4 cm) there is little evidence whether mesh repair 
would be beneficial. In this study we aimed to investigate whether use of a mesh was 
better in reducing recurrence compared with suture repair for smaller umbilical hernias.
Methods
We did a randomized, double-blind, controlled multicenter trial in 12 hospitals (nine in 
the Netherlands, two in Germany, and one in Italy). Eligible participants were adults aged 
at least 18 years with a primary umbilical hernia of diameter 1–4 cm, and were randomly 
assigned (1:1) intraoperatively to either suture repair or mesh repair. In the first 3 years of 
the inclusion period, blocked randomization (of non-specified size) was achieved by an 
envelope randomization system; after this time computer-generated randomization was 
introduced. Patients, investigators, and analysts were masked to the allocated treatment, 
and participants were stratified by hernia size (1–2 cm and >2–4 cm). At study initiation, 
all surgeons were invited to training sessions to ensure they used the same standardized 
techniques for suture repair or mesh repair. Patients underwent physical examinations 
at 2 weeks, and 3, 12, and 24–30 months after the operation. The primary outcome was 
the rate of recurrences of the umbilical hernia after 24 months assessed in the modified 
intention-to-treat population by physical examination and, in case of any doubt, abdomi-
nal ultrasound. This trial is registered with ClinicalTrials.gov, number NCT00789230.
Results
Between June 21, 2006, and April 16, 2014, we randomly assigned 300 patients, 150 
to mesh repair and 150 to suture repair. The median follow-up was 25.1 months (IQR 
15.5–33.4). After a maximum follow-up of 30 months, there were fewer recurrences in 
the mesh group than in the suture group (six [4 percent] in 146 patients versus 17 [12 
percent] in 138 patients; 2-year actuarial estimates of recurrence 3.6 percent [95 per-
cent CI 1.4–9.4] versus 11.4 percent (6.8–18.9); P = 0.01, hazard ratio 0.31, 95 percent CI 
0.12–0.80, corresponding to a number needed to treat of 12.8). The most common post-
operative complications were seroma (one [<1 percent] in the suture group versus five 
[3 percent] in the mesh group), hematoma (two [1 percent] versus three [2 percent]), and 
wound infection (one [<1 percent] versus three [2 percent]). There were no anesthetic 
complications or postoperative deaths.
Conclusions
This is the first study showing high level evidence for mesh repair in patients with small 
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hernias of diameter 1–4 cm. Hence we suggest mesh repair should be used for opera-
tions on all patients with an umbilical hernia of this size.
Funding
Department of Surgery, Erasmus University Medical Center, Rotterdam, Netherlands.
RESEARCH IN CONTEXT
Evidence before this study
Umbilical hernia is a common diagnosis in patients. Approximately 10 percent of all ab-
dominal wall hernias are defined as umbilical hernia. In adults, the global prevalence of 
umbilical hernia is 2 percent. Until now, publications about umbilical hernia included only 
retrospective cohort studies, prospective observational studies, hernia register analyses, 
and randomized controlled studies with smaller sample sizes than our study. We searched 
PubMed, Embase, MEDLINE, Cochrane on Aug 10, 2017, without date or language restric-
tions, for studies including the terms “hernia, ventral”[mesh] OR “ventral hernia”) AND 
(umbilical AND (surgery OR herniotomy OR herniorrhaphy OR hernioplasty) AND (recur-
rence OR “chronic pain” OR “surgical site infections” OR “wound infections” OR “seromas” OR 
“quality of life” OR “cosmesis”. Findings from a previous randomized controlled trial with 
200 patients by Arroyo and co-workers led them to conclude that the hernia recurrence 
rate was significantly higher after suture repair (11 percent) compared with mesh repair 
(1 percent). However, their study had no clear cutoff value for hernia diameter (all hernia 
diameters were included). Mesh repair was associated with low recurrence rates of up to 
1 percent of large umbilical hernia in two randomized controlled trials of mesh versus 
suture repair and in a long-term follow-up, retrospective study. However, there is no level-1 
evidence advocating the use of mesh in smaller umbilical hernias of 1–4 cm diameter.
Added value of this study
In our double-blind, randomized, controlled multicenter trial, we randomly assigned 300 
patients with umbilical hernias of 1–4 cm to receive either mesh or suture repair. After a 
median follow-up of 25 months, there were significantly fewer recurrences in the mesh 
group than in the suture group. This was the first randomized trial that provided evidence 
advocating mesh repair in all smaller umbilical hernias with a defect size between 1 and 
4 cm.
Implications of all the available evidence
Worldwide, there are still many differences in treatment strategies for umbilical hernia re-
pair between hospitals and even within hospitals between surgeons. The results of this trial 
combined with previous studies should lead to more uniformity in treatment strategies 
and enable the development of guidelines for treatment of umbilical hernia. The results 
support the use of mesh in all patients with an umbilical hernia with a diameter of 1–4 cm.
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INTRODUCTION
Umbilical hernia is defined as a midline abdominal wall defect from 3 cm above to 3 cm 
below the umbilicus [1], and is a common diagnosis in adults, with a global prevalence of 
2 percent. Surgical repair is recommended for most symptomatic or clinically apparent 
umbilical hernias, which can be achieved by suture repair or use of mesh. Disappoint-
ingly, high recurrence rates of up to 54.5 percent have been reported with suture repair 
[2]. The use of mesh was proven to be beneficial in incisional and inguinal hernia repair, 
and mesh repair has therefore become the gold standard repair for these types of hernia 
[3-6], associated with low recurrence rates of up to 1 percent of large umbilical hernias in 
two randomized controlled trials of mesh versus suture repair and in a long-term follow-
up, retrospective study [7-9]. However, there is no solid evidence to advocate the use 
of mesh instead of suture repair in small umbilical hernias (diameter ≤4 cm), and most 
surgeons would not use mesh repair for many of these small hernias [10]. Both mesh 
and suture repair are currently used for the treatment of umbilical hernias. We therefore 
did a study to investigate whether mesh was superior in reducing recurrence of small 
umbilical hernias (diameter 1–4 cm) compared with suture repair.
METHODS
Study design and participants
We did a randomized, double-blind, controlled, multicenter trial with patients recruited 
from nine hospitals in the Netherlands, two in Germany, and one in Italy. This trial was 
approved by the Ethics Board of the Erasmus University Medical Center (Rotterdam, 
the Netherlands) and all participating hospitals.
Patients were eligible for inclusion if they were aged at least 18 years and had a primary 
umbilical hernia with a diameter of 1–4 cm. Umbilical hernia was in this study defined 
according to the European Hernia Society definition (i.e., a primary midline abdominal 
wall defect from 3 cm above to 3 cm below the umbilicus) [1]. Exclusion criteria were 
recurrent umbilical hernia, incarcerated umbilical hernia, incisional hernia or epigastric 
hernia, an American Society of Anesthesiologists (ASA) classification higher than ASA III, 
or one or more of the following diseases in their medical history: midline laparotomy, 
laparoscopy with an umbilical entrance port, ascites, peritoneal dialysis, or liver cirrhosis. 
Patients were recruited from the outpatient clinic of the department of surgery. Patients 
who visited the outpatient clinic with an umbilical hernia received an information pack-
age about our trial. If patients decided to undergo an operation, they were recruited for 
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the trial as well. All patients who consented to participate were included in this trial, and 
all patients provided written informed consent.
Randomization and masking
Before the start of the study, a consensus was reached by all participating centers on the 
methods for umbilical hernia repair. The operation started with a para-umbilical incision 
and was followed by dissection of the hernia sac. Resection of the hernia sac was avoided. 
After reduction of the hernia sac, the hernia diameter was measured with a sterile ruler 
(size expressed in mm). Patients were randomly assigned (1:1) intraoperatively using 
blocked randomization (block size was not specified in the protocol) to either suture 
repair or mesh repair. Randomization took place after intraoperative measurement. In 
the first 3 years of the inclusion period, randomization and trial allocation were achieved 
by an envelope randomization system. This blinded envelope randomization system 
was designed by the biostatistician who also did the power calculation for the target 
sample size of the trial (WCJH). After the first 3 years, computer-generated randomiza-
tion was introduced. The randomization process was computerized to link the data of 
the randomization process directly to the database to avoid duplication of work. Patient 
allocation was organized per hospital and patients were stratified by hernia diameter 
(1–2 cm and >2–4 cm). Patients, investigators, and data analysts were unaware of the 
study-group allocation during the entire study. Patients were operated under general 
anesthesia. Randomization was done perioperatively and patients were only informed 
about their actual study group after their last follow-up visit (24–30 months postopera-
tively).
Procedures
At the start of the study, all surgeons were invited to specific trial training sessions, which 
were organized in the surgical SkillsLab of the coordinating center (Erasmus University 
Medical Center, Rotterdam, Netherlands) to ensure that all participating surgeons would 
use the same standardized techniques to close an umbilical hernia. In addition to the 
training sessions, there was a clear chapter on operation techniques provided in the 
study protocol to instruct all surgeons and surgeons in training.
Suture repair of the umbilical defect consisted of adaptation of the fascia in the midline 
by either interrupted or continuous, non-absorbable, monofilament, polypropylene 
sutures of thickness 0/0 (monofilament Prolene suture). Sutures were placed in a 
transverse direction. In this study, Mayo reconstruction of the umbilical defect was not 
permitted [11].
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Mesh repair was done with a flat polypropylene mesh (Bard Mesh or Prolene polypropylene 
mesh) placed in the preperitoneal plane. Fixation of the mesh was achieved using 0/0 
individual, non-absorbable, monofilament sutures (monofilament Prolene). The overlap 
of the mesh had to be at least 3 cm in each direction of the circular mesh [12]. It was 
not preferred to enlarge the umbilical hernia defect during the repair procedure. If the 
surgeon had to enlarge the umbilical defect during the operation to place the mesh in 
the preperitoneal plane, this step was recorded in the operation report. To protect the 
viscera, it was possible to place the remains of the hernia sac between the viscera and 
the mesh. The fascia defect was closed over the mesh by sutures when this was possible 
in a tension-free manner to protect the mesh from contact with the skin. The use of 
drains was permitted. Closure of the subcutaneous tissue and skin could be achieved 
using a method chosen by the individual surgeon.
Postoperative analgesics could consist of diclofenac 50 mg three times daily and 
paracetamol 1000 mg three times daily (or equivalent) administered orally for 6 days 
after surgery. If there were no complaints of pain, patients could stop using analgesics. 
A visual analogue scale (VAS) was used to assess postoperative pain.
Outcomes
The primary endpoint was defined as the rate of hernia recurrences after 24 months. All 
patients were examined preoperatively and at 2 weeks, and 3, 12, and 24–30 months 
postoperatively. Hernia recurrence was assessed by physical examination and, in case of 
any doubt, by supplementary abdominal ultrasound. Secondary endpoints were peri-
operative VAS scores, postoperative pain measured in the short term (at 2 weeks) and 
in the long term (at 2 years), and postoperative complications such as wound infection, 
seroma, and hematoma.
Complications were assessed during all planned visits (2 weeks, 3 months, 12 months, 
and 24–30 months after the operation) and in-between visits when patients came to 
the hospital. Quality of life (QOL) was assessed using the MOS SF-36 health survey [13] 
and the EQ-5D-5L [14] preoperatively and at 12 months postoperatively. The SF-36 
includes one multi-item scale that assesses eight health concepts: limitations in physical 
activities because of health problems; limitations in social activities because of physical 
or emotional problems; limitations in usual role activities because of physical health 
problems; bodily pain; general mental health; limitations in usual role activities because 
of emotional problems; vitality; and general health perceptions. The EQ-5D-5L recog-
nizes five dimensions of QOL: mobility, self-care, usual activities, pain or discomfort, 
and anxiety or depression [13]. A single index is generated for all health states. We also 
assessed a vertical VAS regarding the patient’s own health state on a particular day that 
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was marked by the patient [15]. All outcomes were transformed into a number between 
0 (which indicated the worst possible outcome) and 100 (which indicated the best pos-
sible outcome). All data were collected by masked researchers.
Statistical analysis
The target sample size calculation was based on the primary endpoint (rate of hernia re-
currences after 24 months). Assuming a decrease of 10 percent (13 percent after suture 
repair versus 3 percent after mesh repair after 24 months) [7, 8] in the rate of recurrences, 
135 patients in each group were required at a two-sided significance level of α = 0.05 
and a power of 80 percent (by Fisher’s exact test). To compensate for an expected 10 
percent projected loss to follow-up, 150 patients were recruited per treatment group.
A statistical analysis plan was written before analysis of the data from this clinical trial. All 
analyses were done according to intention-to-treat principles; i.e., analyzed according to 
the treatment group that patients were assigned to. The primary analysis concerned the 
comparison of the time to recurrence during a follow-up period of 24 months between 
the suture repair group and the mesh repair group. All other analyses (i.e., time to recur-
rence between the two groups within subgroups, and postoperative pain, postoperative 
complications, and quality of life) were considered to be exploratory and therefore only 
served as hypothesis generating. All reported P values were two-sided, and were not 
adjusted for multiple testing (nominal P values).
Time to recurrence was estimated by means of the Kaplan-Meier estimator (product-
limit estimator), and the variance (and thus the SE) by the Greenwood formula. Actuarial 
estimates were determined with SEs and 95 percent CIs at appropriate time points, for 
all patients and per treatment group. The formal test for difference in time to recur-
rence between the two treatment arms was done with the stratified log-rank test with 
stratification by the hernia defect size, and a P value of less than 0.05 was considered 
statistically significant. This implied that 20 recurrences had to be reported before the 
final analysis could be done. Additionally, whether there was an effect modification; i.e., 
whether the difference in recurrence rate between both study groups depended on the 
hernia defect size, was investigated by a Cox-regression analysis. Reciprocal Kaplan-
Meier curves (starting at 0 percent instead of 100 percent) were generated to illustrate 
time to recurrence. The study was not powered sufficiently to detect a statistical differ-
ence between the hernia size subgroups.
The secondary endpoints were postoperative pain, postoperative complications, and 
quality of life. Postoperative pain was assessed with VAS pain scores. Postoperative com-
plications were predefined in the study protocol. We scored for postoperative infections, 
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hematoma, seroma, and other complications. Postoperative infections were defined as 
surgical site infections (SSI) that occurred within 30 days after the operation. SSIs were 
divided into three categories, superficial incisional SSI, deep incisional SSI, and organ 
or space SSI [16]. Hematoma was defined as an accumulation of blood in the wound 
area, which warranted surgical exploration and intervention. Seroma was defined as 
accumulation of clear fluid in the surgical field as diagnosed by aspiration of clear fluid. 
Other complications were scored within the categories skin necrosis, pulmonary com-
plications, cardiovascular complications, and urinary tract complications. Post operative 
complication rates were compared using Fisher’s exact test. The two QOL scales (SF-36 
and EQ-5D-5L) at 12 months after surgery were compared using ANCOVA while allowing 
for baseline score, age, and sex. The operation times were compared using the Mann-
Whitney U test. All statistical analyses were done as described in the statistical analysis 
plan using Stata version 13. No data monitoring committee oversaw this study. The 
study was registered at ClinicalTrials.gov, number NCT00789230.
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. The corresponding author had full access to all 
the data in the study and had final responsibility for the decision to submit for publica-
tion.
RESULTS
Between June 21, 2006, and April 16, 2014, we randomly assigned 300 patients to 
repair treatments during surgery; 150 to suture repair and 150 to mesh repair (Figure 
1). There were no anesthetic complications or postoperative deaths. During follow-up, 
16 patients were lost to follow-up or decided to terminate trial participation and were 
excluded from the analysis, leaving 138 in the suture group and 146 in the mesh group 
eligible for analysis.
Most of the participants were male (Table 1) and the median age was 52 years (range 
20–77 years, IQR 44–61). The two groups were well balanced in demographic variables. 
Occurrence of other risk factors such as malnutrition, cardiovascular disease, steroid 
use, benign prostate hyperplasia, or other types of hernia in medical history were less 
frequent and also did not differ between the two groups.
Characteristics of preoperative hernia-related factors were similar in both groups. 
Outpatient examination revealed that the hernia defect was palpable without Valsalva 
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Table 1. Baseline characteristics of the intention-to-treat population
Suture repair (n=138) Mesh repair (n=146)
Sex
Male 113 (82%) 122 (84%)
Female  25 (18%)  24 (16%)
Age (years)  52 (43–59; 20–74)  55 (44–63; 25–77)
Height (cm) 179 (172–185; 152–202) 178 (172–185; 150–198)
Weight (kg)  90 (83–99; 57–155)  90 (83–102; 44–170)
BMI (kg/m²)  28 (25–31; 19–44)  28 (26–31; 19–59)
ASA classification
I  87 (63%)  80 (55%)
II  47 (34%)  58 (40%)
III   4 (3%   8 (5%)
Hernia diameter (cm)
1–2 cm 101 (73%) 101 (69%)
>2–4 cm  37 (27%)  45 (31%)
Risk factors
COPD  15 (11%)  10 (7%)
Diabetes  13 (9%)  13 (9%)
Smoking  23 (18%)  17 (11%)
Operation time (range) min.  33 (25–43; 10–95)  44 (32–57; 20–122)
Data are n (%) or median (IQR; range). BMI = body-mass index. ASA = American Society of Anesthesiolo-
gists. COPD = chronic obstructive pulmonary disease.
Figure 1. Trial profile
Patients were analyzed in the intention-to-treat population.
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manoeuvre in 109 patients (79 percent) in the suture repair group and in 120 patients 
(82 percent) in the mesh group.
Pain was reported by 97 patients (70 percent) in the suture repair group and in 99 
patients (68 percent) in the mesh group. Mechanical complaints were present in 33 pa-
tients (24 percent) in the suture repair group and in 35 patients (24 percent) in the mesh 
group. Cosmetic aspects were the reason for hernia repair in 37 patients (27 percent) in 
the suture repair group and in 37 patients (25 percent) in the mesh group. There were 
no significant differences in the occurrence of hernia symptoms between the two treat-
ment groups.
The median duration of the operation was longer in the mesh group than in the suture 
group (Table 1). Patients in both groups were mainly operated under general anesthesia 
(266 [94 percent]); the other patients were operated under local anesthesia (local infil-
tration around the umbilicus in rectus sheath) or spinal anesthesia.
Most patients underwent surgery through an incision caudally to the umbilicus; 89 
patients (64 percent) in the suture repair group and 87 patients (60 percent) in the mesh 
group (P = 0.40). Crossover of treatment occurred in both groups; four patients (3 per-
cent) in the suture repair group underwent mesh repair and five patients (3 percent) in 
the mesh group underwent suture repair (P = 1.00). The most common reason for cross-
over to mesh repair in the suture group was comorbidity of the patient (high body-mass 
index [BMI] and heavy occupational lifting). The most common reason in the mesh group 
to use a suture repair was the diameter of the hernia defect. Use of drains was more 
frequent in the mesh group than in the suture group: 13 patients versus one, respectively 
(P = 0.002). Drain production did not exceed 30 mL and all drains were removed on the 
first postoperative day.
The 284 patients included in the analysis were operated on by 212 different surgeons 
in training and specialists (in the Netherlands, an individual is either surgeon in training 
or a specialist surgeon). 217 patients were operated on by two surgeons (a specialist 
surgeon with a surgeon in training or two surgeons in training) and 53 patients were 
operated on by one. In 71 cases, patients were operated on by a specialist surgeon with 
or without assistance of a surgeon in training. In 156 cases, patients were operated on 
by a surgeon in training, directly supervised by a specialist surgeon. In 43 cases, patients 
were operated on by a surgeon in training without direct supervision of a specialist 
surgeon. For 14 patients the data about their surgeon were missing. Most participating 
surgeons attended the laboratory course about standardization of repair techniques.
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The median follow-up was 25.1 months (range 0.0–87.8, IQR 15.5–33.4). Consequently, 
there were patients who had more than the intended 24 months of follow-up. The 
presented data, in first instance, were the data after 24 months of follow-up as docu-
mented in the study protocol. Additionally, data were gathered on recurrence outcomes 
after 30 months. From September, 2011, to August, 2012, the trial team was short-staffed, 
and during this period a short gap of follow-up systematics occurred, rendering a 
follow-up of 6 months longer than stated in the protocol. With the data after 30 months, 
a 24-month actuarial estimate of recurrence was calculated. We decided to present the 
data until 30 months of follow-up, because for several patients the 24-months assess-
ment was done after 24 months postoperatively but before 30 months. We also decided 
to assess the recurrence rate as a time-to-event endpoint instead of a dichotomous 
outcome, and censor the follow-up of patients without recurrence at 30 months.
After a maximum follow-up of 30 months, there were fewer recurrences in the mesh 
group than in the suture group (six [4 percent] in 146 patients versus 17 [12 percent]; 
2-year actuarial estimates of recurrence 3.6 percent [95 percent CI 1.4–9.4] versus 11.4 
percent [6.8–18.9]; P = 0.01, hazard ratio [HR] 0.31, 95 percent CI 0.12–0.80; [Figure 2], 
corresponding to a number needed to treat [NNT] of 12.8). The difference in recurrences 
between suture and mesh occurred in both hernia defect size subgroups (1–2 cm and 
>2–4 cm), although the study was not powered sufficiently to detect a difference.
Figure 2. Time to recurrence for mesh versus suture (all hernia diameters, 1–4 cm)
The X-axis shows the time in months until recurrence of an umbilical hernia.
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There were 11 recurrences in 202 patients in the subgroup of hernia size 1–2 cm. In this 
subgroup fewer recurrences occurred in the mesh group than in the suture group (two [2 
percent] versus nine [8 percent] in the suture group; HR 0.23, 95 percent CI 0.05–1.07, Fig-
ure 3). In the subgroup hernia size of greater than 2 cm to 4 cm, 12 recurrences occurred 
Figure 3. Time to recurrence in mesh versus suture (hernia diameters 1–2 cm)
The X-axis shows the time in months until the recurrence of umbilical hernia.
Figure 4. Time to recurrence in mesh versus suture (hernia diameters >2–4 cm)
The X-axis shows the time in months until the recurrence of umbilical hernia.
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in 82 patients. In this subgroup, fewer recurrences again occurred in the mesh group than 
in the suture group (four [9 percent] versus eight [22 percent]; 0.39, 0.12–1.30, Figure 4).
Patients treated by either suture or mesh developed a recurrence after a median 15.0 
months (IQR 6.2–24.8) after their surgery. When divided into the different treatment 
groups, recurrences occurred in the suture group after a median 15.0 months (IQR 
6.2–23.9) and in the mesh group after a median 18.7 months (13.3–24.7). Patients treated 
with sutures developed a recurrence earlier than patients treated with mesh. The onset 
of recurrences in the suture group started 3.6 months after surgery versus 12.6 months 
in the mesh group. The shape of the recurrence curves in all diameter subgroups was 
similar, and BMI did not affect the number of recurrences.
During analysis of all intraoperative data, violations were found in both the mesh and 
suture materials and in the technique that was used during hernia repair. Additional 
analysis of the data without violations was done. In this per-protocol analysis, no changes 
in results were noted compared with the intention-to-treat analysis (appendix).
There were no between-group differences in the incidence of postoperative wound in-
fections (Table 2). No mesh had to be surgically removed because of infection (Table 2). 
There were no significant differences in perioperative VAS scores (Figure 5). Median VAS 
scores after surgery were 2.8 in the suture group and 3.8 in the mesh group (P = 0.13), 
and after 4 days, the median VAS score was 1.0 or less in both groups, and similar be-
tween the two groups at all time points (P values between 0.54 and 0.82). There was no 
difference in the amount of postoperative pain between patients in the mesh and suture 
repair groups at all time points. Two weeks after the operation, 102 patients (74 percent) 
in the suture repair group and 111 patients (76 percent) in the mesh group were free 
from pain (P = 0.57). At 2 years, 129 patients (93 percent) in the suture repair group and 
138 patients (95 percent) in the mesh group were free from pain (P = 0.45).
Table 2. Postoperative complications
Suture repair (n=138) Mesh repair (n=146) Number needed to harm
Wound infection 1 (<1%; 17 days) 3 (2%; 21 days, 14–23)  75
Hematoma 2 (1%; 24 days, 13–34) 3 (2%; 13 days, 11–16) 165
Seroma 1 (<1%; 20 days) 5 (3%; 14 days, 7–20)  37
Seroma evacuation 0 1 (<1%; 20 days) 146
Skin necrosis 0 0   ..
Pulmonary complications 0 0   ..
Cardiovascular complications 0 0   ..
Urinary tract complications 0 0   ..
Data are n (%) or median time in days (range) to occurrence of complication.
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There were no significant between-group differences in other postoperative complica-
tions: seroma (P = 0.21) or hematoma (P = 1.00). Other postoperative complications such 
skin necrosis, pulmonary complications, cardiovascular complications, or urinary tract 
complications did not occur in this study.
SF-36 and EQ-5D-5L data were available at baseline for a maximum of 91 patients in 
the suture group and 82 patients in the mesh group, and for 73 versus 68 patients at 12 
months after operation. For any of the eight health concepts of the SF-36, the single EQ-
5D-5L index and the EQ-5D-5L VAS score, there was no significant difference between the 
two groups at baseline or at 12 months. For example, the median value of the physical 
function was 95 (IQR 80–100) at baseline and at 12 months, in both the suture and mesh 
groups. Further examples are in Figure 6, which shows box-and-whisker plots of SF-36 
general health, SF-36 bodily pain, EQ-5D-5L VAS and EQ-5D-5L index for both groups 
before operation and 12 months after operation. 60 suture patients (43 percent) and 51 
mesh patients (35 percent) completed the forms at both time points and were included 
Figure 5. Box-and-whisker plots of VAS pain scores
Each box is drawn from the 25th percentile to the 75th percentile of the visual analogue scale (VAS) scores, 
and the horizontal bar within the box indicates the median VAS score. Upper error bars go from the 75th 
percentile of the VAS score to the upper adjacent value as defined by Tukey. Dots indicate VAS scores great-
er than the upper adjacent value. pre = before surgery. Day 0 = date of surgery.
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in the ANCOVA analyses. These analyses confirmed that there was no significant effect of 
treatment on outcome of SF-36 and EQ-5D-5L at 12 months after operation.
DISCUSSION
This study showed that mesh repair for small umbilical hernias (diameter 1–4 cm) signifi-
cantly reduced the number of recurrences compared with suture repair. There were no 
between-group differences in pain scores. Since most surgeons would use suture repair 
for smaller hernias, this is a particularly important finding.
Until now, publications about umbilical hernia were limited to retrospective cohort 
studies [17-21], prospective observational studies [8, 22, 23], hernia register analyses 
[24, 25], and randomized controlled studies with smaller sample sizes than this study [7, 
9]. In this study, only patients with umbilical hernia were included, whereas other studies 
included patients with all types of primary ventral hernias [18], para-umbilical hernia 
[26, 27], or both umbilical and epigastric hernia [28, 29]. None of the other studies clari-
Figure 6. Box-and-whisker plots of SF-36 and EQ-5D-5L
Each box is drawn from the 25th percentile to the 75th percentile of the scores, and the horizontal bar 
within the box indicates the median score. Lower error bars go from the 25th percentile of the VAS score 
down to the lower adjacent value as defined by Tukey. Dots indicate scores less than the lower adjacent 
value. SF-36 = 36-Item Short Form Health Survey. EQ-5D-5L = EuroQol five-dimensional five levels of sever-
ity. EQ = EuroQol. VAS = visual analogue scale.
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fied the exact definition of the included hernias. The results of the reported treatments 
in these studies could therefore be affected by the different types of hernias that were 
included [18, 26-29]. Additionally, recurrences were not reported per type of hernia.
In this study, 4 percent of patients in the mesh repair group had a hernia recurrence 
after 24–30 months. 70 percent of patients in this study had a hernia of diameter 1–2 
cm, but mesh repair was shown to be effective in the entire group of 1–4 cm. Surgeons 
might hesitate to use a mesh in the repair of smaller hernias [10]. In the studies of Lal 
and colleagues [26] and Murtaza and colleagues [30], patients were only included in the 
analysis if their hernia defect was at least 4 cm. In this study, only the hernias less than 
1 cm were excluded since mesh placement in these smaller hernias can be difficult and 
could lead to an artificial increase of the hernia defect to achieve mesh placement. The 
role of mesh in these very small umbilical hernias of less than 1 cm remains uncertain.
The number of recurrences overall after 24 months in this study was more than twice 
as high in the suture repair group as in the mesh group, and similar to findings from 
studies by Arroyo and colleagues [7] (11 percent after interrupted suture repair) and 
Polat and colleagues [9] (11 percent after Mayo repair). The recurrence rate in this study 
after suture repair was however higher than shown by Christoffersen and colleagues 
[24] (5.6 percent after suture repair). The proportion of patients with recurrences after 
mesh repair was slightly higher in this study (4 percent) when compared with studies 
by Arroyo and colleagues [7] (1 percent), Polat and colleagues [9] (zero), and Christof-
fersen and colleagues [24] (2.2 percent). Important differences with these studies were 
the type of mesh, the technique of mesh placement, the duration of follow-up, the 
diagnostic methods, the heterogeneous groups, and the study populations that were 
used (smaller randomized samples [7, 9], and a large, non-randomized cohort popula-
tion [24]). Arroyo and colleagues [7] used mesh plug repair in hernias with a diameter of 
less than 3 cm (68 patients) and a standard flat mesh repair in the preperitoneal plane in 
hernias with a diameter of more than 3 cm (32 patients). Follow-up ranged from 21 to 80 
months and it was not specified when recurrences occurred [7]. Polat and colleagues [9] 
studied two different mesh groups: 17 patients with the Prolene Hernia System (Ethicon, 
West Somerville, NJ, USA) and 15 patients with a standard flat mesh repair in the onlay 
technique [9]. However, the mesh groups studied by these investigators were heteroge-
neous. In the case of Polat and colleagues’ study, there were only few patients per mesh 
group. The study by Christoffersen and colleagues [24] was heterogeneous with respect 
to suture techniques.
Another important difference between this study and previous studies was that incarcer-
ated umbilical hernia or emergency operations were not included in this study. This was 
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specifically studied in two other studies by Kulah and colleagues [31] and Abdel-Baki 
and colleagues [32]. In the randomized study by Abdel-Baki and colleagues [32] the use 
of mesh in emergency operations did not lead to a significant increase of complications 
when compared with suture repair in emergency operations (23.8 percent after mesh re-
pair versus 28.6 percent after suture repair). However, the total number of complications 
was much higher in emergency patients than in the randomized studies about elective 
umbilical hernia repair [7, 9]. Complications in these studies were defined as wound 
infection, hematoma, seroma, and other postoperative complications. Recurrences were 
not taken into account. In this study, 8 percent of patients had complications after mesh 
repair versus 3 percent of patients after suture repair; Arroyo and colleagues [7] noted 10 
percent of patients had complications after mesh repair versus 11 percent after suture 
repair, and Polat and colleagues [9] showed 15.6 percent had complications after mesh 
repair versus 16.7 percent after suture repair. Our study was powered for the primary 
endpoint of the number of recurrences after 24 months and could therefore have been 
underpowered to address significant differences in postoperative complications.
Most of the patients in this study were operated under general anesthesia (94 percent). 
This finding was earlier confirmed for treatment of inguinal hernia in the Netherlands 
[33]. Use of general anesthesia can, however, lead to specific postoperative complica-
tions (e.g., pulmonary and cardiovascular complications). However, none of these com-
plications occurred during this study. Operation time between the two study groups 
in this study differed significantly. This result is similar to findings from Arroyo and 
colleagues [7], reporting an operation time of 38 minutes in the suture group and 45 
minutes in the mesh group. In our study, the operation time in the flat mesh technique 
was much shorter than in the flat mesh group reported by Polat and colleagues [9]. 
This could be a result of the more extensive operation procedure studied by Polat and 
colleagues. Generally, one could assume that the smaller the hernia defect, the more 
challenging it might be to place a mesh in the sublay position. This in an important issue 
in the education of residents and the learning curve for every surgeon. In this study, 
none of the surgeons enlarged the hernia defect to place a mesh in the sublay position. 
However, all participating surgeons were largely skilled in hernia repair.
Quality-of-life analyses revealed no significant differences between both study groups 
on the outcome of SF-36 and EQ-5D-5L preoperatively and at 12 months after operation. 
There were no other studies in small umbilical hernias available with a head-to-head 
comparison of SF-36 and EQ-5D-5L between mesh and sutures regarding quality of life. 
A previous study by Malik and colleagues [34] showed a benefit of mesh versus non-
mesh repair in ventral abdominal wall hernias (includes epigastric hernia, para-umbilical 
hernia, umbilical hernia, and incisional hernia). Quality-of-life analysis was done accord-
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ing to their report; however, the exact method that was used was unknown. Malik and 
colleagues concluded that although mesh had a higher complication rate, mesh repair 
was a better option in ventral hernia repair than non-mesh repair and was safe. Long-
term effects of mesh repair were not mentioned in this study.
In another study [35] the long-term effects of intra-abdominal mesh in patients with a 
ventral hernia were assessed. After 49 months, 16 (12 percent) patients complained of 
discomfort in the umbilical region, two (2 percent) patients had an infection of the mesh 
that resulted in removal of the mesh (Ventralex patch), and two (2 percent) required ad-
hesiolysis for obstruction. In our study, the mesh was placed in the preperitoneal plane, 
which does not lead to direct contact between the mesh and the viscera, therefore 
causing fewer adhesions.
A limitation of our study was that no records were kept about the number of patients 
who immediately declined participation, or who were eligible but were not recruited for 
participation in the study. This could have led to a potential selection bias. A conscious 
choice in this study was not to include hernia diameters smaller than 1 cm. Therefore it 
cannot be stated whether mesh repair is beneficial in these hernia defects. Furthermore, 
the follow-up period might have been too short to assess the difference between mesh 
and suture repair. Long-term follow-up could reveal that the differences between the 
two treatment arms are even larger than in our study. However, it has proven to be diffi-
cult to keep young patients with mostly ASA I and ASA II motivated for regular follow-up 
in this study, since patients are most often cured from their hernia after operation. The 
inclusion rate of patients in our study was slow for a few reasons: patient factors (no 
interest in returning to the hospital for study visits and questionnaires), hospital fac-
tors (research infrastructure in a hospital), and researcher factors (this trial had several 
coordinators because of staff shortages). This slow inclusion rate led to a longer recruit-
ment time and partly to a longer follow-up (24–30 months of follow-up in some patients 
instead of the intended 24 months).
An additional flaw to this study might be represented by a few operations (6.3 percent) 
in which the protocol was violated. However, overall results did not differ, although 
subgroup analysis for the smallest hernia group was not conclusive.
In conclusion, this study shows a substantial advantage of mesh use in the treatment 
of small umbilical hernias of 1–4 cm. There were significantly fewer recurrences in the 
mesh group without an increase in postoperative pain or complications and with similar 
quality of life at 12 months after operation. There were no significant differences in 
the incidence of postoperative wound infections, although the incidence in the mesh 
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group was slightly higher in the mesh group versus the suture group. No mesh had to be 
surgically removed because of infection. The number needed to harm was 19 patients. 
Therefore, we advocate using mesh repair in all patients with an umbilical hernia with a 
diameter of at least 1 cm.
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SUPPLEMENTARY APPENDIX
HUMP trial – per protocol analysis
In this material per protocol analysis, 121 patients in the suture group and 145 patients 
in the mesh group were analyzed. The suture group was stratified into 88 patients with a 
hernia of 1–2 cm and 33 patients with a hernia of >2–4 cm. The mesh group was stratified 
into 99 patients with a hernia of 1–2 cm and 46 patients with a hernia of >2–4 cm. In this 
analysis, 70 percent of the patients had a hernia of 1–2 cm. Reasons for exclusion from 
the suture group were use of absorbable sutures (Vicryl® suture (polyglactin 910)), and/
or use of Mayo repair. Reason for exclusion from the mesh group was use of a resorbable 
mesh (Vicryl® mesh (polyglactin 910)). After a maximum follow-up of 30 months, there 
were significantly less recurrences in the mesh group; seven recurrences (4.8 percent) 
versus 13 recurrences (10.7 percent) in the suture group (P = 0.048) (Figure S1).
Figure S1. Time to recurrence in mesh versus suture (material per protocol analysis)
On the X-axis, time in months until the occurrence of a recurrence of umbilical hernia can be found. On the 
Y-axis the cumulative percentage of hernia recurrences is expressed. In this figure both the primary group 
and the mesh group consist of all hernia diameters (material per protocol analysis).
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ABSTRACT
Introduction
The use of mesh repair in a small- or middle-sized umbilical hernia remains controver-
sial, and evidence is based on only few and small heterogeneous randomized trials. The 
primary aim was to assess differences, if any, in recurrence (clinical and reoperation), and 
the secondary aim was to assess differences in infections, seroma formation, hemato-
mas, chronic pain, cosmetic result, and quality of life.
Method
A systematic review (predefined search strategy) and meta-analyses were conducted 
based on pre-study strict and well-defined methodology. The literature search was 
completed on 1 January 2018. The study protocol was registered in PROSPERO.
Results
Five randomized controlled trials were identified (mesh repair, n = 326 versus non-mesh 
sutured repair, n = 330) and 602 records were excluded. Randomized controlled trials 
included patients with defect diameters of ≥1 to 4 cm. Mesh repair reduced the risk 
of recurrence compared with sutured repair with a relative risk of 0.28 (95 percent 
confidence interval = 0.13–0.58, I² = 0 percent, number needed to treat = 13 patients). 
Additional analyses found no differences between the two surgical techniques regard-
ing infection (relative risk = 0.80, 95 percent confidence interval = 0.36–1.79), seroma for-
mation (relative risk = 1.38, 95 percent confidence interval = 0.57–3.32), or hematomas 
(relative risk = 0.55, 95 percent confidence interval = 0.23–1.30). Lack of sufficient data 
precluded meta-analysis evaluating risk of seroma formation, hematomas, chronic pain, 
cosmetic result, and quality of life.
Conclusion
Mesh repair is recommended for umbilical hernia of ≥1 to 4 cm. More evidence is needed 
for the optimal placement of the mesh (sublay or onlay) and the role of mesh in patients 
with an umbilical hernia <1 cm.
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INTRODUCTION
Open umbilical hernia repair is one of the most commonly performed minor surgical 
procedures. The incidence is approximately 1500 repairs in Denmark [1] and 175 000 
repairs in the United States [2]. In particular, recurrence remains a concern, but also the 
risk of chronic pain has drawn increasing attention, although it has only been scarcely 
investigated [3-6]. The controversy concerning the use of mesh in these repairs is not 
settled despite being a high volume and minor surgical intervention [1].
Two previous systematic reviews compared open umbilical or epigastric hernia repair 
with or without mesh reinforcement including only one and three randomized con-
trolled trials (RCTs), respectively [7, 8]. Both analyses contained mainly retrospective 
older cohort studies, a mixture of elective and emergency repairs, and umbilical and 
epigastric hernia repairs. Included studies did not discriminate between recurrences as 
primary or secondary outcomes. Moreover, two recent meta-analyses [8, 9] compared 
a mixture of elective and emergency procedures including a variety of types of ventral 
hernias (i.e. incisional and primary (umbilical) hernia repair) with or without liver cir-
rhosis and did not discriminate between recurrence as primary or secondary outcome. 
Although it is well accepted that reoperation for recurrence severely underestimates 
clinical recurrence [10], the four previous systematic reviews [7-9, 11] and previous 
RCTs [12-15] did not discriminate clinical recurrence or reoperation for recurrence. In 
addition, a large high-quality Dutch RCT (n = 300) was recently published [16] and was 
not included in the previous meta-analyses. Finally, and perhaps most important, none 
of the previous systematic reviews and meta-analysis followed the Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines for meta-analysis 
conductance [17].
For the above-mentioned reasons, it was regarded important to present an updated 
systematic review based exclusively on RCT data on strict inclusion criteria including 
only adult patients undergoing elective open umbilical hernia repair. The primary 
outcomes of this meta-analysis include exclusively primary outcome results from RCTs. 
Before study start, it was decided that the primary aim was to assess the difference, if 
any, in recurrence defined as clinical, reoperation, and combined assessment. Secondary 
aims were to appraise differences, if any, in surgical site infections, seroma formation, 
hematomas, chronic pain, cosmetic result, and quality of life (QOL).
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METHODS
This systematic review was based on a registered protocol in PROSPERO (https://www.
crd.york.ac.uk/prospero/display_record.php?RecordID=46845) and results are reported 
according to the PRISMA guidelines [17].
Search strategy (end of search April 1st 2018)
We searched Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, 
Embase and Science Citation Index Expanded. We used the Cochrane highly sensitive 
search strategies for identification of clinical RCTs (Table 1) [18].
The search string was ((“Hernia, Ventral” (Mesh) OR “ventral hernia”) AND (umbilical 
AND (surgery OR herniotomy OR herniorrhaphy OR hernioplasty)) AND (recurrence OR 
“chronic pain” OR “surgical site infections” OR “wound infections” OR “seromas” OR “qual-
ity of life” OR cosmesis)). In the manual searches, we scanned reference lists of relevant 
articles and proceedings from meetings. We also wrote to the principal authors of RCTs 
for information about any ongoing trials and searched the online trial registries, Clinical-
Trials.gov (clinicaltrials.gov) and World Health Organization (WHO) International Clinical 
Trial Registry Platform (www.who.int/ictrp), for ongoing or unpublished trials. Two 
authors (T.B. and L.L.G.) scrutinized searches, performed additional manual searches, 
listed potentially eligible RCTs, and collected data. Contrary opinions were resolved 
through consensus before analyses. All authors read the potentially eligible RCTs and 
participated in the final selection of RCTs. We described the characteristics of included 
trials in summary tables and described reasons for exclusion for all excluded trials. Ex-
tracted data included study design, type of surgical techniques, number of participants, 
hernia defect size, length of follow-up, and outcomes as defined above.
Table 1. Characteristics of randomized controlled trials (RCTs) included in the meta-analyses
RCT Recurrence 
definition
Defect 
size (cm)
Follow-up method 
(and period)
Suture 
technique
Mesh placement 
Kaufmann et al. 
[16]
Clinical 1–4 Clinical (24 months) Simple 
interrupted 
or continuous
Sublay
Arroyo et al. [13] Clinical >3 Clinical (64 months) Simple 
interrupted 
Sublay 
Lal and Ase [14] Clinical >4 Clinical (12 months) Simple 
interrupted
Onlay
Polat et al. [12] Reoperation Not 
stated
Not stated (24 
months)
Simple 
interrupted
Mesh sandwich or 
Mayo repair with mesh
Sadiq and 
Khurshid [15]
Not stated Not 
stated
Not stated (6 months) Mayo repair Not stated
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We included RCTs regardless of their publication status (published manuscript or ab-
stract). Inclusion of studies was limited to the English language. The assessed interven-
tions were elective umbilical hernia repair with either open mesh repair or non-mesh 
repair. We excluded patients with liver cirrhosis, patients undergoing emergency repairs, 
other types of ventral hernia repair (i.e. epigastric, Spigelian, parastomal, or incisional 
hernia repairs), and repairs during concomitant surgery. To secure robustness of recur-
rence outcomes, we excluded RCTs where recurrence was not the primary outcome as 
mentioned above [19].
Types of outcome measures
Study outcomes were predefined before the study was conducted. The primary analysis 
of the meta-analysis was differences, if any, in clinical recurrence, non-clinical assess-
ment (reoperation and unclear defined recurrence), and total recurrence (clinical and 
not clinically defined). Secondary analyses were also performed on other outcomes such 
as differences, if any, in surgical site infections, seroma formation, hematomas, chronic 
pain, cosmetic result, and QOL after mesh repair or sutured repair. We assessed all out-
comes at the maximum duration of follow-up.
Bias and quality assessment
Bias control was assessed using the Cochrane domains. Due to the nature of the in-
tervention, we only included an assessment of blinding of outcome assessors [20]. The 
domains were combined into an overall assessment and graded RCTs as low risk of bias 
if none of the individual domains were classified as unclear/high risk of bias.
The GRADEpro system [21] was used to evaluate the quality of the combined evidence 
for outcomes reported in the review, considering the within-study risk of bias (method-
ological quality), inconsistency, imprecision, indirectness, and publication bias.
Statistical analyses
Meta-analyses were conducted and results reported as relative risks (RR) with 95 percent 
confidence intervals (CIs). Trial Sequential Analyses were conducted to evaluate the 
risk of error and futility. For our primary outcome, we calculated the number needed 
to treat (NNT) based on 1/risk difference. We expressed heterogeneity as I² values using 
the following thresholds: 0 to 40 percent (unimportant), 40 to 60 percent (moderate), 
60 to 80 percent (substantial), and >80 percent (considerable). We initially conducted 
random-effects and fixed-effect meta-analyses. The estimates of the random-effects and 
fixed-effect meta-analyses were similar for all analyses. We chose to report the random-
effects models, which provided the most conservative estimate of the intervention effect. 
We did not conduct planned subgroup analyses evaluating bias because only one RCT 
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had a low risk of bias [16]. A Trial Sequential Analysis was performed in the assessment 
of primary outcome. The required information size was defined as the number of par-
ticipants needed to detect or reject an intervention’s effect based on the relative risk 
reduction (RRR) and assumed control risk (ACR). We defined evidence as established if 
the Z-curve crossed the monitoring boundary before reaching the required information 
size. We performed the analyses with alpha set to 5 percent, power to 80 percent, and 
model-based diversity. Based on previous evidence [7, 8], we set the RRR to 46 percent 
and the ACR to 10 percent. We performed the analyses in Review Manager 5 (Nordic 
Cochrane Centre, Copenhagen, Denmark), STATA (version 14, Philadelphia, USA), and Trial 
Sequential Analysis (Copenhagen Trial Unit, Copenhagen, Denmark).
RESULTS
The electronic searches revealed 767 potentially eligible references. The manual search-
es identified additional 13 references (Figure 1). We excluded RCTs evaluating patients 
with incisional hernias, liver cirrhosis, or emergency surgery, and a total of 602 records 
were excluded. In total, we included five RCTs (full paper articles published in English 
Records identified through 
database searching 
(n = 767) 
Additional records identified 
through other sources 
(n = 13) 
Records after duplicates removed 
(n = 612) 
Records screened 
(n = 612) 
Records excluded 
(n = 602) 
Full-text articles assessed 
for eligibility 
(n = 10) 
RCTs excluded (n = 5) 
Evaluating incisional 
hernias or emergency 
surgery 
RCTs included 
(n = 5) 
Figure 1. PRISMA flowchart of studies for the analysis
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language) in our meta-analyses [12-16]. The RCTs were published between 2001 and 
2018, and varied clinically in respect of hernia defect size, follow-up method (clinical 
or non-clinical assessment (reoperation and unclear defined recurrence)), and total re-
currence (clinical and non-clinical assessment), follow-up period, and mesh placement 
(Table 1). The duration of follow-up varied between 6 and 64 months.
Bias assessment
Two RCTs reported the allocation sequence generation and one the allocation conceal-
ment (Table 2). None of the trials employed blinded outcome assessment. Only one of 
the RCTs had a low risk of bias in the overall assessment [16].
Table 2. Risk of bias in included RCTs
Bias domain RCT
Arroyo et al. 
[13]
Polat et al. 
[12]
Lal and Ase 
[14]
Sadiq and 
Khurshid [15]
Kaufmann et 
al. [16]
Allocation sequence 
generation
Low risk Unclear risk Unclear risk Unclear risk Low risk
Allocation concealment Unclear risk Unclear risk Unclear risk Unclear risk Low risk
Incomplete outcome data Low risk Low risk Low risk Unclear risk Low risk
Outcome reporting Low risk Low risk Low risk Low risk Low risk
Other bias Low risk Low risk Low risk High risk Low risk
Overall bias assessment High risk High risk High risk High risk Low risk
Meta-analyses
We were able to gather data on recurrence from all five RCTs [12-16] (Figure 1). In total, 
326 patients were randomized to a mesh and 330 to sutured repair. Overall, mesh repair 
reduced the risk of recurrence with a relative risk (RR) of 0.28 (95 percent CI = 0.13–0.5; 
I² = 0 percent; NNT = 13 patients; i.e. for every 13 patients undergoing elective repair for 
an umbilical hernia, use of mesh repair will prevent one hernia recurrence) (Figure 2).
In a sub-analysis of RCTs using either a clinically well-defined classification of recurrence 
or an unclear definition of recurrence, there was a significant difference between mesh 
repair or no mesh repair (RR = 0.24 (95 percent CI = 0.10–0.57) and RR 0.32 (95 percent 
CI = 0.05–2.03), test for subgroup differences, P = 0.06). In Trial Sequential Analysis, the 
Z-curve crossed the monitoring boundary after inclusion of all RCTs, suggesting that the 
result of the meta-analysis did not reflect random or systematic error.
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Figure 2. Risk for recurrence
A Forest plot for risk of recurrence in favor of mesh versus suture repair by subtype using clinically assess-
ment or not assessed clinically (reoperation for recurrence or non-defined recurrence) or combined total 
events. Odds ratios (95 percent CIs) are denoted by black boxes (black lines). The combined OR estimate 
for all subtypes is represented by a black diamond, where diamond width corresponds to 95 percent CI 
bounds. Box and diamond heights are inversely proportional to precision of the OR estimate. The P value 
for heterogeneity (P heterogeneity) of odds ratios by subtype is shown.
Table 3. Relative risks of surgical outcomes in randomized controlled trials (RCTs) comparing mesh versus 
suture
Outcome (events/patients) RCT Relative Risk (95% CI)
Wound infection Arroyo et al. [13] 0.67 (0.11–3.90)
Kaufmann et al. [16] 2.84 (0.30–26.94)
Lal and Ase [14] 0.38 (0.08–1.79)
Polat et al. [12] 0.89 (0.09–9.14)
Sadiq and Khurshid [15] 1.00 (0.22–4.56)
Total 11/326 versus 14/330 0.80 (0.36–1.79)
Seroma formation Arroyo et al. [13] 1.20 (0.38–3.81)
Kaufmann et al. [16] 4.73 (0.56–39.94)
Lal and Ase [14] 4.70 (0.23–94.01)
Polat et al. [12] 0.58 (0.02–13.52)
Sadiq and Khurshid [15] 0.20 (0.01–4.00)
Total 13/326 versus 9/330 1.38 (0.57–3.32)
Hematoma Arroyo et al. [13] 1.00 (0.06–15.77)
Kaufmann et al. [16] 1.42 (0.24–8.36)
Lal and Ase [14] 0.09 (0.00–1.48)
Polat et al. [12] 1.78 (0.27–11.57)
Sadiq and Khurshid [15] 0.14 (0.01–2.65)
Total 6/326 versus 13/330 0.55 (0.23–1.30)
RCT = randomized controlled trial. CI = confidence interval.
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As shown in Table 3, there were no differences between the two surgical techniques 
regarding infection (RR = 0.80, 95 percent CI = 0.36–1.79), seroma formation (RR = 1.38, 
95 percent CI = 0.57–3.32), or hematomas (RR = 0.55, 95 percent CI = 0.23–1.30).
Only one RCT reported data on acute and chronic pain and QOL [16]. No significant 
difference was found in postoperative pain between mesh and suture repair during all 
time points. Two weeks after the operation, 102 patients (74 percent) in the suture repair 
group and 111 patients (76 percent) in the mesh group were free of pain (P = 0.57). After 
2 years, 129 patients (93 percent) in the suture repair group and 138 patients (95 percent) 
in the mesh group were free of pain (P = 0.45). QOL was evaluated using the MOS SF-36 
health survey [22] and the EQ-5D-5L [23]. There was no significant difference at baseline 
preoperatively and 12 months after umbilical repair (P > 0.05).
DISCUSSION
Based on the updated literature search, five RCTs were identified [12-16]. The current 
analysis of the data revealed that mesh repair of umbilical hernia protected significantly 
against recurrence compared with a non-mesh sutured repair. The use of mesh repair 
did not increase risk of surgical site infection, seroma formation, hematomas, or chronic 
pain.
RCTs and meta-analyses based exclusively on RCTs with low heterogeneity provide the 
highest level of evidence for the effects of treatment [24-26]. However, surgical research 
questions, including hernia surgery, cannot always be answered through RCTs. Registry-
based cohort studies tend to reflect the daily clinical practice (high external validity) 
but can be criticized due to risk of selection bias and possible confounding [27]. In the 
present systematic review, all included RCT studies reported significantly lower risk of 
recurrence of umbilical hernia after mesh repair compared with a sutured repair. The 
findings are in line with the results from a recent regional cohort study reflecting daily 
surgical life (nationwide hernia databases are prone to provide high external validity 
opposed to high internal validity from RCTs) [5] by comprising 1313 patients from the 
Danish Ventral Hernia Database. The study demonstrated that mesh reinforcement for 
an umbilical hernia significantly lowered the risk of recurrence [5]. On the other hand, 
a single-center study on 162 patients undergoing sutured repair for epigastric hernias 
performed by two dedicated surgeons found that a simple suture technique leads to 
acceptable low clinical recurrence rate of 6 percent [28]. As mentioned above, previous 
published systematic reviews [7-9, 11] used methodology of problematic quality, in-
cluding several mainly observational prospective and retrospective studies, emergency 
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repairs, patients with liver cirrhosis, and a mixture of repairs for epigastric, incisional, and 
other types of ventral hernias. Furthermore, these meta-analyses included studies that 
did not clearly define primary outcomes in terms of recurrence. The consequence was 
therefore probably lack of robust quality and unclear definition of recurrence [19]. Due 
to the RCTs of moderate or even lower methodology quality [7-9, 11], final conclusions 
from these meta-analyses are not possible. A high-quality RCT has recently been pub-
lished and was therefore not included in previous systematic reviews [16]. Kaufmann 
and colleagues included 300 patients with an umbilical hernia, diameter 1 to 4 cm, 
and a 24- to 30-month follow-up with clinical examination [16]. The findings from the 
Kaufmann study were in accordance with an earlier nationwide study with subgroup 
analyses of hernia defect size in relation to recurrence (>0–1 and >1–2 cm) [5].
Mesh position (onlay, sublay, etc.) has been suggested to be a risk factor for recurrence 
in incisional hernia repair [29]. Recent evidence supports that anatomic position of 
mesh affects the risk of recurrence after incisional hernia repair [29], but this has been 
contradicted by a later long-term follow-up from the same study cohort [30]. A previ-
ous nationwide cohort study on umbilical hernia repair (different mesh positioning 
compared with sutured repair; n = 4786) [31] and RCT data (onlay versus sublay mesh 
position; n = 80 [32]) reported no significant difference regarding mesh position for risk 
of recurrence, surgical site infection, and seroma formation in the onlay mesh position 
[32]. In addition, the onlay mesh repair resulted in significantly shorter operation time 
[32]. It may therefore be concluded that onlay mesh position for umbilical hernia repair 
is probably safe, efficient, and associated with comparable low risk of complication and 
recurrence rates although final conclusion is awaiting more solid data. Also, the neces-
sary mesh overlap is not evidence-based.
In contrast to clinical results after groin hernia repair, chronic pain after umbilical 
hernia mesh repair has not been an often patient-reported outcome. In the recent RCT 
by Kaufmann and colleagues [16], 93 percent patients in the suture repair group and 
95 percent in the mesh group were free of chronic pain 2 years after repair (P = 0.45). 
These findings were confirmed by the smaller Dalenbäck retrospective single-center 
study (n = 162) [28]. Two other retrospective studies (n < 232) [3, 4] and one prospective 
regional study (n = 1313) [5] found that an open umbilical or epigastric hernia repair 
induces chronic pain in 5 percent of the patients but with no difference between mesh 
or sutured repair. Christoffersen and colleagues [5] found that recurrence was the only 
independent risk factor for chronic pain and a previous retrospective study concluded 
that chronic complaints can, in part, be explained by recurrence [3]. However, the overall 
lack of chronic pain as the primary outcome makes final conclusions difficult.
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QOL has exclusively been reported by Kaufmann and colleagues using the MOS SF-36 
health survey [22] and the EQ-5D-5L [23] preoperatively and at 12 months postopera-
tively. The QOL was without significant difference after umbilical repair [16].
The included RCTs in the present meta-analysis [12-16] found seroma prevalence vary-
ing from 0 to 8 percent in the mesh group and 0 to 7 percent in the suture group after 
varying follow-up period. The inconsistencies of the results are comparable with previ-
ous literature and may be explained by the lack of definition and different diagnostic 
procedures. Thus, final conclusions on seroma formation with or without mesh repair 
are not possible.
There are several limitations of the present systematic review. Only one RCT of high quality 
was included [16]. Furthermore, most studies included only few patients, and recurrence 
outcome was not based on a statistical power analysis with the risk of statistical type I 
and II errors. Another limitation is that several of the studies have included different sur-
gical techniques in both groups, which may introduce some possible confounders. The 
literature search was limited to the English language, which may introduce a possible 
language bias. However, it has previously been shown that this restriction will probably 
have only limited impact on final conclusions [33]. In addition, the extensive literature 
search across different databases limited the risk of omitting relevant literature. However, 
the most important limitation of the present analysis is the lack of high methodologic 
quality in the majority of the included studies and that studies, except one [16], were 
probably underpowered and comprised no prior statistical power analysis.
The strength of the present systematic review and meta-analysis is – in contrast to 
previous systematic reviews and meta-analyses – the coherence to a strict meta-analysis 
methodology to reduce risk of bias and subsequently an overestimation of interven-
tion effects impeding final conclusions [34]. The present analysis included exclusively 
patients undergoing elective umbilical hernia repair. A previous study has shown that 
emergency repair has significantly worse outcome than elective repair with up to 15-
fold higher mortality, reoperation, and readmission rates [35]. Therefore, the results on 
emergency and elective repairs are not comparable.
Future long-term high quality RCTs with a long-term follow-up with recurrence as 
primary outcome and chronic pain as secondary are awaited before final recommenda-
tions can be given on routine use of mesh repair in patients undergoing umbilical for 
defects ≤1 cm. Until then, and based on convincing data from a large nationwide clinical 
database study (not included in the present meta-analysis), defects even ≤1 cm may be 
closed using mesh repair.
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In conclusion, mesh repair is probably safe and can be recommended for routine use 
to reduce the risk of recurrence after a small- and middle-sized umbilical hernia repair. 
More data are warranted for the optimal placement of mesh (sublay or onlay) and indi-
cation for mesh patients with an umbilical hernia defects <1 cm.
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ABSTRACT
Introduction
Yearly approximately 4500 umbilical hernias are repaired in the  Netherlands, mostly 
under general anesthesia. The use of local anesthesia has shown several advantages 
in groin hernia surgery. Local anesthesia might be useful in the treatment of umbilical 
hernia as well. However, convincing evidence is lacking. We have conducted a system-
atic review on safety, feasibility, and advantages of local anesthesia for umbilical hernia 
repair.
Methods
A systematic review was conducted according to the PRISMA guidelines. Outcome 
parameters were duration of surgery, surgical site infection, perioperative and post-
operative complications, postoperative pain, hernia recurrence, time before discharge, 
and patient satisfaction.
Results
The systematic review resulted in nine included articles. Various anesthetic agents were 
used, varying from short acting to longer acting agents. There was no consensus regard-
ing the injection technique and no conversions to general anesthesia were described. 
The most common postoperative complication was surgical site infection, with an 
overall percentage of 3.4 percent. There were no postoperative deaths and no allergic 
reactions described for local anesthesia. The hernia recurrence rate varied from 2 to 7.4 
percent. Almost 90 percent of umbilical hernia patients treated with local anesthesia 
were discharged within 24 hours, compared with 47 percent of patients treated with 
general anesthesia. The overall patient satisfaction rate varied from 89 to 97 percent.
Conclusion
Local anesthesia for umbilical hernia seems safe and feasible. However, the advantages 
of local anesthesia are not sufficiently demonstrated, due to the heterogeneity of in-
cluded studies. We, therefore, propose a randomized controlled trial comparing general 
versus local anesthesia for umbilical hernia repair.
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INTRODUCTION
Umbilical hernia is a common diagnosis in surgery [1, 2]. Approximately 10 percent of all 
abdominal wall hernias are defined as umbilical hernia [3], and the prevalence of umbili-
cal hernia in the adult population is 2 percent [4]. The European Hernia Society defines a 
primary umbilical hernia as a ventral hernia present at birth or developed spontaneously 
without trauma to the abdominal wall as the cause of the hernia and with its center 
at the umbilicus [5]. Each year, approximately 4500 umbilical hernias are repaired in 
the Netherlands and most of these patients are operated under general anesthesia.
Worldwide, ever more patients undergo ambulatory hernia surgery performed under 
local anesthesia [6]. Local anesthesia in the treatment for groin hernias has been already 
thoroughly investigated. Studies showed the superiority of local anesthesia for open 
groin hernia repair compared with general anesthesia or spinal anesthesia [7-13]. 
However, only 7 percent of Dutch surgeons uses local anesthesia in Lichtenstein repair 
[13]. This is surprising, since the use of local anesthesia could prevent complications 
related to general anesthesia. Possible advantages of the use of local anesthesia are 
less postoperative pain and extended postoperative analgesia, less perioperative and 
postoperative complications, early mobilization, and therefore a shorter duration of 
hospital stay. Furthermore, use of local anesthesia could be more cost-effective than 
general anesthesia or spinal anesthesia, since there is no anesthesiologist needed and 
only less expensive local anesthetics are used [7, 13-16]. There is a lack of convincing 
literature on umbilical hernia repaired under local anesthesia [1]. We have conducted 
a systematic review of the literature on the safety, feasibility, and advantages of local 
anesthesia for the repair of umbilical hernia.
METHODS
We conducted a systematic review following the PRISMA guidelines [17]. A systematic 
search was performed in MEDLINE, Embase, Web of Science, Scopus, PubMed Publisher, 
and the Cochrane Library.
The search strategy was prepared by the biomedical information specialist of the Medi-
cal Library (Erasmus University Medical Center, Rotterdam, the Netherlands). A syntax 
with search terms was designed, which is available at Appendix 1.
The identified records were independently evaluated by two reviewers. All records 
were screened by title and abstract for eligibility, and the full-text of eligible records 
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was assessed. Studies were included into the analysis if they met the following inclusion 
criteria: adult patients with umbilical hernia or paraumbilical hernia, who were operated 
under local anesthesia with or without a control group operated with another type of 
anesthesia. Articles had to be written in Dutch, English or German, and randomized con-
trolled trials, cohort studies and case series (with more than five patients) were included. 
Exclusion criteria were studies investigating local anesthesia for other types of hernia 
than umbilical hernias, laparoscopic surgery, and animal studies or in vitro experiments.
The following outcome measurements were assessed: postoperative pain, duration of 
surgery, surgical site infection, perioperative and postoperative complications, hernia 
recurrence, time before discharge, and patient satisfaction. We also extracted the base-
line study characteristics from all included studies: study design, study period, and year 
of publication. The quality of the studies was assessed on the Level of Evidence scale of 
the Oxford Centre for Evidence-based Medicine [18].
Both reviewers independently sampled the data in a standardized database. This data-
base was set up in Microsoft Office Excel 2010. The data presented in this review were 
directly abstracted from the original articles. No statistical analyses were performed.
RESULTS
A total of 1107 articles were identified after the removal of duplicates. After screening 
of these records 77 articles were found eligible for further assessment. After assessment 
of the full-text versions of these 77 articles, nine articles were suitable for inclusion in 
this review. The reasons for exclusion were as follows: anesthesia or umbilical hernia 
were not well described and not the main subject, research was performed in children 
or animals, the article contained a case report, there was only an abstract available, or 
the article was written in another language than Dutch, English or German. The PRISMA 
flow diagram is shown in Figure 1.
Of the nine included articles, six were prospective cohort studies, and three were 
retrospective cohort studies. No randomized study comparing local versus general 
anesthesia was found. All studies contained a Level of Evidence of 2B on the scale of the 
Oxford Centre for Evidence-based Medicine. Table 1 gives an overview of the articles we 
included for this review.
In this review, the following outcome parameters will be highlighted: anesthesia tech-
nique, postoperative pain, duration of surgery, surgical site infection, perioperative and 
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postoperative complications, recurrence, time before discharge and patient satisfaction. 
The anesthesia technique was described to outline if there was any consensus regarding 
the injection technique and the type of anesthetics.
Surgical technique
There were two studies in which a Mayo repair was performed, with the classical “vest 
over pants” technique [19, 20]. Bennett and colleagues inserted a polypropylene soft 
mesh plug if the defect was <2 cm. In case the defect was >2 cm, a preperitoneal pocket 
was made and a polypropylene soft mesh was placed, with a 2 cm margin [14]. In the 
study of Kurzer and colleagues a cone polypropylene mesh was used for defects <3 cm, 
and a flat piece of mesh for defects >3 cm [2]. Garcia and colleagues used 1 cm as a cutoff 
point for a primary suture, and “large” hernias, as they stated, received a polypropylene 
mesh [4]. Three articles did not mention which cutoff point they used to determine the 
use of primary sutures or a mesh, and in one study only umbilical hernia operations with 
meshes were performed [1, 3, 6, 19]. Dalenbäck and colleagues were the only authors 
who specified the type of surgical procedure for the type of anesthesia. A total of 162 
Records identified through 
database searching 
(n = 2026) 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 1107) 
Records screened 
(n = 1107) 
Records excluded 
(n = 1030) 
Full-text articles assessed 
for eligibility 
(n = 77) 
Full-text articles excluded, 
with reasons (n = 68) 
 
- Other language: n = 11 
 
- Case report: n = 1 
 
- Irrelevant topic: n = 47 
 
- Abstract only: n = 9 
Studies included in 
systematic review 
(n = 9) 
Figure 1. PRISMA flow diagram
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patients underwent an umbilical hernia operation. Of the patients operated with a 
suture repair, 59 percent were operated under local anesthesia and 41 percent under 
general anesthesia. Of the patients receiving a mesh repair, 18 percent were operated 
under local anesthesia and 82 percent under general anesthesia.
Anesthesia technique
There are various anesthesia techniques assessed in the studies. Only Acevedo and 
Léon described the use of local anesthesia without addition of a sedative [6]. Four other 
studies combined the use of local anesthesia with sedatives and another four studies 
used local anesthesia (without sedatives) or general anesthesia for their patient groups 
[1-4, 14, 19-21]. None of the authors randomized between local anesthesia and general 
anesthesia. Table 2 shows the various types of anesthesia (local anesthesia or general 
anesthesia, local anesthesia with or without sedatives) and the different types of anes-
thetic drugs that were used. The anesthetic drugs varied from the short acting lidocaine 
Table 1. Study characteristics
Author Study type Year of 
publica-
tion
Total 
number of 
patients
Level of 
evidence
Type of hernia Outcome 
measurements
Acevedo 
and Léon 
Prospective 
cohort study
2010 2031 (326 
umbilical 
hernia)
2B Inguinofemoral, 
epigastric, umbilical, 
incisional
Perioperative pain, 
complications
Bennett 
et al.
Prospective 
cohort study
2013 63 2B Paraumbilical Duration of surgery, 
patient satisfaction
Dalenbäck 
et al.
Retrospective 
cohort study
2013 162 2B Umbilical Recurrence, pain, 
complications
Garcia-
Urena et al.
Prospective 
cohort study
2000 157 2B Umbilical, epigastric Complications, time 
to discharge
Kulacoglu 
et al.
Prospective 
cohort study
2012 100 2B Umbilical Pain (VAS), time 
to discharge, 
complications, 
recurrences
Kurzer et al. Prospective 
cohort study
2004 54 2B Umbilical Pain, complications
Menon and 
Brown
Retrospective 
cohort study
2003 32 2B Umbilical Duration of surgery, 
complications, 
recurrence
Sinha and 
Keith
Retrospective 
cohort study
2004 34 2B Umbilical Duration of surgery, 
time to discharge, 
complications, 
recurrences
Stabilini 
et al.
Prospective 
cohort study
2009 69 2B Umbilical, epigastric Time to discharge, 
recurrence, 
complications
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and xylocaine to the longer acting agent bupivacaine. Bennett and colleagues were the 
only authors who described the injection technique, which was a field block technique: 
infiltration of the skin and rectus sheath around the umbilicus [14]. Kulacoglu and col-
leagues studied patients with umbilical hernia treated with local anesthesia. They stated 
there were no conversions to general anesthesia; all patients tolerated local anesthesia 
and there were no intraoperative anesthesia-related complications [1].
Postoperative pain
One study made use of the Visual Analogue Scale (VAS) as a measurement scale to define 
“postoperative pain”. The authors included patients with different types of hernia and 
concluded that 79 percent of lean patients (BMI < 30) had a VAS of < 3, compared with 
71.9 percent of the obese patients (BMI ≥ 30). This difference was statistically significant 
(P = 0.007). In this study, no distinction was made between VAS scores per hernia type. 
It was neither described what VAS score patients had who were operated under local 
anesthesia [6].
Two other studies used terminology like “mild, moderate or severe” and “no severe post-
operative pain” to report pain [1, 2]. The authors did not mention which questionnaire or 
measurement scale was used for these statements.
Table 2. Anesthesia techniques: the different types of anesthesia used and types of local anesthetics
Author LA LA + sedation LA or GA
Acevedo and Léon Lidocaine 0.5% n.a. n.a.
Bennett et al. n.a. n.a. GA: not described
LA: xylocaine 2%, 
bupivacaine 0.5%
Dalenback et al. n.a. n.a. GA: not described
LA: not described
Garcia et al. n.a. Lidocaine 1% + midazolam n.a.
Kulacoglu et al. n.a. Lidocaine, bupivacaine 0.5% + 
midazolam and fentanyl
n.a.
Kurzer et al. n.a. Bupivacaine 0.25% + midazolam n.a.
Menon and Brown n.a. Xylocaine 1% + bupivacaine 0.5% + 
midazolam
n.a.
Sinha and Keith n.a. n.a. GA: not described
LA: xylocaine 1%
Stabilini et al. n.a. n.a. GA: not described
LA: mepivacaine 
LA = local anesthesia. LA + sedation = local anesthesia combined with sedation. LA or GA = local anesthesia 
or general anesthesia. n.a. = not applicable.
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Duration of surgery
Six authors investigated the duration of surgery, which ranged from 24 to 78 minutes [1, 4, 
6, 14, 20, 21]. Table 3 shows that Bennett and colleagues were the only authors making a 
distinction between local anesthesia and general anesthesia for this outcome parameter. 
This study showed that the use of local anesthesia for paraumbilical hernia could lead to 
a shorter duration of surgery than the use of general anesthesia (P value < 0.0003). How-
ever, patients with a lower BMI were more frequently operated under local anesthesia. 
When BMI was categorized to see if there was any difference between patients with a BMI 
less or more than 25, and less or more than 30 (obese), there was no difference found in 
the length of the procedure [14]. Kulacoglu and colleagues and Menon and Brown all in-
cluded patients with umbilical hernia treated with local anesthesia alone. Kulacoglu and 
colleagues showed that the mean operative time was 69 minutes (range 25–150 minutes), 
but in the patient group of Menon and Brown, the duration of surgery was significantly 
shorter with a mean operative time of 30 minutes (range 22–40 minutes) [1, 20].
Table 3. Duration of surgery
Author N Hernia type Anesthesia Duration of surgery, mean (min)
Acevedo and Léon 2031 Inguinofemoral, 
epigastric, umbilical, 
incisional
LA Lean 62 (± 8.6) min
Obese 78 (± 11.7) min, P < 0.001
Bennett et al. 63 Paraumbilical LA + GA LA 24 (17.5–30)
GA 35 (27–45), P < 0.0003
Garcia et al. 157 Umbilical, epigastric LA 49.7
Kulacoglu et al. 100 Umbilical LA 69 (25–150)
Menon and Brown 32 Umbilical LA 30 (22–40)
Sinha and Keith 34 Umbilical LA + GA 50 (40–108)
LA = local anesthesia. LA + GA = local anesthesia and general anesthesia.
Surgical Site Infection
Surgical site infection (SSI) is a common postoperative complication and one of the most 
commonly described outcome parameters. The overall percentage of SSI was 3.4 per-
cent (15/431), and ranged from 1 to 12.9 percent [1, 2, 4, 19, 20]. Three studies described 
that SSI responded well to conservative wound care or oral antibiotics, and no further 
treatment was required. Two remaining studies did not describe the treatment for SSI. 
Besides Acevedo and Léon, none of the authors described in which patient group SSI 
occurred [1, 2, 4, 19, 20]. Acevedo and Léon noted that there was a significantly higher 
rate of SSI in obese patients (BMI > 30) than in non-obese patients, respectively 2.1 
percent and 0.7 percent (P < 0.023). None of the articles specified the SSI rate per hernia 
or anesthesia type, nor was it described if SSIs were more frequently seen in patients 
treated with a mesh.
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Other postoperative complications
The most frequent postoperative complications were seromas, with a range of 3 to 8.9 
percent, and an overall percentage of 4.8 percent. All seromas either resolved spontane-
ously or were successfully treated with drainage [1, 3, 4, 21]. The second most frequent 
postoperative complication were hematomas (1 percent) [1, 3, 4]. There was one patient 
who suffered from postoperative bleeding and one other patient who suffered from 
intestinal obstruction. Both patients needed emergency surgery to resolve these 
complications [19]. Postoperatively, there were two patients suffering from allergic skin 
changes due to a plaster allergy [1]. Finally, there was one 86-year old patient operated 
under general anesthesia, who experienced episodes of confusion and dizziness post-
operatively. Therefore, a prolonged hospital stay of 12 days was needed [21]. In total, 
three patients passed away after surgery, respectively due to the following causes: liver 
cirrhosis, cerebral infarction and chronic renal failure. All causes were not related to the 
operation [3]. No perioperative complications were described. None of the articles made 
a comparison between type of anesthesia.
Recurrence
Seven studies described hernia recurrence rate as an outcome measurement [1-4, 19-
21]. In three of these studies, no recurrences occurred [1, 2, 20]. The mean follow-up in 
these studies was 17 months (5–41), 43 months (28–67), and 70 months (27–142). The 
remaining four articles measured a recurrence rate ranging from 2 to 7.4 percent [3, 4, 
19, 21]. These four studies did not mention which patients presented with a recurrence. 
Dalenbäck and colleagues were the only authors who included umbilical hernia patients 
alone. They made a distinction in recurrence rates between patients operated under 
general anesthesia and patients operated under local anesthesia. The authors found two 
recurrences (out of 144 patients) in the general anesthesia group and five recurrences 
(out of 144 patients) in the local anesthesia group. No statistical comparison was made 
between these two groups [19]. The studies did not describe how the recurrence was 
diagnosed: with physical examination only or with the addition of radiological examina-
tion.
Duration of postoperative stay
The mean duration of postoperative stay at the hospital varied from 2 hours to almost 
2 days [1, 3, 4, 20, 21]. Table 4 gives an overview of the mean time before discharge. 
Kulacoglu and colleagues showed that patients with umbilical hernia, operated under 
local anesthesia, stayed 122 ± 58 minutes in hospital before discharge [1]. Sinha and 
Keith described that 89 percent of the patients in the local anesthesia group were dis-
charged in less than 24 hours, compared with 47 percent of the patients in the general 
anesthesia group [21]. The other articles did not specify the duration of stay for the type 
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of anesthesia or type of hernia. The longest mean duration of stay was 1.8 days (range 
3 hours to 15 days) and was required due to severe associated diseases of the patients, 
emergency surgery for hernia strangulation and wound hematoma [3].
Patient satisfaction
Five studies reported on patient satisfaction, which was reported to be good in 89 to 97 
percent of patients. Different methods of measuring this outcome parameter were used. 
Acevedo and Léon defined patient satisfaction as good, if the VAS for patient satisfac-
tion was >7 points on a 10 points scale, in combination with a positive answer to the 
question “would you recommend this kind of surgery to others?”. This was measured at 
the 1 week control [6]. Sinha and Keith stated that 97 percent of their patient population 
was satisfied, according to the definition of Reitter [21]. The remaining three authors did 
not describe which questionnaire was used to define and measure patient satisfaction 
[1, 14, 19]. Two authors specified the patient satisfaction with regard to the body mass 
index of the patient [6, 14]. None of the articles specified the patient satisfaction per 
hernia type or anesthesia type [1, 19, 21].
DISCUSSION
The data from this systematic review reveal that the use of local anesthesia in umbilical 
hernia repair led to a shorter duration of postoperative stay, and that repair of a paraum-
bilical hernia performed under local anesthesia leads to a shorter duration of surgery. 
The use of local anesthesia did not lead to perioperative complications, serious post-
operative complications, allergic responses or anesthesia-related deaths.
Umbilical hernia is a common surgical problem [1, 2]. At this moment, data on umbilical 
hernia surgery under local anesthesia are only scarcely available. In contrast, groin her-
nias operated under local anesthesia are very well described in literature, and several 
Table 4. Time to discharge
Author Type of anesthesia Type of hernia Time to discharge (mean)
Garcia et al. LA Umbilical, epigastric 7.2 hours
Kulacoglu et al. LA Umbilical 122 min ± 58 min (45–420)
Menon and 
Brown
LA Umbilical Same day, discharge before 
20:00 p.m. 
Sinha and Keith GA or LA Paraumbilical LA: 89% discharged < 24 hours
GA: 47% discharged < 24 hours
Stabilini et al. GA or LA Umbilical, epigastric 1.8 days (3 hours to 15 days)
LA = local anesthesia. GA = general anesthesia.
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studies have been performed [7, 10-13, 15, 22]. All these studies show the advantages 
of local anesthesia: less postoperative and general anesthesia-related complications, a 
shorter duration of surgery, less overnight admissions, less postoperative pain and no 
deaths. Van Veen and colleagues showed that significantly more urinary retentions oc-
curred in patients undergoing Lichtenstein hernia repair under spinal anesthesia [13]. 
Furthermore, the conversion rate to general anesthesia was lower for patients operated 
under local anesthesia (2 percent) than patients operated under spinal anesthesia (10 
percent) [15]. Nordin and colleagues also showed that local anesthesia has significant 
cost advantages compared to spinal anesthesia and general anesthesia [15]. We therefore 
performed a review of literature to investigate the safety and feasibility of the use of local 
anesthesia for umbilical hernia and to explore if there are any advantages to the use of 
local anesthesia for umbilical hernia.
We have performed a literature search and found no randomized controlled trials or 
other significant papers giving solid evidence for the use of local anesthesia as being 
superior in the treatment of umbilical hernias. Only a few small prospective or retrospec-
tive cohort studies were included in this review. The studies we included do not solely 
include umbilical hernias, and when the studies did include solely umbilical hernias, the 
authors did not describe their local anesthesia treatment well.
If we take a closer look at the included studies, a very high heterogeneity can be noticed. 
First of all; there is no consensus regarding the local anesthetic drug, and the technique 
to induce local anesthesia. The used local anesthetic drug varies from shorter acting 
lidocaine to the longer acting ropivacaine. The technique to inject is not discussed in 
most of the articles, one article mentioning the “field block” as a way to induce local 
anesthesia. Some authors diluted their anesthetic with another type of anesthetic, 
others diluted it with saline or adrenaline. Amid and colleagues described a simple step-
by-step infiltration technique for inguinal hernia, which is adapted and followed in most 
of the studies using local anesthesia for inguinal hernia [7, 10, 13, 15, 23]. Furthermore, 
Amid and colleagues used a solution which consisted of 1 percent lidocaine, 1 percent 
bupivacaine and epinephrine, which is used by other authors as well [7, 15]. In local 
anesthesia of umbilical hernia, a standardized protocol is missing and should, therefore, 
be set up.
Pain is an important outcome measurement. However, not all studies describe peri-
operative or postoperative pain as an outcome measurement, and not all authors who 
do describe postoperative pain use the Visual Analog Scale (VAS) to measure pain. Sev-
eral studies regarding inguinal hernia have shown that postoperative pain in patients 
treated with local anesthesia is (significantly) lower compared to general anesthesia or 
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spinal anesthesia [7, 15], but this outcome measurement is, despite of its importance, 
not thoroughly investigated for umbilical hernia. Due to this inconsistency, comparison 
of the studies is impossible.
Another essential outcome measurement is represented by postoperative complica-
tions. Surgical site infections and seromas are the most common complications. In the 
underlying studies, these complications either resolved spontaneously, were treated 
with drainage or antibiotics, and had no serious consequences for the patient. It is 
not clear if complications occurred more frequently among patients treated with local 
anesthesia, since the authors did not describe which patient developed a postoperative 
complication. There were no perioperative complications, nor any allergies against local 
anesthetics, or deaths described.
The hernia recurrence rate varied from 2 to 7.4 percent, with a higher percentage for 
patients who were treated with primary sutures. This is comparable with the available 
literature, which describes a recurrence rate of approximately 2 percent for mesh repair, 
rising up to 8 percent for suture repair [24, 25]. However, recently the cohort study of 
Christoffersen and colleagues showed that the total cumulated recurrence rate after 
primary repair was 10 percent for mesh repair and 21 percent for sutured repair after 55 
months of follow-up (P = 0.001) [26], which is a surprisingly high percentage. Dalenbäck 
and colleagues showed that the recurrence rate among umbilical hernia patients oper-
ated under local anesthesia was higher (5/144) than in patients operated under general 
anesthesia (2/144) [19]. However, since there was no statistical comparison made, no 
conclusions can be drawn.
The duration of surgery varied from 24 to 78 minutes and was for all studies, with one 
exception, not specified per type of hernia or type of anesthesia. Bennett and colleagues 
were the only authors who did specify the outcomes per anesthesia type and showed 
that patients with a paraumbilical hernia operated under local anesthesia had a shorter 
duration of surgery than patients operated under general anesthesia [14]. However, 
when BMI was categorized (more or less than BMI 25, and more or less than a BMI of 30), 
there were no differences found for duration of surgery. It can be concluded that BMI 
was a confounding factor, and patients who were operated under local anesthesia had 
more frequently a lower BMI.
Almost 90 percent of the patients operated with local anesthesia were discharged 
within 24 hours. This percentage rate is almost twice as high as patients operated under 
general anesthesia: 47 percent was discharged within 24 hours. This is comparable with 
the available literature for groin hernias. Studies show a significantly shorter in hospital 
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stay as well, and significantly less postoperative overnight admissions [7, 15]. There is 
no study comparing the difference in discharge time for local anesthesia and general 
anesthesia in umbilical hernia patients.
In our opinion, patients that would be eligible to undergo umbilical hernia repair under 
local anesthesia are cooperative patients with a low to normal BMI without certain men-
tal disorders or physical disabilities and with a primary, up to maximally 4–5 cm large, 
non-recurrent umbilical hernia that will undergo repair in an elective setting. In case of 
end-stage cardiac and/or pulmonary disease local anesthesia must be considered as the 
preferred option.
This review has some limitations. Heterogeneity is the main disadvantage of this study. 
There is no consensus regarding the injection technique or the anesthetic drug that 
should be used. Postoperative pain, an essential outcome parameter, is not thoroughly 
described, and no standardized questionnaires were used to measure this outcome 
parameter. Furthermore, it is not clear if the complications and recurrences described 
in the included articles, occurred in the patient group we aimed to investigate. Finally, 
we cannot conclude if patients with umbilical hernia treated with local anesthesia have 
a shorter duration of operation and a shorter duration of stay, since no comparison is 
made with a control group. Based on our findings, we cannot state that local anesthesia 
for umbilical hernia patients has any advantages.
CONCLUSION
Local anesthesia for umbilical hernia patients seems safe and feasible. However, the 
advantages of local anesthesia are not sufficiently demonstrated in the currently avail-
able literature. Almost every outcome parameter is not specified for the patient group 
we aimed to investigate: patients with umbilical hernia treated with local anesthesia. 
We still do not know if local anesthesia for umbilical hernia gives excellent results, so we 
cannot implement it in daily practice. Therefore, we propose to initiate a randomized 
controlled trial, comparing local anesthesia with general anesthesia for patients with 
umbilical hernia. This could reveal if local anesthesia has any advantages.
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APPENDIX 1
Literature search strategy
PubMed Publisher: 15
In PubMed the following search strategy was performed: ((((umbilic*[tiab] OR ‘‘abdomi-
nal wall’’[tiab] OR ventral[tiab]) AND (herni*[tiab] OR defect*[tiab])) OR exomphal*[tiab])) 
AND ((((local[tiab] OR topical[tiab] OR region*[tiab] OR infiltrat*[tiab] OR conduct*[tiab] 
OR block*[tiab]) AND (anesthe*[tiab] OR anaesthe*[tiab])) OR ((ambula*[tiab] OR 
day[tiab] OR daycare[tiab] OR outpatient*[tiab] OR “short stay”[tiab]) AND (surg*[tiab] 
OR setting*[tiab] OR operati*[tiab] OR procedure*[tiab] OR treat*[tiab] OR therap*[tiab] 
OR repair*[tiab] OR hernioplast*[tiab] OR herniorrhaph*[tiab])) OR ‘‘day case’’[tiab])) AND 
publisher[sb].
Embase: 507
In Embase the following search strategy was performed: (‘umbilical hernia’/de OR 
‘abdominal wall hernia’/de OR (umbilicus/de AND (hernioplasty/de OR herniorrhaphy/
de)) OR (((umbilic* OR ‘abdominal wall’ OR ventral) NEAR/6 (herni* OR defect*)) OR 
exomphal*):ab,ti) AND (‘local anesthetic agent’/exp OR ‘local anesthesia’/exp OR ‘am-
bulatory surgery’/de OR ‘outpatient department’/de OR outpatient/de OR ‘ambulatory 
care’/de OR ‘anesthetic needle’/de OR (((local OR topical OR region* OR infiltrat* OR 
conduct* OR block*) NEAR/3 (anesthe* OR anaesthe*)) OR ((ambula* OR day OR daycare 
OR outpatient* OR ‘short stay’) NEAR/3 (surg* OR setting* OR operati* OR procedure* 
OR treat* OR therap* OR repair* OR hernioplast* OR herniorrhaph*)) OR ‘day case’):ab,ti).
MEDLINE: 36
In MEDLINE the following search strategy was performed: (‘‘Hernia, Umbilical’’/OR ‘‘Her-
nia, Ventral’’/OR (umbilicus/AND (herniorrhaphy/)) OR (((umbilic* OR ‘‘abdominal wall’’ 
OR ventral) ADJ6 (herni* OR defect*)) OR exomphal*).ab,ti.) AND (‘‘Anesthesia, Local’’/
OR ‘‘Anesthetics, Local’’/OR ‘‘Ambulatory Surgical Procedures’’/OR ‘‘outpatients’’/OR ‘‘Am-
bulatory Care’’/OR (((local OR topical OR region* OR infiltrat* OR conduct* OR block*) 
ADJ3 (anesthe* OR anaesthe*)) OR ((ambula* OR day OR daycare OR outpatient* OR 
“short stay”) ADJ3 (surg* OR setting* OR operati* OR procedure* OR treat* OR therap* 
OR repair* OR hernioplast* OR herniorrhaph*)) OR ‘‘day case’’).ab,ti.).
Cochrane: 6
In Cochrane the following search strategy was performed: ((((umbilic* OR ‘abdominal 
wall’ OR ventral) NEAR/6 (herni* OR defect*)) OR exomphal*):ab,ti) AND ((((local OR topi-
cal OR region* OR infiltrat* OR conduct* OR block*) NEAR/3 (anesthe* OR anaesthe*)) OR 
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((ambula* OR day OR daycare OR outpatient* OR ‘short stay’) NEAR/3 (surg* OR setting* 
OR operati* OR procedure* OR treat* OR therap* OR repair* OR hernioplast* OR hernior-
rhaph*)) OR ‘day case’):ab,ti).
Web of Science: 152
In Web of Science the following search strategy was performed: TS = (((((umbilic* OR 
‘‘abdominal wall’’ OR ventral) NEAR/6 (herni* OR defect*)) OR exomphal*)) AND ((((local 
OR topical OR region* OR infiltrat* OR conduct* OR block*) NEAR/3 (anesthe* OR anaes-
the*)) OR ((ambula* OR day OR daycare OR outpatient* OR “short stay”) NEAR/3 (surg* 
OR setting* OR operati* OR procedure* OR treat* OR therap* OR repair* OR hernioplast* 
OR herniorrhaph*)) OR ‘‘day case’’))).
Scopus: 230
In Scopus the following search strategy was performed: TITLE-ABS-KEY(((((umbilic* OR 
‘‘abdominal wall’’ OR ventral) W/6 (herni* OR defect*)) OR exomphal*)) AND ((((local OR 
topical OR region* OR infiltrat* OR conduct* OR block*) W/3 (anesthe* OR anaesthe*)) 
OR ((ambula* OR day OR daycare OR outpatient* OR “short stay”) W/3 (surg* OR setting* 
OR operati* OR procedure* OR treat* OR therap* OR repair* OR hernioplast* OR hernior-
rhaph*)) OR ‘‘day case’’))).
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ABSTRACT
Introduction
Complications after inguinal hernioplasty pose a significant burden on individual 
patients and society because of high numbers of repair procedures. Recently, the 
long-term results of a self-gripping ProGrip™ mesh for open inguinal hernia repair have 
become available. The aim of this meta-analyses was to compare these long-term results 
with the results of a Lichtenstein hernioplasty with a sutured mesh focusing on chronic 
pain, recurrence rate, foreign body sensation, and operation duration.
Methods
A systematic review of the literature was undertaken to identify randomized controlled 
trials comparing open inguinal hernia repair with a self-gripping ProGrip™ mesh and a 
conventional Lichtenstein hernioplasty.
Results
In the present meta-analysis, the outcomes of ten randomized controlled trials enrolling 
2541 patients were pooled. The mean follow-up was 24 months (range 6–72 months). 
There was no significant difference in the incidence of chronic pain (odds ratio = 0.93; 
95 percent confidence interval, 0.74–1.18), recurrence (odds ratio = 1.34; 95 percent 
confidence interval, 0.82–2.19), or foreign body sensation (odds ratio = 0.82; 95 percent 
confidence interval, 0.65–1.03), between the self-gripping mesh and sutured mesh 
group at all follow-up time points. The mean operating time was significantly shorter 
(odds ratio = −7.58; 95 percent confidence interval, −9.58 to −5.58) in the self-gripping 
mesh group.
Conclusions
The self-gripping mesh has comparable results with a sutured mesh regarding the 
incidence of chronic postoperative inguinal pain, recurrence and foreign body sensa-
tion. However, long-term results still are based on relatively small patient numbers and 
outcomes measures are heterogenic. The main advantage of the self-gripping mesh is 
the consistently significantly reduced operation time.
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INTRODUCTION
Open hernia repair according to Lichtenstein and endoscopic inguinal hernia tech-
niques still are recommended as the best evidence-based options for the repair of a 
symptomatic primary unilateral inguinal hernia, providing the surgeon is sufficiently ex-
perienced in the specific procedure [1]. Factors popularizing the Lichtenstein technique 
compared with the endoscopic techniques are its easiness to perform, lower rate of seri-
ous complications, and the possibility to perform the operation under local anesthesia 
[2-4]. Because the recurrence rate for both techniques has been reduced to less than 
the rate of chronic postoperative inguinal pain (CPIP), CPIP and its consequences for the 
quality of life (QOL) are the challenges of modern hernia surgery [5]. This is also urged by 
the high incidence of CPIP – which is ≈ 10 percent – and because of its socioeconomic 
effects [1, 5, 6]. The pathophysiology of CPIP is regarded multifactorial due to patient-
related and surgery-related risk factors [6-9]. Among the surgical risk factors are the type 
of mesh and its fixation technique [5, 10, 11]. Several meta-analyses have shown that 
lightweight meshes are associated with less CPIP and less foreign body feeling because 
of a reduced inflammatory response and a less intense foreign body reaction, although 
the incidence of severe CPIP is not significantly lower [12-14]. It is thought that fixation 
of meshes with traumatic devices such as sutures or tacks can cause entrapment and 
injury of muscles and nerve fibers [15, 16]. Numerous studies therefore aimed to reduce 
the need for fixating materials in tension-free hernia repair. Results of meta-analysis 
examining glue fixation of mesh are heterogeneous [17-20]. Another atraumatic way 
of mesh fixation may be found in the self-gripping ProGrip™ mesh (Medtronic, Dublin, 
Ireland). This component semiresorbable macroporous knit made of monofilament 
polypropylene (Parietene™ ProGrip™) or polyester (Parietex™ ProGrip™) incorporates a 
one-sided coating of resorbable micro-hooks providing atraumatic anchorage of the 
mesh in the underlying tissue bed. The self-gripping mesh is supposed to reduce CPIP 
because of atraumatic mesh fixation and the use of low-weight monofilament mesh, 
thereby reducing the material-dependent inflammatory reaction. Several randomized 
controlled trials have compared the Lichtenstein repair using this self-gripping mesh 
with the Lichtenstein repair using a conventionally sutured mesh, and long-term results 
of these studies have become available. Because former meta-analyses are based on 
short-term results, a new meta-analysis was performed to investigate differences in the 
occurrence of CPIP and recurrence rate between a sutured mesh and a self-gripping 
mesh in the long term [21-24].
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METHODS
The systematic review and meta-analysis was conducted following the Preferred Report-
ing Items for Systematic Reviews and Meta-Analysis (PRISMA) statement [25]. All trials 
published up to January 2017 comparing self-gripping mesh and conventional sutured 
mesh for the Lichtenstein procedure were identified. The literature search was performed 
in the following databases: Embase, MEDLINE Ovid, CINAHL EBSCOhost, Cochrane, Web 
of Science, Scopus, and Google Scholar. The search strategy was designed by a biomedi-
cal information specialist of the Medical Library (Erasmus University Medical Center, 
Rotterdam, the Netherlands). A syntax with search terms was prepared; both the syntax 
and the search strategy are available in Appendix 1.
All identified records were transferred into an EndNote database (EndNote X7.7.1, Thom-
son Reuters, New-York). Two identical duplicate versions of this database were evalu-
ated individually by two independent reviewers (M.M. and R.K.). First, all records were 
screened by title and abstract for eligibility. After this step, both independent libraries 
were combined and compared via an EndNote comparing strategy [26]. Then all full-text 
articles were assessed for eligibility. Any discrepancies were discussed between the two 
reviewers and the senior author (J.F.L.).
Studies were included in the meta-analysis if they met all the following inclusion criteria: 
randomized controlled trials enrolling adult patients with a unilateral or bilateral primary 
inguinal hernia; hernia repair according to Lichtenstein comparing either a self-gripping 
polypropylene or polyester mesh (respectively, Parietene™ ProGrip™ and Parietex™ 
ProGrip™ mesh, Medtronic) with a conventional mesh being sutured; CPIP among the 
primary or secondary outcomes. Articles had to be written in Dutch, English, or German. 
Interim analyses were excluded if an article with longer follow-up was available.
The following outcomes were extracted from the included trial: CPIP, foreign body sen-
sation (FBS), and recurrence of hernia. The methodologic quality of the included studies 
was assessed according to criteria specified by the Cochrane handbook for Systematic 
Reviews of Interventions Version 5.0.1 and the guidelines of Jadad and colleagues [27] 
and Higgins and colleagues [28]. In addition, all trials were scored on the availability of 
a baseline pain score, a validated assessment tool for CPIP, a definition of the outcome 
parameter CPIP, data on extra sutures placed in the self-gripping mesh group and peri-
operative nerve handling. Both reviewers independently sampled the data of all articles 
into a standardized database. This database was set up in Review Manager (RevMan, 
version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 
2014). A random check was performed by the senior author (J.F.L.).
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Data analysis
A random effects model was used to calculate a pooled mean of the data, taking into ac-
count both the variance between studies and study populations and the variance within 
a study [29]. For continuous data, the mean difference with a 95 percent confidence 
interval (CI) was calculated; for dichotomous data, the effect measures odds ratio (OR) 
and risk ratio (RR) with 95 percent CI were calculated to evaluate the statistical difference 
between outcomes. Because RevMan 5.3 excludes trials with zero events when calculat-
ing an OR or RR, a risk difference (RD) also was calculated in which zero event trials 
were included. Outcomes were displayed in forest plots. Statistical heterogeneity was 
assessed by calculating the test statistic Cochran’s Q. The consistency of study effects 
was tested using I² statistic [30]. I² values of 0 to 25 percent was assigned as low, 25 to 
50 percent moderate, and 75 to 100 percent as high. In addition, the overall effect was 
provided for each total or subtotal. Analyses were performed using RevMan 5.3.
Outcomes not presented as mean (SD) but as mean (range, 95 percent CI, interquartile 
range or nothing at all) were not included in the combined analyses.
RESULTS
In total, 464 articles were identified after the removal of duplicates. After screening of 
these records, 42 articles were found eligible for full-text assessment. After assessment 
of the full-text versions, nine articles were suitable for inclusion in this meta-analysis. 
Another article was identified though a monthly mail summarizing recently published 
articles [31]. During the writing of the meta-analyses the long-term results of two already 
included studies were published and included in the meta-analyses [32, 33]. A PRISMA 
flowchart of the literature search is shown in Figure 1.
The included ten randomized controlled trials enrolled 2541 patients (n  =  1216 self-
gripping mesh group, n = 1245 sutured mesh group). The duration of follow-up ranged 
from 6 to 72 months. Study characteristics are shown in Tables 1 and 2.
Methodologic quality of included studies
The quality assessment of the study methods according to the Cochrane guidelines is 
given in Table 3, including a Jadad Score. Three of the ten included studies scored <4 
points. The quality of two trials was poor (2 points) due the absence of an adequate 
randomization technique or no information about it, absence of blinding, no power 
calculations, and no baseline score [34, 42]. The quality of one trial was moderate (3 
points) due to the absence of blinding and baseline scoring [40]. The study reported by 
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Fan and colleagues scored 5 points, although it was not powered for the outcome CPIP 
and did not provide a definition nor an assessment method of CPIP [31].
Four studies did not perform a baseline pain score although preoperative pain is a well-
known risk factor for CPIP [31, 34, 35, 40]. Four studies only performed a quantitative 
assessment of CPIP and no qualitative assessment with some kind of QOL score [34, 39, 
40, 42].
Some trials compared different types of meshes in the two study groups instead of only 
changing the method of mesh fixation (polypropylene and polyester, and heavyweight 
and low-weight) [31, 33, 34, 40].
CPIP definition
Other than Fan and colleagues [31] and Esteban and colleagues [35], all authors provided 
a definition of the primary or secondary outcome parameter CPIP. Three studies referred 
Records identified through 
database searching 
(n = 1021) 
Additional records identified 
through other sources 
(n = 1) 
Records after duplicates removed 
(n = 464 + 1) 
Records screened 
(n = 465) 
Records excluded 
(n = 422) 
Full-text articles assessed 
for eligibility 
(n = 43) 
Full-text articles excluded (n = 33): 
- Non-RCT study design (n = 12) 
- Meta-analysis (n = 5) 
- Interim analysis (n = 3) 
- Recurrent hernia (n = 3) 
- Abstract only (n = 2) 
- Letter to the editor (n = 2) 
- Review article (n = 2) 
- Glue fixation (n = 2) 
- Different hernia (n = 1) 
- Different mesh (n = 1) 
Studies included in 
qualitative synthesis 
(n = 10) 
Studies included in 
quantitative synthesis 
(meta-analysis) 
(n = 10) 
Figure 1. PRISMA flow diagram
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Table 2. Characteristics of included studies
First Author
Year of 
publication
Type of anesthesia
ProGrip versus Sutured 
mesh
Operation team Extra 
stitch
Nerve handling
Chatzimavroudis 
2014 [34]
 GA Experienced surgeons Chastan† Nerves were identified 
and preserved
Esteban 2014 [35]  SA Experienced surgeons No Nerves were preserved, 
but not systematically 
search
Fan 2017 [31]  17 versus 19 SA
  5 versus  4 GA
Experienced surgeons 
or supervised 
advanced surgical 
trainees; P > 0.05*
No Nerves were protected
Jorgensen 2013 
[36]
 22 versus 16 LA
  2 versus  4 SA
 77 versus 81 GA
Experienced surgeons No Attention was paid 
to identification and 
preservation of nerves. 
Any nerve division was 
recorded
Molegraaf 2017 
[37]
123 versus 119 SA
 41 versus  47 GA
Experienced surgeons 
or supervised surgical 
trainees; P > 0.05*
Chastan† According to Wijsmuller et 
al.‡; nerve divisions were 
recorded
Nikkolo 2014 [38]   1 versus  0 LA
  7 versus 11 SA
 93 versus 89 GA
Experienced surgeons 
or supervised surgical 
trainees; P > 0.05*
No All nerves in the inguinal 
canal were identified and 
preserved when possible
Pierides 2012 [39]  63 versus 61 LA + IV sed
 34 versus 34 SA
  3 versus  5 GA
Experienced surgeons – All nerves in the inguinal 
canal were identified and 
preserved when possible
Porrero 2015 [40]  RA Experienced surgeons No All nerves in the inguinal 
canal were identified and 
preserved when possible
Sanders 2014 [41]  17 versus 20 LA + IV sed
 17 versus 16 SA
 66 versus 65 GA
Experienced surgeons Chastan† According to Wijsmuller et 
al.‡; nerve divisions were 
recorded
Zwaans 2018 [33] 133 versus 139 SA
 49 versus  42 GA
Experienced surgeons 
or supervised surgical 
trainees; P > 0.05*
No All nerves in the inguinal 
canal were identified and 
preserved when possible; 
nerve divisions were 
recorded
GA = general anesthesia. SA = spinal anesthesia. LA = local anesthesia. IV sed = intravenous sedation. RA = 
regional anesthesia.
* No significant difference in experience level per study group.
† Chastan: one suture (2-0 polypropylene suture, Prolene®, Ethicon, Johnson & Johnson, New Brunswick, 
New Jersey) is allowed to be placed superficially to the pubic tubercle to prevent mesh dislocation [44].
‡ Wijsmuller et al.: identify and preserve all three inguinal nerves during open inguinal hernia repair to re-
duce the risk of chronic groin pain; perform elective resection of a suspected injured nerve [10].
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to the definition provided by the International Association for the Study of Pain, which 
states that “chronic pain is any pain that persists beyond the normal tissue healing time 
usually taken to be 3 months” [34, 37, 39, 43]. Three other studies used a threshold of a 
minimal Visual Analog Scale score of ≥30/100 [36], 40/100 [40], or 45/150 [41] after which 
discomfort was regarded to be pain. Three authors used a time frame of 6 [32] or 12 [33, 
36] months.
Meshes
In the study group, patients were treated with either a polypropylene self-gripping 
mesh (Parietene™ ProGrip™ mesh, 64 percent) or a polyester self-gripping mesh (Pari-
etex™ ProGrip™ mesh, 36 percent). In the control group, different meshes were used (i.e., 
heavyweight polypropylene [31, 33, 34, 40], low-weight polypropylene [35], Parietene™ 
Light [36, 39, 41], Parietex™ Light [37], or Optilene® LP [32]). Five studies assessed meshes 
of the same material, construction, and weight in both the study group and the control 
Table 3. Risk of bias
First Author
Year of 
publication
Randomization 
technique 
(selection bias)
Allocation 
concealment
Blinding 
(performance 
bias)
Lost to or 
incomplete FU
ProGrip mesh
Sutured mesh
Baseline 
comparable
Jadad
scores
Chatzimavroudis 
2014 [34]
NG Sealed 
envelope
Not blind 0/25
0/25
No baseline 
score
2
Esteban 2014 
[35]
Self-written Drawing a 
paper out of 
a bag
NG 6/45
5/45
No baseline 
score
2
Fan 2017 [31] Computer 
generated
Computer 
display during 
operation
Double blind 13/58 No baseline 
score
5
Jorgensen 2013 
[36]
Computer 
generated
Sealed 
envelopes
Double blind 4/163
4/171
Yes 5
Molegraaf 2017 
[37]
Computer 
generated
Online 
message 
during the 
operation
Double blind 18/166
16/164
Yes 5
Nikkolo 2014 
[38]
Computer 
generated
Sealed 
envelopes
Single blind 1/70
2/75
Yes 4
Pierides 2012 
[39]
Shuffled 
envelopes
Sealed 
envelopes
Double blind 40/198
30/196
Yes 4
Porrero 2015 
[40]
Computer 
generated
Computer-
generated list
Not blind 0/89
0/89
No baseline 
score
3
Sanders 2014 
[41]
Computer 
generated
Sealed 
envelopes
Single blind 26/270
31/287
Yes 4
Zwaans 2018 
[33]
Computer 
generated
Sealed 
envelopes
Double blind 14/168
14/170
Yes 5
NG = not given; FU = follow-up
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group except for the additional polylactic acid micro-hooks on the study group mesh 
[35-37, 39].
Chronic pain
CPIP was assessed in all trials and nine of them reported the incidence of chronic pain 
according to the definition used in their study protocol [31-37, 39, 40]. Incidence rates 
were analyzed separately for the different moments of follow-up (3, 6–12, 24, 36, and 72 
months). Heterogeneity between the trials was very unlikely (P = .87, Q/df < 1, I² 0 percent). 
At all follow-up time points, there was no significant difference in the incidence of CPIP 
between the self-gripping mesh and sutured mesh group (3 months OR = 0.89, 95 per-
cent confidence interval [CI], 0.48–1.64; 6–12 months OR = 1.00; 95 percent CI, 0.75–1.34; 
24 months OR = 1.00; 95 percent CI, 0.39–2.61; 36–72 months OR = 0.77; 95 percent CI, 
0.38–1.58). The forest plot is shown in Figure 2A. A subgroup analyses (Figure 2B) account-
ing for mesh weight and including only studies that used a lightweight mesh in both the 
study and control group also showed no difference in CPIP rates between the self-gripping 
mesh and sutured mesh (OR = 0.89; 95 percent CI, 0.68–1.16) [32, 36, 37, 39, 42].
All studies except that of Fan and colleagues [31] presented an assessment of the in-
tensity of chronic pain, but different assessment methods were used. Although all had 
a visual analog scale score among it, both a 0 to 100 mm and a 0 to 150 mm scale were 
used. Also, outcomes were presented in different ways hindering a combined analysis. 
However, none of the studies reported a significant difference in pain intensity scores for 
CPIP between the two kinds of meshes.
A combined analysis of the quantitative assessment of CPIP, reflecting the influence 
of CPIP on daily life, was not possible because the four studies that used this kind of 
measure (SF-12, SF-36, Activity Assessment Scale (AAS)) did not provide full outcomes 
[36-38, 41]. The separate studies did not find significant differences in the QOL scores 
between the two meshes, except for Pierides and colleagues who found significantly 
improved social functioning with the self-gripping mesh [39].
Foreign body sensation
Five studies reported the rate of FBS. There was no heterogeneity among the trials (P 
= .86, Q/df < 1 and I² 0 percent). None of the studies reported a significant difference 
between groups for the rate of FBS, although the combined analyses showed a trend 
toward less FBS in the self-gripping mesh group (Figure 3). A subgroup analyses (not 
shown) corrected for mesh weight also did not reach significance. Incidences were de-
clining during follow-up except among the study population of Zwaans and colleagues 
who reported a higher incidence after 3 years compared with 1 year postoperatively [33].
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Recurrence
All trials reported recurrence rates after 12 months of follow-up. Two studies also pro-
vided recurrence rates after 24 months [34, 37], two after 36 months [32, 33], and one 
after 72 months [31]. There was no heterogeneity among the trials (P = .41, Q/df < 1 and 
I² 4 percent). The difference in recurrence rate between the self-gripping mesh group 
Figure 3. Foreign body sensation
Figure 4. Recurrence rate
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and the sutured mesh group was not significant at 12 months (OR = 1.19, 95 percent CI, 
0.61–2.31), 24 months (OR = 1.06, 95 percent CI, 0.27–4.17), or 36 months (OR = 0.95, 95 
percent CI, 0.18–5.14). A RD analysis showed the same results (12 months: RD = 0.00, 95 
percent CI, –0.01 to 0.01; 24 months: RD = 0.00, 95 percent CI, –0.03 to 0.03; Figure 4).
Extra stitch in the self-gripping mesh group
In seven of the ten studies in this meta-analyses, no extra sutures were placed in the 
self-gripping mesh group [31-33, 35, 36, 39, 40]. The three studies that allowed an extra 
stitch according to the instructions of Chastan did not perform a subgroup analysis [34, 
37, 41, 44].
Nerve handling and paresthesia
Except for Esteban and colleagues [35], all trials tried to identify and preserve the ingui-
nal nerves; four reported the actual rates of nerve identification and resection [33, 36, 
37, 41]. The techniques of nerve division of a suspected injured nerve were not clear 
from the study methods, and numbers were not always recorded (Table 2). Five stud-
ies investigated postoperative numbness in the groin region [32, 33, 36, 37, 39]. They 
found no significant difference in numbness between the two mesh fixation methods 
and reported comparable rates of nerve resection for the two study groups. Sanders and 
colleagues performed a subgroup analysis on the impact of nerve resection and mesh 
fixation method on CPIP and found that when the iliohypogastric nerve was preserved, 
postoperative pain was significantly lower in the self-gripping mesh group than the 
sutured mesh group at all follow-up points from discharge to 1 year postoperatively. 
There was no significant difference between the groups when the iliohypogastric nerve 
was resected [41]. Zwaans and colleagues reported no relation between hypesthesia or 
hyperesthesia and previous neurectomy [33].
Operation duration
Five studies reported mean operating time with SD and could contribute to the com-
bined analyses (Figure 5). The mean operating time was significantly shorter in the 
Figure 5. Operation duration
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self-gripping mesh group than in the sutured mesh group (mean difference −7.58; 95 
percent CI, −9.58 to −5.58). There was a high heterogeneity direction of effect, and the 
effect size was high and significant (Z = 7.44; P < .00001). The trials that could not con-
tribute to the combined calculation confirmed this significant reduction in operating 
time for the self-gripping mesh. The mean reduction in operation time ranged from 1 to 
10 minutes (17 percent) [36, 37].
DISCUSSION
Chronic pain and recurrence are the main complications of inguinal hernia surgery and 
need to be studied during long-term follow-up. Recently, four large trials published their 
long-term results comparing the self-gripping mesh with a sutured mesh for open ingui-
nal hernia repair; therefore, a new meta-analysis was performed, focusing on these long-
term results [31, 33, 37, 41]. In line with the individual studies, the meta-analysis showed 
no significant benefits regarding the incidence of CPIP, FBS, and recurrence rate. The 
main advantage of the self-gripping mesh thus lies in its efficiency, thereby significantly 
reducing operative times. Previous meta-analyses reported similar outcomes, but the 
inclusion of studies with short-term follow-up, low inclusion rates, or no randomization 
limits their conclusions [21-23, 45]. The negative results should be interpreted through 
patient-related and surgery-related factors as well as methodologic factors.
Before looking at the pathophysiologic factors of CPIP, there are methodologic issues 
to address when a study fails to reach its primary outcome [46]. First, is there an indi-
cation of benefit using a self-gripping mesh? It was hypothesized that a self-gripping 
lightweight mesh would lower the incidence of CPIP because of avoidance of traumatic 
suture fixation and reduction in the amount of foreign body reaction because of its 
material reduced structure. Although this hypothesis is reasonable because of the ex-
pected reduction of neuropathic and nociceptive pain stimuli, it is too simplistic. Only 
the fixation method and material weight of the mesh are changed, but not, for example, 
the surgical approach, which still needs dissection in a neuralgic plane. Therefore, 
some will wonder why an open anterior approach should be performed at all, because 
laparoscopic techniques have shown faster recovery times and a lower chronic pain risk 
[47, 48]. This disregards the obligation that surgeons have to tailor treatments based 
on expertise, local/national resources, and patient-related or hernia-related factors. For 
high-risk inguinal hernia patients with extensive comorbidities or patients with pelvic 
scarring, an open mesh repair (under local anesthesia) still is the preferred technique as 
is the case for recurrent inguinal hernia after laparoscopic repair according to the 2016 
world guidelines for groin hernia management.
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A second contributor in failure to meet the primary outcome may be that studies were 
underpowered because half of the studies enrolled <100 patients. This meta-analysis 
should address the limitations of the study size of individual RCTs; however, not all RCTs 
could contribute to the combined analyses because of differences in outcome measures. 
The combined analysis for the between-group difference in incidence of CPIP after 6 to 
12 months was based on the response of 750 patients in the self-gripping mesh group 
and 767 patients in the sutured mesh group. After 36 months, these numbers were 231 
and 233 per group, respectively, for the incidence and recurrence of CPIP. Hence, the 
long-term conclusions about CPIP and recurrence rate still are based on relatively low 
patient numbers, which lowers the strength of the results.
Other questions to be asked are whether the trials had deficiencies in their treatment 
regimen, the studied population, and the trial conduct. The latter is a focus of concern 
for two studies because they had an inadequate randomization technique, no blinding, 
no power calculations, and no baseline score [34, 35]. In addition, two other studies 
did not measure a baseline pain score, although preoperative pain is a well-known risk 
factor for CPIP [31, 40]. Thereafter, four studies did not perform a qualitative assessment 
of CPIP to evaluate the influence of CPIP on daily life and well-being [34, 35, 39, 40].
Meta-analysis should be conducted when a group of studies is sufficiently homoge-
neous in terms of subjects involved, interventions, and outcomes to minimize perfor-
mance and measuring bias so to provide a meaningful summary. This was the reason for 
including only RCTs that compared the two meshes for a Lichtenstein hernia repair in 
adult patients with a primary hernia. Recurrent hernias were excluded because this is a 
risk factor for the development of CPIP. Although the inclusion criteria were strict, there 
was still heterogeneity among the trials in this meta-analysis, caused by clinical and 
methodologic variation. First, the hernia repairs were performed by different surgeons 
with different levels of experience (trainees, general surgeons, hernia specialists). It is 
known that there is a substantial disparity between the state-of-the-art Lichtenstein 
repair and its application in general practice, especially with respect to steps that are 
suggested to play a role in the origin of chronic groin pain [49]. Other clinical variations 
that could modify the intervention effect were different types of anesthesia (spinal, 
general, regional), use of different meshes in the conventional Lichtenstein group (both 
heavyweight and lightweight), differences in the method of nerve handling, timing of 
follow-up, and whether an extra stitch was allowed for the self-gripping mesh. However, 
this clinical heterogeneity reflects daily practice and will therefore be of less influence 
on the generalizability of the results. Methodologic variation was caused by the variable 
definitions and assessment methods for CPIP and the unstandardized way of presenting 
outcomes. Thus, comparisons could be made for between-group differences in CPIP 
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rates, but not for incidence rates of CPIP overall or special subgroups. This methodologic 
heterogeneity is a common problem in hernia research and hinders comparison of out-
comes to draw firm conclusion [50-52].
Regarding surgical factors, there are several discussions specific to self-gripping mesh. 
First, there is discussion on the influence of the extra stitch in the self-gripping mesh 
group; this stitch is placed near the neuralgic pubic tubercle to prevent a medial recur-
rence. The RCTs in this meta-analysis did not perform subgroup analyses on whether 
the stitch induced more CPIP. However, a recent evaluation of the Herniamed register 
did not find a correlation. The same applies to recurrence rates [53]. From this, it may 
be concluded that although it seems to have no influence on CPIP rates, avoidance of 
the single stitch could be recommended in this neuralgic place, especially in the case of 
small or medium size hernias. A second consideration is the influence of the additional 
polylactic acid micro-hooks. It is possible that the presence of micro-hooks and their 
disintegration exaggerates the foreign body reaction, leading to inflammatory damage 
to surrounding nerves. This was not seen in experimental models, and human studies 
are not available [54]. However, because CPIP and FBS rates are not increased for the 
microgrip-added meshes, the inflammatory reaction to these micro-hooks seems be of 
less influence. Because the foreign body reaction decreased over time, however, there 
may be a relation with the resorption of the micro-hooks, which are completely resorbed 
at 12 months postoperatively. Zwaans and colleagues [33] were the only group to report 
increased FBS during follow-up, especially for their group sutured with heavyweight 
mesh. Thereafter, a possible augmented inflammatory reaction may be counterbal-
anced by the lightweight nature of the self-gripping mesh, because lightweight meshes 
are known to induce less fibrosis and hence less FBS. This brings us to the third factor 
of discussion, the influence of the lightweight macroporous structure of the ProGrip™ 
mesh. This was supposed to augment the pain-reducing effect of the atraumatic fixa-
tion, but they together failed to do so.
Nerve injury during dissection or mesh placement and fixation (or afterward by the 
inflammatory reaction), is regarded to be one of the major causative factors for CPIP; 
therefore, nerve handling is important to report [55]. Almost all studies reported trying 
to identify and protect the nerves and to resect nerves that were accidentally damaged 
or in the way of mesh placement, but only four studies reported identification and 
resection rates [33, 36, 37, 41]. These were comparable for the self-gripping and sutured 
mesh groups and do not seem to influence the between-group results. Sanders and 
colleagues and Zwaans and colleagues performed subanalyses of the effect of neurec-
tomy and found no significant influence of neurectomy on the rates of CPIP or an altered 
sensation in the groin [33, 41].
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Finally, patient-related risk factors need to be addressed. Known risk factors for the 
development of CPIP are moderate to severe preoperative pain >1 month, psychologic 
vulnerability, female sex, younger age, and genetic predisposition. They often are un-
derestimated compared with surgical factors, but there is increasing awareness of the 
individual variance in foreign body reaction and sensory disturbances that may or may 
not lead to CPIP. Hence, these patient-related risk factors need to be considered in the 
indication for surgery, which in the future can be facilitated with tests like genotyping 
and quantitative sensory testing [9, 55-57].
In this meta-analysis we did not address acute postoperative pain because we wanted to 
report the long-term results of self-gripping mesh. However, acute postoperative pain is 
one of the strongest and most consistent risk factors for CPIP, urging an approach of so-
called “preventive or pre-emptive analgesia” by the use of preoperative local anesthesia 
[58-60].
Several conclusions can be made. First, self-gripping mesh has results comparable to 
sutured mesh regarding the incidence of CPIP and recurrence. Second, the self-gripping 
mesh does not resolve CPIP; however, conclusions on long-term results still are based 
on relatively small patient numbers. Third, there is high heterogeneity in CPIP definition, 
assessment, and presentation of outcomes, making it hard to compare incidence rates. 
There must be a call for a more uniform methodology. Finally, the main advantage of 
the self-gripping mesh is its efficiency, with consistently significantly reduced operation 
times. To date, no cost-effectiveness study has been performed, but when the reduction 
time ≤17 percent is translated into better utilization of operating theatre resources and 
manpower, the higher price of the mesh could be amply compensated.
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SUPPLEMENTARY DATA: APPENDIX 1
Search strategy
Inguinal hernia open self-adhesive versus sutured mesh
Embase 262 258
MEDLINE ovid 163 18
Web of science 157 56
Scopus 292 83
Cochrane 43 1
CINAHL EBSCOhost 5 0
Google scholar 100 48
Total 1021 464
Embase: 262
(‘inguinal hernia’/exp OR hernia/de OR ‘herniorrhaphy’/de OR hernioplasty/de OR (((in-
guinal* OR groin*) NEAR/6 herni*) OR (hernia* NEAR/6 (repair* OR surg* OR operat*)) 
OR herniorrhap* OR hernioplas* OR herniaplas* OR lichtenstein* OR (liechtenstein* 
NEAR/3 (procedure* OR operat* OR surg* OR method* OR technique*))):ab,ti) AND 
(‘adhesive agent’/de OR (adhesive* OR selfadhesive* OR Self-grip* OR progrip OR su-
tureless* OR suture-less*):ab,ti) AND (‘suture’/exp OR ‘suturing method’/de OR (sutur* 
OR tacking):ab,ti)
MEDLINE Ovid: 163
(“Hernia, Inguinal”/ OR hernia/ OR “Herniorrhaphy”/ OR (((inguinal* OR groin*) ADJ6 
herni*) OR (hernia* ADJ6 (repair* OR surg* OR operat*)) OR herniorrhap* OR hernioplas* 
OR herniaplas* OR lichtenstein* OR (liechtenstein* ADJ3 (procedure* OR operat* OR 
surg* OR method* OR technique*))).ab,ti.) AND (“Adhesives”/ OR (adhesive* OR selfad-
hesive* OR Self-grip* OR progrip OR sutureless* OR suture-less*).ab,ti.) AND (“Sutures”/ 
OR “Suture Techniques”/ OR (sutur* OR tacking).ab,ti.)
CINAHL EBSCOhost: 5
(MH “Hernia, Inguinal” OR MH hernia OR MH “Herniorrhaphy” OR TI (((inguinal* OR groin*) 
N5 herni*) OR (hernia* N5 (repair* OR surg* OR operat*)) OR herniorrhap* OR herniop-
las* OR herniaplas* OR lichtenstein* OR (liechtenstein* N2 (procedure* OR operat* OR 
surg* OR method* OR technique*))) OR AB (((inguinal* OR groin*) N5 herni*) OR (hernia* 
N5 (repair* OR surg* OR operat*)) OR herniorrhap* OR hernioplas* OR herniaplas* OR 
lichtenstein* OR (liechtenstein* N2 (procedure* OR operat* OR surg* OR method* OR 
technique*)))) AND (MH “Adhesives” OR TI (adhesive* OR selfadhesive* OR Self-grip* OR 
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progrip OR sutureless* OR suture-less*) OR AB (adhesive* OR selfadhesive* OR Self-grip* 
OR progrip OR sutureless* OR suture-less*)) AND (MH “Sutures” OR MH “Suture Tech-
niques” OR TI (sutur* OR tacking) OR AB (sutur* OR tacking))
Cochrane: 43
((((inguinal* OR groin*) NEAR/6 herni*) OR (hernia* NEAR/6 (repair* OR surg* OR oper-
at*)) OR herniorrhap* OR hernioplas* OR herniaplas* OR lichtenstein* OR (liechtenstein* 
NEAR/3 (procedure* OR operat* OR surg* OR method* OR technique*))):ab,ti) AND ((ad-
hesive* OR selfadhesive* OR Self-grip* OR progrip OR sutureless* OR suture-less*):ab,ti) 
AND ((sutur* OR tacking):ab,ti)
Web of science: 157
TS=(((((inguinal* OR groin*) NEAR/5 herni*) OR (hernia* NEAR/5 (repair* OR surg* OR 
operat*)) OR herniorrhap* OR hernioplas* OR herniaplas* OR lichtenstein* OR (liech-
tenstein* NEAR/2 (procedure* OR operat* OR surg* OR method* OR technique*)))) AND 
((adhesive* OR selfadhesive* OR Self-grip* OR progrip OR sutureless* OR suture-less*)) 
AND ((sutur* OR tacking)))
Scopus: 292
TITLE-ABS-KEY(((((inguinal* OR groin*) W/5 herni*) OR (hernia* W/5 (repair* OR surg* 
OR operat*)) OR herniorrhap* OR hernioplas* OR herniaplas* OR lichtenstein* OR (liech-
tenstein* W/2 (procedure* OR operat* OR surg* OR method* OR technique*)))) AND 
((adhesive* OR selfadhesive* OR Self-grip* OR progrip OR sutureless* OR suture-less*)) 
AND ((sutur* OR tacking)))
Google scholar: 100
“inguinal | groin hernia” | ”hernia repair | surgery | operation” | herniorrhapy | hernioplasty | 
herniaplasty | ”lichtenstein procedure | operation | surgery | method | technique” selfadhe-
sive | ”self adhesive” | ”Self grip | gripping” | progrip | sutureless | ”suture less” suture | sutures

10
An international consensus algorithm 
for management of chronic 
postoperative inguinal pain
J.F.M. Lange, R. Kaufmann, A.R. Wijsmuller,  
J.P.E.N. Pierie, R.J. Ploeg, D.C. Chen, P.K. Amid
Hernia 2015 Feb;19(1):33-43
Chapter 10
228
ABSTRACT
Introduction
Tension-free mesh repair of inguinal hernia has led to uniformly low recurrence rates. 
Morbidity associated with this operation is mainly related to chronic pain. No consensus 
guidelines exist for the management of this condition. The goal of this study is to design 
an expert-based algorithm for diagnostic and therapeutic management of chronic 
inguinal postoperative pain (CPIP).
Methods
A group of surgeons considered experts on inguinal hernia surgery was solicited to 
develop the algorithm. Consensus regarding each step of an algorithm proposed by the 
authors was sought by means of the Delphi method leading to a revised expert-based 
algorithm.
Results
With the input of 28 international experts, an algorithm for a stepwise approach for 
management of CPIP was created. Twenty-six participants accepted the final algorithm 
as a consensus model. One participant could not agree with the final concept. One 
expert did not respond during the final phase.
Conclusion
There is a need for guidelines with regard to management of CPIP. This algorithm can 
serve as a guide with regard to the diagnosis, management, and treatment of these 
patients and improve clinical outcomes. If an expectative phase of a few months has 
passed without any amelioration of CPIP, a multidisciplinary approach is indicated and 
a pain management team should be consulted. Pharmacologic, behavioral, and inter-
ventional modalities including nerve blocks are essential. If conservative measures fail 
and surgery is considered, triple neurectomy, correction for recurrence with or without 
neurectomy, and meshoma removal if indicated should be performed. Surgeons less 
experienced with remedial operations for CPIP should not hesitate to refer their patients 
to dedicated hernia surgeons.
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INTRODUCTION
With the success of tension-free mesh-based inguinal repair, the incidence of chronic 
postoperative inguinal pain (CPIP) has surpassed that of recurrence after open and 
laparoscopic herniorrhaphy. Due to different definitions of CPIP the reported incidences 
of CPIP ranges from 1 to 63 percent [1-7]. Significant CPIP affects daily life of 5 to 10 per-
cent of patients [8, 9]. Quality of life has become the most relevant outcome of inguinal 
hernia repair. Considering the high prevalence of CPIP, a systematic approach is needed 
for optimal management.
In 2008, two international consensus conferences led by widely published and lectured 
panelists formally defined CPIP as new or different quality of pain (if pain existed prior to 
hernia repair) arising as a direct consequence of a nerve lesion or a disease affecting the 
somatosensory system after inguinal hernia repair [10]. Common sources of CPIP were 
considered to include hernia recurrence, nociceptive problems (tissue inflammation, 
foreign material, meshoma) and neuropathic causes (direct nerve injury or perineural 
scarring). There is no discrete distinction between neuropathic and nociceptive pain, 
and the diagnosis is further complicated by excitatory coupling between sympathetic 
and afferent nociceptive nerve fibers, neuroplasticity, deafferentation hyperalgesia, and 
pain centralization, in addition to economic, social, genetic, and patient-related factors. 
Patients with neuropathic pain classically demonstrate hypo- or hyperesthesia, allodynia, 
and paresthesia. While the majority of these patients can be managed with pharmaco-
logic, interventional, and behavioral measures, operative management is sometimes 
necessary. Complicating the management of this challenging patient population, there 
is no universally agreed consensus upon pathophysiology or treatment for CPIP. In 1999, 
Heise and Starling proposed the new syndrome of mesh-related inguinodynia [11]. It is, 
however, important to recognize that the problem of CPIP preceded mesh-based repairs 
and, in their report, CPIP after tissue-based repairs was far more common. Although 
ultrastructural histologic changes of neural tissue in contact with mesh material have 
been clinically and experimentally described, the presence of a mesh, per se, is not 
causative [12-14]. In 2004, Amid described potential risk factors for developing acute 
pain after open mesh repair: taut fixation of the mesh instead of fixation with some 
laxity, peri-ostial sutures, and herniotomy instead of repositioning of the hernia sac [15].
In CPIP, neuropathic pain predominates over nociceptive or visceral pain. Amid empha-
sized the role of iatrogenic damage to one or more of the three inguinal nerves from 
direct damage due to direct contact of mesh with nerves, unrecognized nerve injury, or 
nerve entrapment from suture or mesh fixation as the primary cause of neuropathy. The 
central causative role of the three inguinal nerves in CPIP is supported by the favorable 
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results of therapeutic neurectomy [16-18]. Structural changes of the mesh as it contracts 
and fibroses may lead to nociceptive pain or nerve entrapment by wrinkling of the mesh, 
representing a so-called meshoma [19]. Mesh excision has reduced CPIP in patients in 
which a meshoma was identified based on clinical and radiographic examination.
There are several options for the treatment of CPIP often dictated by the expertise of the 
specialist caring for a patient. Conservative treatment modalities include non-steroidal 
anti-inflammatory agents, neuropathic medications, opioids, topical anesthetics, behav-
ioral therapy, and physical therapy. Non-surgical interventional treatment includes local 
nerve blocks, steroid injections, cryotherapy, alcohol or phenol injection, transcutane-
ous nerve stimulators, and neurolysis [20]. These methods may serve both diagnostic 
and therapeutic roles and can aid in the identification and localization of the involved 
nerves. Operative management is reserved for cases refractory to conservative measures 
and consists of variations of groin exploration, mesh removal, and neurectomy [11, 14, 
21].
Despite numerous publications addressing treatment of CPIP, no consensus guidelines 
regarding its management currently exist. Considering the high prevalence of CPIP, the 
magnitude of the problem is too great to depend solely upon dedicated hernia surgeons 
for management. Most hernia repairs are performed by general surgeons and the initial 
management of CPIP is done by a general surgeon or primary care physician. Many 
patients can be treated without reoperation and early intervention will help to prevent 
centralization of pain. The goal of this project was to develop a consensus algorithm 
with a stepwise approach to patients with CPIP, summarizing best-available practices 
based on the expertise of international specialists managing this condition.
METHODS
The objective of this study was the development of a consensus algorithm based on the 
opinion of an international group of surgeons considered experts on inguinal hernia 
surgery. Experts invited to participate in this study were:
1. Surgeons with one or more publications on surgical aspects regarding CPIP.
2. Chairman of study sessions on CPIP in major international hernia congresses in 2010, 
2011 and 2012 (EHS Istanbul, RICH Rotterdam, AHS New York).
3. Surgeons identified as experts by peers in the first two groups.
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An initial algorithm proposed by the authors was presented to this group for commen-
tary. All inputs were implemented into a revised version of the algorithm. This second 
algorithm was the focus of discussion and debate during an expert meeting on CPIP 
during the 2012 combined congress of the American (AHS) and European (EHS) Hernia 
Societies in New York leading to a revised third version.
In the subsequent stage of the study, consensus regarding each step of the algorithm 
was sought based on the Delphi method in which anonymous and ongoing responses 
from the predefined group of surgeons led to a decision that is representative of this 
“collective intelligence” [22]. All consultants were asked to anonymously respond to each 
step of the algorithm. Steps that did not have 100 percent agreement were submitted 
back as a multiple choice survey in which all responses of the expert group were incor-
porated as possible answers. It was agreed that the answer with the most votes would 
be the consensus response for that respective step. The final version distilled from this 
process was sent to all experts for review. Three response options were possible:
1. Total agreement
2. Partial agreement but approval of the flowchart for practical use
3. Disagreement and rejection
RESULTS
Forty-seven experts were identified and invited to participate in this study. Of these 47 
experts, 28 responded and agreed to participate. From these 28 consultants, 15 partici-
pants provided additional comments and feedback on the initially proposed algorithm. 
Responses were collected and analyzed, with identification of common and conflicting 
viewpoints summarized in a second iteration.
The second version did not differ significantly with regard to the basic structure of the 
algorithm. The algorithm starts with the two categories of patients who require medi-
cal attention: patients with pain immediately after inguinal hernia surgery (acute pain) 
and patients who develop pain later in their course. This second group is subdivided 
in two categories: patients who complain in the early postoperative phase and those 
who have persistent pain or develop pain after some months. Acute, excruciating pain 
is considered an indication for early re-exploration. If postoperative pain develops later 
in the course of recovery or if symptoms of pain persist beyond the normal postopera-
tive recovery period, an expectative phase of 3 months is indicated. During this time, 
analgesics and conservative measures are recommended.
Chapter 10
232
If pain persists after 3 months, recurrence should be excluded based on physical exami-
nation. In cases of clinical recurrence, operative correction is indicated, with or without 
triple neurectomy depending on the type of pain (neuropathic or nociceptive). If physi-
cal examination does not demonstrate recurrence, ultrasonography is recommended as 
the initial diagnostic procedure of choice to exclude occult recurrence or meshoma. If 
ultrasonography is unrevealing, cross-sectional imaging with MRI might detect poten-
tial recurrence, meshoma, or other pathologies.
If recurrence is identified and associated with pain, open anterior repair is recommend-
ed in conjunction with triple neurectomy if accompanied by neuropathic pain. If the 
initial hernia operation was an anterior repair (Lichtenstein, Shouldice, Bassini, McVay), 
laparoscopic surgery is not the primary recommended modality because placement of 
mesh in the preperitoneal space may lead to additional neuropathy of the preperitoneal 
nerves (main trunk of the genitofemoral nerve and the preperitoneal segment of its 
genital branch). This is contrary to the recommendations for simple recurrence without 
neuropathic pain which would favor a laparoscopic remedial operation. If laparoscopic 
repair of recurrence fails to address the pain, it would not be possible to differentiate 
whether the source of pain is from neuropathy of nerves in front or behind the trans-
versalis fascia. If the initial hernia operation was a posterior repair (TEP, TAPP, PHS, TIPP, 
and other preperitoneal repairs), anterior repair is recommended with open “extended” 
triple neurectomy including the genitofemoral nerve trunk if needed. Laparoscopic 
repair for recurrence may be performed but neuropathic pain if present must be ad-
dressed with retroperitoneal triple neurectomy proximal to the site of neuropathy.
If no anatomical pathology is identified, the surgeon should refer the patient to a 
pain management team familiar with CPIP. In addition to pharmacologic and behav-
ioral treatment, interventions play a major role in the diagnosis and treatment of CPIP. 
Nerve blocks of the ilioinguinal, iliohypogastric, and genital nerves are of significant 
importance as they serve both a diagnostic and therapeutic role. If conservative or 
interventional modalities are unsuccessful or not durable, surgical intervention should 
be offered. If the original operation involves mesh in the preperitoneal space from open 
or laparoscopic repair, open extended triple neurectomy to resect the genitofemoral 
trunk or laparoscopic retroperitoneal triple neurectomy is indicated [18].
With the second iteration, all participating experts were independently surveyed. 
Consensus was reached on 19 of the 28 steps in this algorithm. There were divergent 
responses on nine of the 28 steps. The authors defined nine multiple choice questions 
based on the submitted responses. Participants of the expert panel agreed that the 
majority response would be selected in the algorithm.
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MULTIPLE CHOICE QUESTIONS ABOUT ALGORITHM ON CPIP
1.  When a patient presents with postoperative pain after inguinal hernia surgery without any signs of 
overt pathology like recurrence, abscess, hematoma etc., how long do we want to stay expectative 
after operation?
 A) 0–3 months
 B) 3–6 months
 C) 6–9 months
 D) 9–12 months
2. What should we do during the expectative phase?
 A) Only watchful waiting, possibly with “basic analgesics”
 B) Already try to treat with specific analgesics such as Neurontin or Lyrica
 C) Already consult pain team
 D) Already consult neurologist
3. How to differentiate between neuropathic and nociceptive pain?
 A) The surgeon can differentiate this based on his physical examination and experience
 B) The surgeon should use the McGill-pain questionnaire
 C) The surgeon should use the CRPS-score
 D) Differentiation should be done by a dedicated anesthesiologist
 E) Differentiation should be done by a neurologist
  F)  There is no need to differentiate between nociceptive and neuropathic pain; pain=pain and 
differentiation has no implication for the algorithm
4. To evaluate if the patient has a recurrence
 A) Physical examination is enough and as reliable as imaging
 B) Ultrasonography is the first choice of imaging, like in the current algorithm
 C) Ultrasonography should be bypassed by MRI directly
 D) Herniography is as good as ultrasonography as a first choice of imaging
5. When recurrence is diagnosed as the cause of pain (no obvious consensus 52 versus 48%)
 A) Repair is sufficient
 B) Repair should always be accompanied by triple neurectomy
 C) Repair should be accompanied by triple neurectomy only if there is neuropathic pain
6. When re-operation is indicated in case of postoperative pain
  A)  The pain team should be consulted for elaborate peri-operative pain management in case of pain due 
to recurrence
  B)  The pain team should be consulted for elaborate peri-operative pain management in case of 
neuropathic pain
  C)  The pain team should be consulted for elaborate peri-operative pain management in case of meshoma
  D) The pain team should be consulted for elaborate peri-operative pain management in all cases
  E) The pain team is already involved because re-operation should be recommended by the pain team
7. When a meshoma is diagnosed with ultrasonography
  A) You do not have to verify this by MRI as ultrasonography is sufficient to diagnose meshoma
  B) MRI should always be performed to verify this
8. Re-operation in case of pain should
  A) Always be performed by an expert/herniologist
  B) Can be performed by a general surgeon
  C) Can be performed by a general surgeon only in case of recurrence (without neuropathic pain)
9. Local infiltration in diagnostic or therapeutic setting
  A) Should be performed by the pain team
  B) Should be performed by the surgeon
Figure 1. Most-voted answers are underlined
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Twenty-one of the original 28 experts participated in the Delphi method stage of al-
gorithm development. The nine questions with divergent opinions are listed in Figure 
1 with the majority answer underlined. For eight out of nine questions, there was an 
answer with a vast majority. Question No. 5 had equal responses for answer A and C and 
the responses were integrated to represent both opinions. The majority responses of 
the 23 remaining experts led to the final iteration of the algorithm (Figure 2). Of the 28 
participating experts, 26 accepted the consensus algorithm: 12 totally agreed with the 
algorithm, 14 agreed despite a few minor details with overall approval of the algorithm. 
One expert could not agree with the final concept. One expert did not respond during 
the final phase.
DISCUSSION
Recurrence has become a lesser issue in modern inguinal hernia surgery owing to the 
success of tension-free mesh-based repairs. Correspondingly, quality of life and the 
avoidance of CPIP are considered primary outcomes of elective inguinal herniorrhaphy. 
The high incidence of CPIP has become a significant factor in the consideration of a 
“watchful waiting” approach for elderly and asymptomatic inguinal hernia patients. CPIP 
has increasingly been identified as an important outcome of clinical trials and its pre-
vention and management have become prominent topics in inguinal hernia research.
The International Association for the Study of Pain (IASP) broadly classifies postherni-
orrhaphy inguinodynia into nociceptive and neuropathic pain [23]. Nociceptive pain 
is caused by activation of nociceptors by nociceptive molecules. It is caused by tissue 
injury or inflammatory reaction. Neuropathic pain is caused by direct nerve injury. It 
is characterized by inguinodynia with radiation to the scrotum/femoral triangle, pares-
thesia, allodynia, hyperpathia, hyperalgesia, hyperesthesia, hypoesthesia, and positive 
Tinel’s sign. There is no precise demarcation between nociceptive and neuropathic pain, 
and the complexity of diagnosis is increased by social, genetic, patient, and psychologi-
cal factors.
In-depth groin neuroanatomy knowledge is of paramount importance to prevent and 
treat postherniorrhaphy chronic pain. Knowledge of the original operative technique 
and detailed evaluation of the original operative report help to determine the likely 
etiologies of pain and the nerves at risk. The diagnosis is very much dependent on a 
detailed history and physical examination. Physical exam findings are dependent on the 
neuroanatomic course of the three inguinal nerves, their respective dermatomes, and 
the presences of mesh or recurrence. Tools including pre-operative dermatomal map-
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ping [18], quantitative sensory testing, imaging, and diagnostic interventions (nerve 
blocks) help to characterize the etiology and direct treatment.
Treatment of the patient with CPIP remains a challenge and several different therapeutic 
strategies have been proposed. Conservative treatment with pharmacologic, topical, be-
havioral, and expectant measures is advocated in all patients. Interventional techniques 
including nerve infiltration, blockade, neuromodulation, and ablative techniques have 
all been used in the management of CPIP. Results of selective or triple neurectomy of one 
or more of the three inguinal nerves and resection of meshoma have been published 
with practical efficacy [15, 19]. Despite this volume of information, no consensus on the 
management of CPIP has been published and high-level evidence on the management 
of CPIP is lacking. Triple neurectomy described by Amid in 1995 is currently an accepted 
surgical treatment for neuropathic pain refractory to conservative measures [10].
While some surgeons have had success with selective neurectomy, triple neurectomy 
is generally recommended due to neuroanatomic and technical considerations. There 
is significant cross-innervation between the inguinal nerves and reoperating in the 
scarred field becomes increasingly more difficult and morbid for subsequent remedial 
operations. Extensive study of the anatomical variation of these nerves from the retro-
peritoneum to its terminal branches in the inguinal canal demonstrates significant varia-
tion in the number, location, and cross-innervation of these three nerves. In addition, 
visual identification of the nerve at the time of reoperation cannot adequately exclude 
injury. Electron micrography of grossly normal nerves resected at the time of triple 
neurectomy often demonstrates ultrastructural nerve damage. It is often challenging 
to identify nerves in the scarred field. Reoperation, especially with concurrent mesh 
removal, carries the added risk of recurrence, vascular injury, testicular compromise, 
and visceral injury. Best-available evidence suggests that triple neurectomy has higher 
efficacy than selective neurectomy.
Open or endoscopic methods are available to perform triple neurectomy depending on 
the type of prior repair, the presence of recurrence or meshoma, and if orchialgia is pres-
ent. Open triple neurectomy involves re-exploration through the prior operative field 
and is indicated when recurrence or meshoma is present or for treatment of patients 
that originally underwent anterior repair without preperitoneal placement of mesh. 
The ilioinguinal nerve is identified lateral to the internal ring, between the ring and the 
anterior superior iliac spine. The iliohypogastric nerve is identified within the anatomi-
cal cleavage between the external and internal oblique aponeurosis. The nerve is then 
traced proximally within the fibers of the internal oblique muscle to a point lateral to 
the field of the original hernia repair. Failure to do so may leave the injured intramus-
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cular segment of the nerve behind. The inguinal segment of the genital branch of the 
genitofemoral nerve can be identified adjacent to the external spermatic vein between 
the cord and the inguinal ligament and traced proximal to the internal ring where it is 
severed. Alternatively, the nerve may be visualized within the internal ring through the 
lateral crus of the ring. Standard triple neurectomy does not address neuropathy of the 
preperitoneal nerves (main trunk of genitofemoral nerve and preperitoneal segment 
of its genital branch) after open or laparoscopic preperitoneal repair. In these cases, an 
“extended” triple neurectomy may be performed dividing the floor of the inguinal canal 
to access the genitofemoral trunk in the retroperitoneum directly over the psoas muscle.
Nerves should be resected proximal to the field of original hernia repair. Although there 
are no specific data available, ligation of the cut ends of the nerves to avoid sprouting 
and neuroma formation and intramuscular insertion of the proximal cut end to keep 
the nerve stump away from scarring within the operative field are recommended [10]. 
Neurolysis, which does not address ultrastructural changes of nerve fibers, is not recom-
mended. Simple removal of entrapping sutures or fixating devices while leaving the 
injured nerves behind is not recommended and does not address irreversible damage 
to the nerve.
Endoscopic retroperitoneal triple neurectomy allows for access proximal to all potential 
sites of peripheral neuropathy overcoming many of the limitations of open triple neu-
rectomy after laparoscopic or open preperitoneal repair [18, 24, 25]. Prior preperitoneal 
laparoscopic or open procedures may damage or entrap the nerve in the preperitoneal 
position making proximal access to the three nerves a challenge. Endoscopic access 
to these three nerves in the retroperitoneum allows for definitive identification of the 
ilioinguinal and iliohypogastric nerves at the L1 nerve root overlying the quadratus 
lumborum muscle and the genital and femoral branches of the genitofemoral nerve ex-
iting from the psoas muscle. The operative technique is safe and proximal to the field of 
scarring from all prior inguinal hernia repairs. Complications including deafferentation 
hypersensitivity are a significant concern. In addition to numbness in the groin region 
and flank, patients undergoing proximal neurectomy may develop bulging of the lateral 
abdominal wall because of the additional loss of motor function of the iliohypogastric 
and ilioinguinal nerve (innervation of transversus abdominis muscle). In the absence 
of recurrence or meshoma, endoscopic management may be the preferred technique 
for definitive operative management of CPIP. Selection of appropriate patients is most 
important and management is best deferred to experienced hernia specialists.
The consensus recommendation is that re-operation for CPIP should be performed only 
by experienced surgeons [10].
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CPIP caused by recurrence is a less common etiology in these predominantly neuro-
pathic pain syndromes. However, it still represents a cause of CPIP largely to be excluded 
by physical examination and imaging. This contrasts with neuropathic pain, for which 
there are no reliable tests and can be considered a diagnosis per exclusionem. Ultrasound 
is recommended as the first diagnostic test for recurrence (and meshoma) because of 
costs and facility. It becomes more complicated if there is a possible combined origin 
for pain: recurrence and neuropathic pain. In case of the combination of recurrence and 
neuropathic pain it is important to consider the prior technique of hernia repair and 
the location of the mesh as this will dictate the ideal approach for neurectomy and the 
subsequent repair (Figure 3). In case of initial anterior repair, anterior to the transversalis 
fascia (i.e., Lichtenstein procedure, Shouldice, tissue repairs), a standard open triple 
neurectomy including resection of the intramuscular segment of the iliohypogastric 
nerve should be performed [26]. Laparoscopic repair of the recurrence can potentially 
lead to neuropathy of the preperitoneal nerves (main trunk of genitofemoral nerve and 
preperitoneal segment of its genital branch) and when combined with open triple 
neurectomy, it would not be possible to differentiate between neuropathy of nerves 
in front and behind the transversalis fascia as source of pain after this second opera-
tion. An alternative is to perform an endoscopic hernia repair and an endoscopic triple 
neurectomy. In case of recurrence and neuropathic pain after preperitoneal mesh repair 
(i.e., TEP, TIPP, TAPP), the recurrence should be corrected with an anterior technique 
(preferable Lichtenstein procedure) to avoid the prior scarred field. However, a triple 
neurectomy via this approach would not be useful as the potential damaged nerves are 
located behind the transversalis fascia. As a result the anterior correction should ideally 
be combined with an endoscopic triple neurectomy in the “untouched” plane proximal 
to the preperitoneal mesh. A remedial laparoscopic operation is an alternative approach 
with proximal neurectomy if indicated.
Neuropathic pain without recurrence
After anterior 
tension-free or 
tissue repair
Open anterior triple neurectomy
OR
preperitoneal (endoscopic) triple 
neurectomy
After TEP, 
Pelissier or 
TAPP
Preperitoneal (endoscopic) triple 
neurectomy
Recurrence with signs of neuropathic pain
After anterior 
tension-free or 
tissue repair
Anterior correction + 
open anterior triple neurectomy
OR
Endoscopic correction +
preperitoneal endoscopic triple 
neurectomy
After TEP, 
Pelissier or 
TAPP
Anterior correction + 
preperitoneal (endoscopic) triple 
neurectomy
Figure 3. Management of chronic postoperative inguinal pain with and without recurrence
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Partial or complete mesh removal is indicated in case of meshoma pain refractory to 
conservative management. Meshoma as a pathologic entity can present in different 
gradations from mass-like density to more subtle effects of mesh wrinkling or fibrosis. 
While meshoma will require surgical intervention if persistent and severe, occasionally 
patients whose overall pain levels improve can be managed without re-exploration and 
removal. If the pain team is able to decrease the pain with pharmacologic, behavioral, 
and interventional treatment, this would be preferable. The greatest morbidity in these 
reoperative surgeries is from removal of the mesh given its apposition to vital structures 
with the potential for bleeding, testicular loss, visceral injury, and creation of a new 
hernia. Any potential to spare a patient from surgery is advisable.
Systematic triple neurectomy instead of removal of meshoma only or removal of the 
nerves entrapped by meshoma only, is recommended because of neuroanatomic and 
technical considerations [24]. From a neuroanatomic perspective, there is significant 
cross-innervation of the nerves within the inguinal canal and within the preperitoneal 
space. Any neuropathic pain cannot be isolated to one specific nerve and if neurectomy 
is performed, all potentially damaged nerves within an operative field should be taken. 
From a technical perspective, the reoperative surgery to remove the mesh will likely 
damage the nerves within the operative field and neurectomy was advised by the panel.
Chronic testicular pain (orchialgia) has been left out of the scope of this algorithm, 
focusing primarily on inguinal pain. In most cases of orchialgia, the etiology is neu-
roanatomically and causatively distinct from CPIP. Accordingly, triple neurectomy is 
typically ineffective for this indication. The management of orchialgia after inguinal 
herniorrhaphy remains challenging and it is important to note that it can arise after 
all variants of inguinal repair [18, 24, 27]. Resection of the paravasal fibers or spermatic 
cord denervation might be an option for patients with neuropathic testicular pain but 
must be performed proximal to the level of pathology. Orchiectomy remains an option, 
but should only be reserved for refractory cases with evidence of nociceptive pain and 
parenchymal testicular compromise [28].
This current study was designed to create a working algorithm using the Delphian 
method integrating the existing cumulative knowledge on the clinical management of 
CPIP. This method is predicated on the concept of “collective intelligence” of a focused 
group and is designed to prevent bias through anonymity and regular feedback. By 
ensuring these factors, personal bias is minimized and free expression of opinions is 
encouraged without influence from authority or personality. Open critique is fostered 
allowing for admission of errors and revision of the working construct. The process 
continues through thesis and antithesis, until synthesis and consensus are reached. Bias 
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within the group is minimized through this method. The limitation of this process is that 
some notable and respected authorities in the field did not participate. That being said, 
the product of 26 authorities on CPIP represents the most comprehensive and inclusive 
effort to create a consensus algorithm to date.
The flowchart produced is the first consensus version of a fluid algorithm based upon 
best-available evidence and opinion to date. As it is opinion-based by nature, it should 
not be considered as a strict guideline. Rather, it should serve as a practical tool for 
surgeons and clinicians treating the complex problem of CPIP. The algorithm can help 
direct appropriate management based upon the standard practice of an international 
group of surgeons considered expert on inguinal hernia surgery. It will also serve as a 
standard for further research representing the starting point for a developing dynamic 
algorithm.
In conclusion: with the frequency of inguinal hernia correction as one of the most 
performed operations worldwide and the high incidence of CPIP, there is need for 
guidelines with regard to management of CPIP. This algorithm will hopefully serve as 
a guide to the management of these patients and help to improve clinical outcomes. 
If an expectative phase of a few months has passed without any amelioration of CPIP, 
a multidisciplinary approach is indicated and a pain management team should be 
consulted. If conservative measures fail and surgery is considered, triple neurectomy or 
correction for recurrence with or without neurectomy should be performed. Surgeons 
less experienced with remedial operations for CPIP should not hesitate to refer their 
patients to dedicated hernia surgeons.
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In Chapter 1 the subject of the thesis is introduced: different types of repair of abdominal 
wall hernias. In this thesis, abdominal wall hernias include umbilical, inguinal, incisional, 
and complex abdominal wall hernias. There are mainly two techniques to repair hernias: 
by suture repair, only successful in small hernias, and by mesh repair. Suture repair can 
be executed with various suture materials and in various techniques (interrupted sutures 
or continuous sutures). Mesh repair can also be executed with various mesh materials 
(synthetic mesh, biological mesh, or resorbable synthetic mesh). These meshes can be 
placed in different anatomical planes (onlay, inlay, sublay, and intra-abdominally). Both 
suture and mesh techniques can be executed in an open or laparoscopic fashion.
PART 1. MESH IN EXPERIMENTAL MODELS
The first part of this thesis consists of studies about the use of mesh in experimental 
models.
Chapter 2 reports the results of a systematic review of the literature on experimental 
animal models for abdominal wall hernia research. In this chapter, a complete overview 
of all animal models published between 2000 and 2014 is provided. It was decided to 
limit the study to 168 articles concerning rat models. It was concluded that there is a 
lack of comparability among experimental hernia research, limiting the impact of this 
experimental research. Consequently the establishment of guidelines for experimental 
hernia research by the European Hernia Society is proposed.
In Chapter 3 data of a randomized animal study are presented, in which five meshes 
were assessed: Parietene™ (polypropylene), Permacol™ (cross-linked porcine acellular 
dermal matrix), Strattice™ (non-cross-linked porcine acellular dermal matrix), XCM Bio-
logic® (non-cross-linked porcine acellular dermal matrix), and Omyra® Mesh (condensed 
polytetrafluoroethylene). The meshes were implanted into the abdominal wall of healthy 
rats. The rats were sacrificed after 30, 90, or 180 days. Incorporation, shrinkage, adhe-
sions, abscess formation, and histology were assessed for all meshes. It was concluded 
that based on incorporation, adhesions, mesh shrinkage, and histologic parameters 
Strattice™ performed best in this experimental rat model.
Most meshes respond differently in presence of an infection. In Chapter 4 both biological 
and synthetic meshes were evaluated in an experimental model of peritonitis to define 
their characteristics in vivo. Five meshes were investigated: Parietene™ (polypropylene), 
Permacol™ (cross-linked porcine acellular dermal matrix), Strattice™ (non-cross-linked 
porcine acellular dermal matrix), XCM Biologic® (non-cross-linked porcine acellular 
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dermal matrix), and Omyra® Mesh (condensed polytetrafluoroethylene). The rats were 
killed after either 30, 90 or 180 days. Incorporation and shrinkage of the mesh, adhesion 
coverage, strength of adhesions, and histology were analyzed. This experimental study 
suggested that XCM Biologic® was superior in terms of incorporation, macroscopic mesh 
infection, and histological parameters such as collagen deposition and neovasculariza-
tion. There must be sufficient overlap of mesh during placement, as XCM Biologic® 
showed a high rate of shrinkage.
Adhesions are a common complication of mesh in the intra-abdominal cavity. The 
presence of adhesions can be evaluated by many different adhesions scoring systems 
(qualitative versus quantitative scoring of adhesions). In Chapter 5 a consensus score on 
mesh-tissue adhesions is presented. This adhesion score is designed by a panel of inter-
national expert using a modified Delphi method (RAND-UCLA). This study comprises of 
two questionnaire-based rounds and one international consensus meeting. The META-
consensus score presented in this paper can be used to assess and classify mesh-related 
adhesions and is based on the opinion of 18 international leading experts. The use of 
this score is advocated in all future research to increase the interstudy comparability 
and objectivity.
PART 2. USE OF MESH
The second part of this thesis consists of studies about the use of mesh in patients. 
These studies are performed in patients that underwent a surgical repair of their umbili-
cal hernias.
In Chapter 6 the data of a randomized controlled trial are presented in which patients with 
small umbilical hernias were assessed. Small umbilical hernias of 1–4 cm can be repaired 
with either sutures or mesh. In this randomized controlled trial were both treatments 
compared in umbilical hernia repair in adults. Eligible participants were adults aged at 
least 18 years with a primary umbilical hernia of diameter 1–4 cm. Patients were randomly 
assigned (1:1) intraoperatively to either suture repair or mesh repair. Patients underwent 
physical examinations at 2 weeks, and 3, 12, and 24–30 months after the operation. The 
primary outcome was the rate of recurrences of the umbilical hernia after 24 months. The 
median follow-up was 25.1 months. After a maximum follow-up of 30 months, there were 
significantly fewer recurrences in the mesh group than in the suture group. It was con-
cluded that this is the first study showing high level evidence for mesh repair in patients 
with small umbilical hernias of diameter 1–4 cm. Hence it is suggested that mesh repair 
should be used for operations on all patients with an umbilical hernia of this size.
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In Chapter 7 data of a meta-analysis are presented in which it was assessed whether 
treatment of umbilical hernias with either mesh or sutures leads to less recurrences. 
The primary aim was to assess differences in the risk of recurrence (clinical and reopera-
tion) and secondarily differences in infections, seroma formation, hematomas, chronic 
pain, cosmetic result, and quality of life. A systematic review with meta-analyses was 
conducted. Five randomized controlled trials were identified (mesh repair n = 326 versus 
non-mesh sutured repair n = 330) and 602 records were excluded. The randomized con-
trolled trials included patients with defect diameters of ≥1–4 cm. Mesh repair reduced 
the risk of recurrence compared with sutured repair with a relative risk (RR) of 0.28. It was 
concluded that mesh repair is recommended for umbilical hernia of ≥1 cm up to 4 cm. 
More evidence is needed for the optimal placement of the mesh (sublay or onlay) and to 
assess the role of mesh in patients with an umbilical hernia <1 cm.
In Chapter 8 the data of a systematic review of the literature are presented. Umbilical 
hernia is often treated under general anesthesia. However, in this review the feasibility 
of local anesthesia is assessed for the surgical treatment of umbilical hernia. Outcome 
parameters were duration of surgery, surgical site infection, perioperative and postop-
erative complications, postoperative pain, hernia recurrence, time before discharge, and 
patient satisfaction. The systematic review resulted in nine included articles. There is 
a large variation in anesthetic agents and there is no consensus about injection tech-
niques. No conversions to general anesthesia were described. Local anesthesia for um-
bilical hernia seems safe and feasible. However, the advantages of local anesthesia are 
not sufficiently demonstrated, due to the heterogeneity of included studies. Therefore 
a randomized controlled trial is proposed comparing general versus local anesthesia for 
umbilical hernia repair.
PART 3. COMPLICATIONS OF MESH
The third part of this thesis consists of studies about possible complications of mesh in 
patients.
Chronic postoperative inguinal pain is a common complication after mesh-assisted 
inguinal hernia repair. In Chapter 9 it was assessed in a meta-analysis whether the use 
of a new self-gripping mesh instead of a sutured mesh leads to a decrease in chronic 
postoperative inguinal pain. In the present meta-analysis, the outcomes of ten random-
ized controlled trials enrolling 2541 patients were pooled. The mean follow-up was 24 
months. There was no significant difference in the incidence of chronic pain, recurrence, 
or foreign body sensation, between the self-gripping mesh and sutured mesh group at 
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all follow-up time points. The mean operating time however was significantly shorter in 
the self-gripping mesh group. It was concluded that the self-gripping mesh has com-
parable results with a sutured mesh regarding the incidence of chronic postoperative 
inguinal pain, recurrence and foreign body sensation. However, long-term results are 
still based on relatively small patient numbers and outcomes measures are heterogenic. 
The main advantage of the self-gripping mesh is the consistently significantly reduced 
operation time.
In Chapter 10 an algorithm is presented with a treatment strategy for the management 
of patients with chronic postoperative inguinal pain. The goal of this study was to de-
sign an expert-based algorithm for diagnostic and therapeutic management of chronic 
inguinal postoperative pain. A group of surgeons considered experts on inguinal hernia 
surgery was solicited to develop the algorithm. Consensus regarding each step of an 
algorithm proposed by the authors was sought by means of the Delphi method leading 
to a revised expert-based algorithm. With the input of 28 international experts, an algo-
rithm was created for a stepwise approach for the management of chronic postopera-
tive inguinal pain. Twenty-six participants accepted the final algorithm as a consensus 
model. It was concluded that there is a need for guidelines with regard to management 
of chronic postoperative inguinal pain. This algorithm can serve as a guide with regard 
to the diagnosis, management, and treatment of these patients, and can improve clinical 
outcomes. If an expectative phase of a few months has passed without any amelioration 
of chronic postoperative inguinal pain, a multidisciplinary approach is indicated and a 
pain management team should be consulted.
In Chapter 11 data are presented about patients that had to undergo a complex 
abdominal wall hernia repair. All patients were treated with a cross-linked biological 
mesh (Permacol™). A total of 77 patients was assessed in the outpatient clinic. The mean 
follow-up was 22.2 ± 12.6 months. The most frequent postoperative complication was 
wound infection (n = 21; 27.3 percent), meshes had to be removed in five patients (6.5 
percent). By the time of their visit to the outpatient clinic, 22 patients (28.6 percent) had 
a recurrence of whom ten (13 percent) had undergone reoperation. Thirty-nine patients 
(50.6 percent) had bulging of the abdominal wall. It was concluded that bulging and/
or recurrence were frequently observed in patients treated with a cross-linked biologi-
cal mesh for complex abdominal wall hernia repair. Considering both recurrence and 
bulging as undesirable outcomes of treatment, a total of 46 patients (59.7 percent) had 
an unfavorable outcome. Infection rates were high, but comparable with similar patient 
cohorts. Quality-of-life analyses revealed that patients were satisfied with their general 
health.
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In Chapter 12 another group of patients with a complex abdominal wall hernia is 
presented. These patients underwent a hernia repair and were treated with a non-
cross-linked biological mesh (Strattice™). Twenty-seven patients have been assessed for 
long-term follow-up (14 male, mean age 67.5 years, mean follow-up 42.4 months). With 
regard to the surgical intervention, the most frequently used mesh size was 400 cm² and 
the most frequent postoperative complication was wound infection (39.1 percent). The 
non-cross-linked biological mesh did not have to be removed. Four patients had passed 
away after surgery (range 5–904 days). By the time of outpatient clinic visit, six out of 23 
patients (26.1 percent) had a recurrence of hernia, of whom one patient had undergone 
reoperation. Another five patients (21.7 percent) had bulging of the abdominal wall. 
Quality-of-life analyses revealed that patients judged their scar with a median 3.5 out of 
10 points (0 is best) and judged their restrictions during daily activities with a median 
of 0 out of 10.0 (0 means no restriction). It was concluded that despite a high rate of 
postoperative wound infection no biological mesh had to be removed. Both the recur-
rence rate and the amount of bulging after long-term follow-up are high (failure rate of 
47.8 percent). The reported quality of life is good after repair of these complex hernias.
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Abdominal wall hernia is a frequently occurring disease. In this thesis, umbilical, inguinal 
and incisional hernia, and different aspects of their respective treatment strategies are 
discussed. The most common treatment of an abdominal wall hernia is operation with 
mesh [1-6]. The use of mesh has become a major component in hernia operations. There 
are various meshes available; however the “ideal mesh” has not been developed yet [7-9].
PART I: MESH IN EXPERIMENTAL MODELS
In the preclinical phase, meshes are investigated in experimental models, both in vitro 
and in vivo. In this thesis, only results of in vivo studies were presented. Preclinical mesh 
assessment is necessary to assess the biocompatibility and effectiveness of new meshes 
before using them in patients [10-12]. Chapter 2 of this thesis was about the best ex-
perimental model for mesh testing in vivo [13]. An in-dept literature assessment showed 
that there is a large variety in experimental models and that the quality of experimental 
mesh studies strongly varies. This has also been acknowledged by the United Kingdom-
based scientific organization National Centre for the Replacement Refinement & Reduc-
tion of Animals in Research. They designed the ARRIVE guidelines to stimulate profound 
scientific reports about experimental animal studies [14]. To improve the quality of 
experimental hernia research, guidelines should be designed to improve publishing and 
reporting of these studies.
The introduction of mesh in incisional hernia repair has drastically lowered the 10-year 
recurrence rates [3]. Currently, there are many different meshes available; meshes differ 
in material of origin, structure, shape, weight, and even composites are available [15]. 
The most often used products are conventional synthetic meshes and polypropylene 
is the most popular material, as it is biocompatible, strong and cheap [16]. In specific 
situations, the choice for a synthetic mesh is less favorable. In those often contaminated 
situations a biological mesh could provide a solution [17, 18]. Since these meshes are 
expensive, they are only rarely used. Therefore is only little known about these biological 
meshes compared with the synthetic meshes. Most studies have short-term follow-up 
and heterogeneous populations [19-21]. We investigated commonly used biological 
and synthetic meshes in an intraperitoneal environment on incorporation, shrinkage, 
adhesion formation, abscess formation, and histology after 30, 90, and 180 days. Two 
different experimental animal studies were performed: (1) the meshes were examined 
in a physiologic, non-contaminated rat model with intraperitoneal mesh placement 
(Chapter 3), and (2) the meshes were examined in a peritonitis rat model with intraperi-
toneal mesh placement (Chapter 4) [22]. The performance of the meshes differed in the 
presence or absence of an infection. In the absence of infection, Strattice™ performed 
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best. However, in the presence of infection, XCM Biologic® was superior. Both meshes 
are non-cross-linked porcine acellular dermal matrices. Strattice™ and XCM Biologic® 
performed best in the two experiment, taking into account incorporation, mesh shrink-
age, adhesion surface, and adhesion strength. Intra-abdominal adhesions can lead to 
serious complications, therefore the surgeon has an important role in the prevention of 
adhesion formation.
Placement of a mesh in the intra-abdominal cavity is a well-known inducer of adhe-
sions between the intestines and mesh [23]. The presence of adhesions is a known 
cause of serious postoperative complications such as bowel obstructions [24, 25]. If 
intra-abdominal adhesions occur in the presence of a mesh, there is no consensus yet 
on the clinical scoring of these adhesions. The META consensus score was designed 
based on the opinion of 18 international leading experts and deduced by a Delphi 
method (Chapter 5). The score consist of four main items: “percentage of mesh surface 
covered with adhesions”, “tenacity”, “thickness of adhesions”, and “organ involvement”. 
All parameters consist of macroscopic items. However, also macroscopic items could be 
of great interest. The quantity of inflammatory cells, the amount of collagen deposition, 
and neovascularization can provide valuable information regarding the foreign body 
response on a mesh and the adhesions formation [25, 26]. Microscopic parameters 
should therefore be assessed in future research. The new scoring system was designed 
to improve comparability between different studies about adhesions. The score is based 
on the consensus between 18 experts in adhesion research. These experts represent 
a large group of experts from the hernia community. Since it is a consensus score, 
there will always be researchers that cannot fully agree with the rationale behind this 
new scoring system. In comparison with existing adhesion scoring systems, the META 
consensus score is more enhanced. In this new scoring system, the best items of five 
adhesion scoring systems were integrated to one scoring system. The META consensus 
score is based on previous studies from De Oliveira and colleagues [26], Diamond and 
colleagues [27], Zühlke and colleagues [28], Bellón and colleagues [29], and Garrard 
and colleagues [30]. The META consensus score has not been validated yet, nor have 
other adhesion scoring systems. The META consensus score was designed to improve 
interstudy comparability. We therefore recommend to use the META consensus score 
in all new studies on adhesions; not only to maximize the interstudy comparability, but 
also to validate the new scoring system.
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PART II: USE OF MESH
The use of mesh in patients is legally only allowed, when meshes pass various tests in the 
preclinical phase. In this part of the thesis, the use of meshes in umbilical hernia patients 
was assessed. In a previous study by Schumacher and colleagues about umbilical hernia 
repair high recurrence rates of up to 54.5 percent have been reported in the suture 
repair group [31]. Previous data about large umbilical hernias suggest low recurrence 
rates of up to 1 percent after mesh repair [4, 32, 33]. For the smaller umbilical hernias 
(diameter ≤4 cm) there is no solid evidence that the use of mesh instead of suture repair 
leads to better results. Therefore, most surgeons would not use mesh repair for many of 
these small hernias [34].
The data from the HUMP trial showed that there were significantly more recurrences of 
umbilical hernia after suture repair compared with mesh repair (Chapter 6) [35]. These 
data are similar to previous findings by Arroyo and colleagues [32] (11 percent after in-
terrupted suture repair) and Polat and colleagues [33] (11 percent recurrence after Mayo 
repair). The recurrence rates were however slightly higher than in the study of Christof-
fersen and colleagues [36] (5.6 percent after suture repair). The amount of postoperative 
complications found in our study was fairly low: 8 percent of patients had complications 
after mesh repair versus 3 percent of patients after suture repair. In literature the com-
plication rates vary: a previous study of Arroyo and colleagues [32] found complications 
in 10 percent of patients after mesh repair versus 11 percent after suture repair, and 
Polat and colleagues [33] found that 15.6 percent of patients had complications after 
mesh repair versus 16.7 percent after suture repair. Quality-of-life analyses revealed no 
significant differences between both study groups on the outcome of SF-36 and EQ-5D-
5L preoperatively and at 12 months after operation. Thus was concluded that this is the 
first study showing high level evidence for mesh repair in patients with small umbilical 
hernias of diameter 1–4 cm. Evidence for the use of mesh in umbilical hernia repair was 
previously limited to retrospective cohort studies [37-41], prospective observational 
studies [4, 42, 43], hernia register analyses [36, 44], and randomized controlled studies 
[32, 33] with smaller sample sizes than this study [35]. We suggest mesh repair should be 
used for operations on all patients with an umbilical hernia of 1–4 cm.
The data of the previous chapter were used in a new meta-analysis (Chapter 7) [45]. 
In this meta-analysis the data of the following studies were included: Arroyo and col-
leagues [32], Polat and colleagues [33], Lal and Ase [46], Sadiq and Khurshid [47], and 
Kaufmann and colleagues [35]. Meta-analysis of these data revealed that mesh repair of 
umbilical hernia significantly lowered the amount of recurrences compared with suture 
repair. There was no increase found in the risk of surgical site infection, seroma forma-
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tion, hematomas, or chronic pain after mesh repair. Even though this meta-analysis was 
based on only randomized controlled trials, there were differences found in the quality 
of the included studies. There was only one randomized controlled trial identified that 
had a high quality [35]. The amount of patients in each study varied strongly (range 
50–300 patients per study), and most studies did not report in their paper whether they 
were based on a statistical power calculation prior to the start of the study. Therefore, 
studies could have been underpowered. Another issue that has not been addressed in 
the included studies, is how to handle the smallest umbilical hernias (<1 cm). A new, 
high-quality randomized controlled trial with long-term follow-up could address the risk 
for recurrence and the incidence of chronic postoperative pain after repair of umbilical 
hernias smaller than 1 cm. We concluded that mesh repair is probably safe and can be 
recommended for routine use to reduce the risk of recurrence after a small- and middle-
sized umbilical hernia repair [45]. In the future, more data are necessary to determine 
the optimal placement of mesh (sublay or onlay) and to assess whether there is an 
indication for mesh in patients with an umbilical hernia defect <1 cm.
In the Netherlands, approximately 4500 umbilical hernias are repaired every year. Most 
of these umbilical hernia operations are performed under general anesthesia. Another 
option is an operation under local anesthesia. This technique has been thoroughly in-
vestigated for inguinal hernias. However, only a minority of 7 percent of Dutch surgeons 
uses local anesthesia in Lichtenstein repair [48]. The use of local anesthesia however 
could prevent complications related to general anesthesia and could lead to a shorter 
duration of stay in the hospital. There is a lack of convincing literature on umbilical 
hernia repair under local anesthesia [49]. A systematic review was performed on the 
safety, feasibility, and advantages of local anesthesia for the repair of umbilical hernia 
(Chapter 8) [50]. The data showed that the use of local anesthesia in umbilical hernia 
repair led to a shorter length of postoperative stay, and that repair of a paraumbilical 
hernia performed under local anesthesia led to a shorter duration of surgery [50]. The 
use of local anesthesia did not lead to perioperative complications, serious postopera-
tive complications, allergic responses or anesthesia-related deaths. The difficulty in this 
systematic review was the heterogeneity of the included studies. There was no consen-
sus regarding the local anesthetic drug, nor about the technique to achieve local anes-
thesia. A standardized protocol is missing and should be designed to achieve a better 
implementation of the use of local anesthesia in umbilical hernia repair. Also the design 
of the trials on this topic should be adjusted. Pain is an important outcome parameter. 
However, not all studies in this systematic review described pain as an outcome and 
various pain measurement scales were used. We could not conclude from the available 
data if patients operated because of an umbilical hernia had a shorter duration of stay 
if they were operated under local anesthesia. Based on the current findings, it was 
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concluded that local anesthesia for umbilical hernia seems safe and feasible. Though 
due to heterogeneity in the included studies, the advantages of local anesthesia are not 
sufficiently demonstrated. Further studies are necessary to investigate whether there 
is an advantage of the use of local anesthesia compared with general anesthesia for 
umbilical hernia repair.
PART III: COMPLICATIONS OF MESH
The use of mesh in abdominal wall hernia has not only advantages, but also leads to 
complications in certain situations. Complications after inguinal hernia repair pose a 
significant burden on individual patients and society due to the high numbers of repair 
procedures worldwide. A well-known complication is chronic postoperative inguinal 
pain. A possible solution to lower the incidence of chronic postoperative inguinal pain 
could be the use of a self-gripping mesh (ProGrip™ mesh) instead of a sutured mesh. A 
meta-analysis of recent long-term results was undertaken (Chapter 9) [51]. The aim of 
this study was to compare these long-term results with the results of a Lichtenstein her-
nioplasty with a sutured mesh. The analyses were focusing on chronic pain, recurrence 
rate, foreign body sensation, and operation duration. From this meta-analysis, the fol-
lowing conclusions were drawn: the use of self-gripping mesh has results comparable to 
sutured mesh regarding the incidence of recurrence and chronic postoperative inguinal 
pain. The use of a self-gripping mesh does not resolve chronic postoperative inguinal 
pain; however, conclusions on long-term results are still based on relatively small patient 
numbers. A complicating factor was the large heterogeneity in the included studies: 
there were vast differences in the definition of chronic postoperative inguinal pain, the 
assessment of patients, and the presentation of outcomes, making it hard to compare 
incidence rates. We therefore plead for a more uniform methodology of studies, to 
improve the interstudy comparability. Consistently, the main advantage of using a 
self-gripping mesh is its efficiency (consistently significantly reduced operation times 
compared with the sutured mesh).
Since the introduction of tension-free mesh repair of inguinal hernias, the recurrence 
rates dropped to uniformly low recurrence rates. The main complication is chronic 
postoperative inguinal pain. No consensus guidelines existed for the management of 
this condition. The goal of this study was to design an algorithm for the diagnostic and 
therapeutic management of chronic postoperative inguinal pain based on expert opin-
ion and deduced by Delphi method (Chapter 10) [52]. With the input of 28 international 
experts, an algorithm for a stepwise approach for management of chronic postoperative 
inguinal pain was created. The main outcome was that after an expectative phase of a 
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few months has passed without any decrease of the pain, one should choose a multidis-
ciplinary approach and consult a pain management team. The treatment should include 
pharmacologic, behavioral, and interventional modalities, including nerve blocks [52]. 
If surgery is considered, a triple neurectomy, correction for recurrence with or without 
neurectomy, and meshoma removal – if indicated – should be performed. If surgeons are 
not that experienced with remedial operations in case of chronic postoperative inguinal 
pain, they are encouraged to refer their patients to dedicated hernia surgeons [53].
When treating patients with a complex abdominal wall hernia, the use of synthetic mesh 
in potentially contaminated and contaminated incisional hernias may lead to a higher 
morbidity and mortality after such operations. Use of biological meshes may provide 
a solution. However, due to their price they are only scarcely used and therefore only 
little data are known. A cohort of patients underwent complex abdominal wall hernia 
repair with a cross-linked porcine acellular dermal matrix (Permacol™) (Chapter 11). It 
was found that recurrence and bulging are frequently observed and 59.7 percent of the 
patients had an unfavorable outcome. Infection rates were high, but comparable with 
similar patient cohorts. Quality-of-life analyses revealed that patients were satisfied with 
their general health, but scored significantly lower on most quality-of-life modalities 
of the Short Form-36 questionnaire. This study enrolled patients belonging to a very 
difficult treatment group. All patients had a potentially contaminated or infected 
ventral hernia i.e. grade 3 to 4 hernia according to the Ventral Hernia Working Group 
classification [54]. Most patients suffered from multiple comorbidities and risk factors 
which increased the risk of postoperative complications such as wound infection and 
hernia recurrence. The recurrence rate in our study (28.6 percent) was similar to that 
seen in the RICH study [55]. In another study of Rosen and colleagues a much higher 
recurrence rate of over 50 percent was found after three years of follow-up [56]. In our 
study, only ten out of 77 patients underwent reoperation to treat hernia recurrence. This 
is relatively low in comparison with other studies published in literature [56, 57]. Given 
the patient population, there was a relatively low recurrence rate in our study. However, 
a high rate of abdominal wall bulging was observed. This finding was also seen in other 
studies, but these studies displayed a lower percentage of bulging than the present 
study [58, 59]. An explanation for this difference could be that larger hernia defects 
were included in our study in which patients also had a higher Ventral Hernia Working 
Group classification. In our study, 21 patients had a wound infection, but many of these 
infections could be treated conservatively. The mesh removal rate following a wound 
infection was 6.5 percent in the current study, a rate similar to that seen in the study of 
Diaz and colleagues [57], but much lower than that seen by Helton and colleagues [60] 
and Rosen and colleagues [56]. Until date, no ideal mesh has been identified for complex 
abdominal wall hernia repair. Therefore future studies are required. It is nevertheless of 
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paramount importance that both the patient and the surgeon have realistic expecta-
tions of the treatment with cross-linked porcine acellular dermal matrix.
Another alternative could be the use of non-cross-linked porcine acellular dermal 
matrix. This is another type of biological matrix, which is also only rarely used because 
of its costs [61-64]. A cohort of patients undergoing a complex abdominal wall hernia 
repair was treated with a non-cross-linked porcine acellular dermal matrix (Strattice™) 
(Chapter 12). Twenty-seven patients have been assessed for long-term follow-up (14 
male, mean age 67.5 years, mean follow-up 42.4 months). Four patients had passed 
away after surgery (range: 5–904 days). The most observed postoperative complication 
was wound infection (39.1 percent). No meshes needed to be removed. Six out of 23 
patients (26.1 percent) had a recurrence of hernia, of whom one patient had undergone 
reoperation. Another five patients (21.7 percent) had bulging of the abdominal wall. 
Quality-of-life analyses revealed that patients judged their scar with a median 3.5 out 
of 10 points (0 is best) and judged their restrictions during daily activities with a median 
of 0 out of 10.0 (0 means no restriction). These results show that despite a high rate of 
postoperative wound infection no biological mesh had to be removed. Both the recur-
rence rate and the amount of bulging after long-term follow-up are significant (failure 
rate of 47.8 percent). The reported quality of life is good after repair of these complex 
hernias. This study has a similar recurrence rate as the RICH study by Itani and colleagues 
[55]. In the RICH study, a recurrence rate of 28 percent was found after two years of 
follow-up [55]. The recurrence percentage in this study is 26.1 percent, the follow-up in 
this study is however much longer (42.4 months versus 24.0 months [55]). In another 
study of Maxwell and colleagues a much lower recurrence rate of 11.2 percent was found 
after median 20.9 months follow-up [65]. Maxwell and colleagues had both a lower 
recurrence rate, but also a shorter follow-up than our study. The patients in Maxwell’s 
study received an additional CT scan to confirm recurrence. Patients with bulging on the 
CT scan were excluded from the study. Excluding this subgroup could lead to certain 
bias, since bulging is also an unfavorable outcome. In a study by Rosen and colleagues a 
much higher recurrence rate of over 50 percent was found after three years of follow-up. 
In Rosen’s study, the following meshes were assessed: Strattice™, Alloderm™, Biodesign®, 
XenMatrix™, and GORE® BIO-A® Mesh [56]. The high recurrence rate could be explained 
by the use of different meshes. The follow-up is shorter than in this current study. In 
this study, the most observed postoperative complication was wound infection (39.1 
percent). This percentage is slightly lower than in a study by Roth and colleagues [66] 
(43 percent). The median follow-up was one year. The wound infection percentage in our 
study however was somewhat higher compared with other studies (Itani and colleagues 
[55] (35 percent), Diaz and colleagues [57] (33 percent), Maxwell and colleagues [65] 
(26.2 percent), Helton and colleagues [60] (23 percent) and Cheng and colleagues [67] 
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(5 percent)). All studies [55, 57, 60, 65, 67] included hernias that were classified as clean 
or clean contaminated according to the Ventral Hernia Working Group classification [54]. 
This could have led to a lower postoperative infection rate. In this study, the mesh did not 
have to be removed representing a better result than found in the studies of Diaz and 
colleagues [57] (five mesh removals; 6.7 percent) and Helton and colleagues [60] (five 
mesh removals; 9.8 percent). Alternatives for the use of biological mesh are explored. 
These alternatives could be found in the use of biosynthetic meshes (like Phasix™ Mesh, 
GORE® BIO-A® Mesh, and TIGR® Matrix Surgical mesh). However, Köckerling and col-
leagues wrote recently a consensus review about mesh use in complex abdominal wall 
hernia concluding that there is lack of studies comparing the use of biological or bio-
synthetic meshes versus synthetic meshes in complex abdominal wall hernia Therefore 
the routine use of biological and biosynthetic meshes could not be recommended [68].
CONCLUSION
Regarding all evidence, it can be concluded that abdominal wall hernia surgery is a 
diverse field of surgery. Although there are many different preclinical and clinical studies 
available; one still has to assess the value of all these data. Therefore the more complex 
abdominal wall hernia surgery should be executed by dedicated hernia surgeons. These 
surgeons will be more familiar with the varieties in “hernia disease”, the anatomical pos-
sibilities, and materials (meshes, fixation techniques). The choice when which mesh with 
which fixation technique (suture, staple, glue) will be applied is a decision based on a 
large variety of research, but should still be a tailormade approach for each patient. Still 
more research needs to be performed to assess the most suitable mesh for complex 
abdominal wall hernia management.
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The future of abdominal wall hernia research lies within reach and there are various 
things that can brighten this future.
Most important is the attitude towards abdominal wall hernia repair. For years it has 
been a disease that surgeons treated as “part of their jobs”, now it is evolving towards a 
new and exciting research field with many opportunities. These opportunities lie within 
research, but also in collaboration between various fields.
Research was traditionally performed within universities, however mesh products were 
assessed premarket as well by mesh manufacturers. Results of the latter are only rarely 
published. Collaboration in hernia research gives responsibility to the mesh industry, the 
researchers, and the healthcare professionals. It can lead to more transparency. It would 
be a great development if mesh manufacturers could only market their products with 
approved data. These data should be gathered by independently working researchers 
that should be working without sponsoring by individual mesh manufacturers. In this 
respect the role of international scientific societies like the European, American and 
Asian Pacific Hernia Societies are considered pivotal.
Collaboration could not only lead to better and fairer sharing of results, but in case of 
premarket studies, it can also lead to a decrease in animal studies. In this respect have 
simulation models of the abdominal wall – as recently developed by our research group 
– already proven to be of help. This all goes well with the adagio reduction, replace-
ment and refinement. This adagio is used in the design of animal studies to decrease the 
number of animals that are used within a study.
Another way of collaboration is through social media. In December 2012, a Facebook 
group for hernia enthusiasts was established. This International Hernia Collaboration 
has grown ever since to an online community of to date almost 7000 members. On this 
Facebook site surgeons can share their cases via short videos or ask for advice from their 
fellow hernia colleagues in a difficult case.
Finally, researchers and hernia surgeons must wonder what is the most important 
outcome of abdominal wall hernia surgery. What is the true hernia parameter? Is it the 
percentage of recurrences (easily quantified) or is it the regained quality of life of an in-
dividual patient? And lies the solution in the use of mesh? Patients and patient-reported 
outcomes have to be involved in research. Generous striving for new collaborations!
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a
NEDERLANDSE SAMENVATTING
Hoofdstuk 1 beschrijft het onderwerp van dit proefschrift: verschillende typen ope-
raties van buikwandbreuken. In dit proefschrift omvat de term buikwandbreuken na-
velbreuken, liesbreuken, littekenbreuken en complexe buikwandbreuken. Er zijn grosso 
modo twee technieken om buikwandbreuken te behandelen: door deze te hechten 
(alleen succesvol bij kleine buikwandbreuken) of door een mesh (mat) te plaatsen. Een 
operatie met behulp van hechtingen alleen kan worden uitgevoerd met verschillende 
hechtmaterialen en verschillende technieken (staande hechtingen of doorlopende 
hechtingen). Herstel door middel van mesh kan worden uitgevoerd met verschillende 
soorten meshes (synthetische mesh, biologische mesh of resorbeerbare synthetische 
mesh). De meshes kunnen worden geplaatst in verschillende anatomische vlakken 
(onlay, inlay, sublay en intra-abdominaal). Zowel herstel door middel van hechtingen 
als met een mesh kan uitgevoerd worden door gebruik te maken van een open of een 
laparoscopische techniek.
DEEL 1. MESH IN EXPERIMENTELE MODELLEN
Het eerste deel van dit proefschrift omvat studies over het gebruik van mesh in experi-
mentele diermodellen.
In Hoofdstuk 2 worden de resultaten besproken van een systematische review van de 
literatuur over het gebruik van experimentele diermodellen bij onderzoek naar buik-
wandbreuken. In dit hoofdstuk wordt een compleet overzicht gegeven van alle diermo-
dellen die gepubliceerd zijn tussen 2000 en 2014. Er werd besloten de zoektermen te 
limiteren op ratten, waarbij gekeken werd naar 168 artikelen over ratmodellen. Daarbij 
werd geconcludeerd dat er een gebrek aan vergelijkbaarheid is bij experimentele stu-
dies over buikwandbreuken, waardoor de impact van dit onderzoek afneemt. Er wordt 
voorgesteld om richtlijnen voor experimentele studies over buikwandbreuken op te 
stellen via de European Hernia Society om de vergelijkbaarheid tussen experimentele 
studies te verbeteren.
In Hoofdstuk 3 worden de data van een gerandomiseerde dierenstudie besproken. 
In deze studie zijn vijf meshes onderzocht: Parietene™ (polypropyleen), Permacol™ 
(gecrosslinkte matrix van acellulair collageen van varkenshuid), Strattice™ (niet-
gecrosslinkte matrix van acellulair collageen van varkenshuid), XCM Biologic® (niet-
gecrosslinkte matrix van acellulair collageen van varkenshuid) en Omyra® Mesh (gecon-
denseerd polytetrafluoroethyleen). De meshes werden geïmplanteerd in de buikwand 
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van gezonde ratten. De ratten werden geofferd na 30, 90 of 180 dagen. Er werd bij alle 
meshes gekeken naar ingroei, krimp, adhesievorming, abcesvorming en histologische 
parameters. Strattice™ presteerde het best in dit experimentele ratmodel.
In Hoofdstuk 4 werd gekeken naar de in vivo eigenschappen van zowel biologische 
als synthetische meshes in een peritonitis ratmodel, aangezien de meeste meshes an-
ders reageren in de aanwezigheid van een infectie. Er werden vijf meshes onderzocht: 
Parietene™ (polypropyleen), Permacol™ (gecrosslinkte matrix van acellulair collageen 
van varkenshuid), Strattice™ (nietgecrosslinkte matrix van acellulair collageen van 
varkenshuid), XCM Biologic® (nietgecrosslinkte matrix van acellulair collageen van var-
kenshuid), Omyra® Mesh (gecondenseerd polytetrafluoroethyleen). De ratten werden 
geofferd na 30, 90 of 180 dagen. Er werd gekeken naar de ingroei en krimp van de mesh, 
het percentage adhesies op de mesh, de sterkte van deze adhesies en de histologische 
eigenschappen van de mesh. Deze experimentele studie suggereert dat XCM Biologic® 
het beste presteerde op basis van ingroei van de mesh, (de afwezigheid van) macrosco-
pische mesh infectie en histologische parameters zoals collageen depositie en neovas-
cularisatie. Er moet wel voldoende overlap van de mesh zijn gedurende plaatsing, daar 
XCM Biologic® een grote hoeveelheid krimp heeft laten zien.
Adhesies zijn een vaak voorkomende complicatie van mesh in de intra-abdominale 
ruimte. Er zijn verschillende adhesiescoringssystemen beschikbaar (kwalitatieve versus 
kwantitatieve scoringsmethoden van adhesies), maar er is nog geen consensus over hoe 
adhesies gescoord moeten worden in de aanwezigheid van een mesh.
In Hoofdstuk 5 is een nieuwe consensus score gepresenteerd, waarmee adhesies tus-
sen de mesh en de intra-abdominale weefsels geclassificeerd kunnen worden. Deze 
adhesiescore is ontwikkeld door een panel van internationale experts door gebruik te 
maken van een gemodificeerde Delphi methode (RAND-UCLA). Deze studie omvatte 
twee rondes gebaseerd op vragenlijsten en één internationale consensus bijeenkomst. 
De META-consensus score die in dit hoofdstuk gepresenteerd wordt kan worden ge-
bruikt om adhesies in aanwezigheid van een mesh te onderzoeken en te classificeren 
en is gebaseerd op de mening van 18 internationale vooraanstaande experts. Er wordt 
gepleit om deze score in toekomstige studies te gebruiken om de vergelijkbaarheid 
tussen studies en de objectiviteit te vergroten.
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DEEL 2. HET GEBRUIK VAN MESH
Het tweede deel van dit proefschrift bevat studies over het gebruik van mesh bij patiën-
ten. Deze studies zijn uitgevoerd met patiënten die operatief herstel van een navelbreuk 
ondergingen.
In Hoofdstuk 6 worden de data gepresenteerd van een gerandomiseerde en gecon-
troleerde studie waarin patiënten met kleine navelbreuken worden onderzocht. Deze 
kleine navelbreuken van 1 tot 4 cm kunnen zowel met hechtingen als met een mesh 
geopereerd worden. In deze gerandomiseerde en gecontroleerde studie worden beide 
behandelingen vergeleken bij navelbreukherstel bij volwassenen. Patiënten waren 
geschikt voor inclusie in de studie als zij 18 jaar of ouder waren en een primaire na-
velbreuk hadden met een diameter van 1 tot 4 cm. Patiënten werden intra-operatief 
gerandomiseerd in een verhouding van 1:1 naar ofwel hechtingen ofwel mesh. Patiën-
ten ondergingen lichamelijk onderzoek 2 weken, 3 maanden, 12 maanden en 24 tot 30 
maanden na de operatie. De primaire uitkomst was het aantal recidieven navelbreuk na 
24 maanden. De mediane follow-up was 25,1 maanden. Na een maximale follow-up van 
30 maanden werden er significant minder recidieven gezien in de mesh groep dan in de 
hechtingen groep. Er werd geconcludeerd dat dit de eerste studie is, waarin bewijs van 
hoge kwaliteit geleverd wordt voor mesh-herstel bij patiënten met kleine navelbreu-
ken met een diameter van 1 tot 4 cm. Daarom wordt gesuggereerd dat mesh-herstel 
gebruikt zou moeten worden bij alle patiënten met een navelbreuk van die diameter.
In Hoofdstuk 7 worden de data gepresenteerd van een meta-analyse, waarin werd 
onderzocht of de behandeling van navelbreuken ofwel met mesh ofwel met hechtingen 
tot minder recidieven leidt. Het primaire doel was om verschillen te onderzoeken in het 
risico op recidief (klinisch of heroperatie). Het secundaire doel was om de verschillen 
te onderzoeken in infecties, seroomvorming, hematomen, chronische pijn, cosmetische 
resultaten en kwaliteit van leven. Er werd een systematische review met meta-analyse 
uitgevoerd, waarbij vijf gerandomiseerde en gecontroleerde studies geïdentificeerd 
(herstel met behulp van mesh n = 326 versus herstel met hechtingen n = 330) en 602 
records geëxcludeerd werden. De gerandomiseerde en gecontroleerde studies hebben 
patiënten geïncludeerd met navelbreuken met een diameter van ≥1 tot 4 cm. Mesh-
herstel liet het risico op recidief afnemen ten opzichte van herstel met hechtingen met 
een relatief risico van 0,28. Er werd geconcludeerd dat herstel door middel van mesh 
aangeraden wordt voor navelbreuken van ≥1 tot 4 cm. Er is meer onderzoek nodig naar 
de optimale positie van de mesh (sublay of onlay) en de rol van mesh bij patiënten met 
een navelbreuk van <1 cm.
316
Nederlandse samenvatting
In Hoofdstuk 8 worden data gepresenteerd van een systematische review van de 
literatuur aangaande de haalbaarheid van navelbreuk-herstel onder lokale anesthesie. 
Uitkomsten waren operatieduur, het ontstaan van wondinfecties, perioperatieve en 
postoperatieve complicaties, postoperatieve pijn, recidief navelbreuk, opnameduur en 
patiënttevredenheid. In dit systematische review konden negen studies geïncludeerd 
worden. Er was een grote variatie in de geneesmiddelen die gebruikt werden voor 
lokale anesthesie en er bleek geen consensus over de te gebruiken injectietechnieken. 
Er werden geen conversies naar algehele anesthesie beschreven. Lokale anesthesie voor 
navelbreukherstel lijkt veilig en haalbaar. Niettemin, de voordelen van lokale anesthesie 
zijn niet voldoende aangetoond door heterogeniteit van de geïncludeerde studies. 
Daarom wordt voorgesteld om een gerandomiseerde en gecontroleerde studie uit te 
voeren waarin algehele en lokale anesthesie voor navelbreukherstel wordt vergeleken.
DEEL 3. COMPLICATIES VAN MESH
In het derde deel van dit proefschrift worden studies naar de mogelijke complicaties 
van mesh in patiënten gepresenteerd.
In Hoofdstuk 9 werd in een meta-analyse onderzocht of het gebruik van een nieuwe 
zelf-fixerende mesh leidt tot een afname van chronische postoperatieve inguinale pijn 
ten opzichte van een met hechtingen gefixeerde mesh, aangezien chronische postope-
ratieve inguinale (lies)pijn een bekende complicatie na liesbreukherstel met mesh is. In 
de huidige meta-analyse werden de data van tien gerandomiseerde en gecontroleerde 
studies samengevoegd (2541 patiënten). De gemiddelde follow-up was 24 maanden. 
Er waren geen significante verschillen in het optreden van chronische pijn, recidief of 
“vreemd lichaam gevoel” tussen de zelf-fixerende en de met hechtingen gefixeerde 
mesh op alle follow-up momenten. Niettemin was de gemiddelde operatieduur signifi-
cant korter bij de groep met de zelf-fixerende mesh. Er werd geconcludeerd dat de zelf-
fixerende mesh vergelijkbare resultaten had als de met hechtingen gefixeerde mesh voor 
de incidentie van chronische postoperatieve inguinale pijn, recidief en “vreemd lichaam 
gevoel”. Echter, langetermijnresultaten zijn gebaseerd op relatief kleine patiëntgroepen 
en uitkomstmaten zijn heterogeen. Het voornaamste voordeel van de zelf-fixerende 
mesh is de consequent significant verlaagde operatieduur.
In Hoofdstuk 10 wordt een algoritme gepresenteerd met een behandelingsstrategie 
voor het behandelen van patiënten met chronische postoperatieve inguinale pijn. Het 
doel van deze studie was om samen met experts een algoritme te ontwikkelen voor de 
diagnostische en therapeutische aanpak van chronische postoperatieve inguinale pijn. 
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Een groep chirurgen, die expert geacht werd op het gebied van liesbreukchirurgie, werd 
uitgenodigd om mee te werken aan de ontwikkeling van dit algoritme. Er werd een 
algoritme voorgesteld door de auteurs, waarna consensus gevraagd werd voor elke stap 
in dit algoritme door middel van de Delphi methode. De antwoorden werden gebruikt 
om een gereviseerd, expert-gebaseerd algoritme te maken. Met de bijdrages van 28 
internationale experts, werd een algoritme opgesteld voor de stapsgewijze aanpak van 
chronische postoperatieve inguinale pijn. Door 26 deelnemers werd het definitieve al-
goritme geaccepteerd als consensus model. Er werd geconcludeerd dat het nodig is dat 
richtlijnen voor de aanpak van chronische postoperatieve inguinale pijn geformuleerd 
worden. Dit algoritme kan fungeren als een leidraad voor de diagnose, het beleid en de 
behandeling van deze patiënten en kan bijdragen aan een verbetering van het klinisch 
resultaat. Als een expectatieve fase van enkele maanden achter de rug is, waarin de 
chronische postoperatieve inguinale pijn niet verbeterd is, dient er gekozen te worden 
voor een multidisciplinaire aanpak en zou een chronisch pijnteam geconsulteerd moe-
ten worden.
In Hoofdstuk 11 worden data gepresenteerd van patiënten die herstel van een com-
plexe buikwandbreuk hebben ondergaan. Alle patiënten werden behandeld met een 
gecrosslinkte biologische mesh (Permacol™). In totaal werden 77 patiënten gezien 
op de polikliniek. De gemiddelde follow-up was 22,2 ± 12,6 maanden (SD). De meest 
voorkomende postoperatieve complicatie was wondinfectie (n = 21; 27,3 percent), bij 
5 patiënten (6,5 percent) moesten de meshes verwijderd worden. Tijdens het polikli-
niekbezoek bleken 22 patiënten (28,6 percent) een recidief van de buikwandbreuk te 
hebben gehad, waarbij 10 patiënten (13 percent) een heroperatie hadden ondergaan. 
Ook hadden 39 patiënten (50,6 percent) bulging van de buikwand. Er werd geconclu-
deerd dat bulging en/of recidief vaak voorkwamen bij patiënten die behandeld waren 
met een gecrosslinkte biologische mesh voor de indicatie complexe buikwandbreuk. 
In ogenschouw nemende dat zowel recidief als bulging onwenselijke uitkomsten zijn, 
had een totaal aantal van 46 patiënten (59,7 percent) een ongunstige uitkomst. Infec-
tiepercentages waren hoog, maar vergelijkbaar met soortgelijke patiëntencohorten. 
Uit de kwaliteit van leven-vragenlijsten bleek dat patiënten tevreden waren met hun 
algemene gezondheid.
In Hoofdstuk 12 werden data van een andere patiëntengroep met complexe buikwand-
breuken gepresenteerd. Deze patiënten hadden een herstel ondergaan met behulp van 
een niet-gecrosslinkte biologische mesh (Strattice™). Er werden 27 patiënten onderzocht 
voor de langetermijnresultaten (14 mannen, gemiddelde leeftijd 67,5 jaar, gemiddelde 
follow-up 42,4 maanden). Wat betreft de chirurgische interventie was de meest gekozen 
afmeting van de mesh 400 cm² en de meest voorkomende postoperatieve complicatie 
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was wondinfectie (39,1 percent). De niet-gecrosslinkte biologische mesh hoefde niet 
verwijderd te worden. Vier patiënten zijn postoperatief overleden (range: 5–904 dagen). 
Tijdens het polikliniekbezoek hadden 6 van de 23 patiënten (26,1 percent) een recidief 
complexe buikwandbreuk, waarbij 1 patiënt een heroperatie had ondergaan. Nog eens 
5 patiënten (21,7 percent) hadden bulging van de buikwand. Uit de kwaliteit van leven-
vragenlijsten bleek dat patiënten hun litteken gemiddeld een cijfer 3,5 uit 10 punten 
gaven (0 was het best) en zij beoordeelden hun restrictie tijdens dagelijkse activiteiten 
met gemiddeld 0 uit 10 punten (0 betekent geen restrictie). Er werd geconcludeerd 
dat ondanks een hoog percentage postoperatieve wondinfecties, geen van de meshes 
verwijderd hoefde te worden. Zowel recidief als bulging komen vaak voor in de lange 
termijn follow-up (faalpercentage 47.8 percent). De gerapporteerde kwaliteit van leven 
is goed na herstel van deze complexe buikwandbreuken.
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LIST OF ABBREVATIONS
Abbreviation Meaning
AAS Activity assessment scale
ACR Assumed control risk
AHS American Hernia Society
ANCOVA Analysis of covariance (statistical method)
ARRIVE Animal research: reporting of in vivo experiments (reporting guideline)
ASA American Society of Anesthesiologists
BC Before Christ
BIQ Body image questionnaire
BMI Body-mass index
CAWHR Complex abdominal wall hernia repair
CENTRAL Cochrane Central Register of Controlled Trials
CI Confidence interval
CLP Cecum ligation puncture (experimental model)
COPD Chronic obstructive pulmonary disease
CPIP Chronic postoperative inguinal pain
CT scan Computerized Tomography scan (imaging technique)
ECM Extracellular matrix
EHS European Hernia Society
Embase Excerpta Medica database
e-PTFE Expanded-polytetrafluoroethylene
EQ EuroQol
EQ-5D-5L EuroQol five dimensions five level version (quality-of-life questionnaire)
EuraHS European registry of abdominal wall hernias
FBGC Foreign body giant cells
FBS Foreign body sensation
FDA Food and Drug Administration (agency of United States Department of Health and Human 
Services)
FU Follow-up
GA General anesthesia
HE Hematoxylin and eosin (staining)
HPF High-power field
HR Hazard Ratio
HW Heavyweight (qualification of mesh weight)
IASP International Association for the Study of Pain
IEHS International Endohernia Society
IPOM Intraperitoneal onlay mesh
IQR Interquartile range
IV Intravenous
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Abbreviation Meaning
LA Local anesthesia
LA + sedation Local anesthesia combined with sedation
LW Lightweight (qualification of mesh weight)
MOS SF-36 Short Form-36 (quality-of-life questionnaire)
MS Microsoft
n Number
n.a. Not applicable
NG Not given
No. Number
NIH National Institutes of Health (agency of United States Department of Health and Human 
Services)
NNH Number needed to harm
NNT Number needed to treat
OR Odds ratio
PADM Non-cross-linked porcine acellular dermal matrix
PHS Prolene® Hernia System (polypropylene mesh)
PRISMA Preferred reporting items for systematic reviews and meta-analysis (reporting guideline)
PROSPERO International database of prospectively registered systematic reviews in health
PTFE Polytetrafluoroethylene
PubMed NCBI National Library of Medicine
QOL Quality of life
RA Regional anesthesia
RAM RAND-UCLA Appropriateness Method (research technique)
RAND-UCLA Modified Delphi method (research technique)
RCT Randomized controlled trial
RD Risk difference
RR Relative risk or risk ratio
RRR Relative risk reduction
SA Spinal anesthesia
SD Standard deviation
SE Standard error
SF-12 Short Form-12 (quality-of-life questionnaire)
SF-36 Short Form-36 (quality-of-life questionnaire)
SPS Surgical Pain Scale
SPSS Statistical package for the social sciences
SR Sirius red (staining)
SSI Surgical site infection
STATA Statistical software package
STROBE Strengthening the reporting of observational studies in epidemiology (reporting guideline)
STROCCS Strengthening the reporting of cohort studies in surgery (reporting guideline)
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Abbreviation Meaning
TAPP Transabdominal preperitoneal (hernia repair)
TEP Totally extraperitoneal (hernia repair)
TIPP Transinguinal preperitoneal (hernia repair)
VAC Vacuum-assisted therapy
VAS Visual analogue scale
VHWG Ventral Hernia Working Group
VRS Verbal Rating Scale
WHO World Health Organization
X-PADM Cross-linked porcine acellular dermal matrix
μm Micrometer (10−6 meter)
18-G 18-Gauge (needle size, i.e. 1.2 mm)
3D Three dimensional
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DANKWOORD
Bij de totstandkoming van een proefschrift krijg je hulp uit vele en onverwachte hoeken. 
Ik wil dan ook een ieder die bijgedragen heeft aan mijn proefschrift enorm bedanken! 
Enkele mensen wil ik in het bijzonder noemen in dit dankwoord.
Allereerst veel dank aan alle patiënten, die belangeloos deelgenomen hebben aan de 
onderzoeken. Ook alle artsen en (poli)medewerkers, die geholpen hebben bij het or-
ganiseren van de verschillende studies: zonder jullie hulp had ik het niet kunnen doen.
Zeer geachte professor Lange, zeer gewaardeerde promotor, ik ben u erg dankbaar voor 
het vertrouwen, de kansen en de vrijheid die ik heb gekregen tijdens het doen van mijn 
onderzoek. U was altijd bereikbaar voor overleg, moedigde nieuwe ideeën van harte 
aan en stuurde bij waar nodig. Ik heb genoten van alle discussies. Zowel op wetenschap-
pelijk vlak als in het gewone leven viel en valt er gelukkig genoeg te bespreken. Veel 
dank voor uw humor en enthousiasme!
Zeer geachte professor Jeekel, zeer gewaardeerde copromotor, wat een voorrecht om 
met u samen te mogen werken. Uw enthousiasme voor onderzoek is aanstekelijk en heb 
ik als een goede drijfveer ervaren. Ik vind het indrukwekkend welke staat van dienst u 
verworven hebt in de hernia-wereld. Mooi om te zien dat ook het “Music in medicine” 
project zo’n vlucht heeft genomen. Veel dank uw toewijding, vertrouwen en nimmer 
aflatende energie!
Zeer geachte professor Kleinrensink, wat een feest om met u samen te werken. U bent 
ongekend positief en dat werkt enthousiasmerend. Dank voor uw bijdrage aan mijn 
onderzoek. Naast alle hardcore wetenschap was er gelukkig ook genoeg tijd voor een 
praatje, een kop koffie of een (Skillslab)borrel. Uw aanwezigheid tijdens de REPAIR-
vergadering garandeerde veel humor. Jammer dat u niet bij mijn verdediging kunt zijn. 
Gelukkig bent u sinds geruime tijd weer mede-Hagenaar en hoop ik binnenkort weer 
eens aan te schuiven voor een borrel.
Zeer geachte dr. Menon, beste Anand, de drie musketiers hebben een nieuwe protegé. 
Als (jongste) supervisor van de REPAIR wil ik je danken voor je positieve en frisse blik op 
het doen van onderzoek. Veel dank dat je zitting wilt nemen in de promotiecommissie.
Zeer geachte professoren Bouvy, Van Eijck, Verhoef en Wijnen, veel dank dat u zitting 
wilt nemen in de leescommissie van mijn proefschrift.
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Zeer geachte leden van de promotiecommissie, veel dank dat u op 29 maart deel wilt 
uitmaken van de corona. Ik kijk er naar uit om met u van gedachten te wisselen.
Beste coauteurs, veel dank voor de mooie samenwerkingen. Ik kijk uit naar nieuwe, 
gezamenlijke projecten! Dear co-authors, many thanks for the beautiful collaborations. 
I’m looking forward to new, joint projects!
Een speciaal woord van dank gaat ook uit naar Marian Clahsen-van Groningen. Veel 
dank voor de gezellige pathologie-sessies. Je wist me te winnen voor een onbekend 
terrein. Top!
Beste Annelies, je weet niet alleen professor Lange in goede banen te leiden, maar je 
wist ook de eindfase van mijn promotie soepel te laten verlopen. Veel dank voor je hulp 
en begeleiding tijdens de laatste loodjes van dit traject.
Het hebben van een goede datamanager maakt het leven als arts-onderzoeker een stuk 
eenvoudiger. Daarom Anneke van Duuren, veel dank voor je jarenlange inzet en het 
minutieus bijhouden van de HUMP database. Mede dankzij jouw hulp staat er nu een 
prachtige publicatie.
Beste oud-collega’s van het Erasmus MC, zowel in de Z-flat als in “de kelder”, dank voor 
alle koffie, verjaardagstaartjes, (Schmidt)lunches, borrels, diners, skireizen en andere 
memorabele momenten. Ik heb een heerlijke tijd gehad! Het ga jullie goed.
“Eens een REPAIR’der, altijd een REPAIR’der.” Wat een prachtige club! Pas achteraf realiseer 
ik me welke kansen ik bij de mooiste onderzoeksgroep van het Erasmus MC gekregen 
heb. Kansen die niet alleen gecreëerd worden door de professoren, maar zeker ook 
door de samenwerkingen met collega-onderzoekers. Eva, Irene, Simone, Konstantinos, 
Zhouqiao, Sandra, Joost, An, Barry, Lucas, Marijke, Leonard, Yağmur, Heijdo, Michael, 
Daniël, Cloë en alle voorgangers/opvolgers, het was een genoegen om met jullie te 
werken. De wekelijkse REPAIR-vergadering met het “uurtje cultuur(tje)” leerde me welke 
jazz-giganten ons nu weer ontvallen waren en welke tentoonstellingen en films ik kon 
bezoeken. Ook op wetenschappelijk gebied leverde het vaak waardevolle nieuwe in-
zichten op. Veel dank voor alle mooie momenten zowel bij het doen van onderzoek als 
tijdens de momenten van ontspanning.
Beste oud-collega’s van het Maasstad. Onder leiding van drs. Rene Klaassen maakte ik bij 
jullie na mijn onderzoekstijd de eerste stappen in de kliniek. Hard werken en er samen 
voor gaan. Dank voor jullie geduld en begeleiding!
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Beste oud-collega’s uit het Albert Schweitzer Ziekenhuis. Onder leiding van dr. Peter 
Plaisier – dé dokter – mocht ik verder kennismaken met de chirurgie. Ik heb een ge-
weldige tijd gehad met jullie. Veel dank voor alle vrijdagen in Lambarene, goede koffie, 
mooie feestjes, hamertje tik, een briljant skiweekend en de rondleiding op Curaçao. 
Lieve Yvonne, Joanny en Sjanie, veel dank voor verse koffie en mooie verhalen.
Beste collega’s uit Tergooi, onder de bezielende leiding van dr. Nanette van Geloven. 
Jullie zijn mijn nieuwe thuis geworden. Ik voel me enorm welkom bij jullie en geniet van 
karaoke, koffiemomenten en samen lunchen. Veel dank voor jullie steun en interesse in 
de laatste fase van dit proefschrift!
Lieve Bassie, vriend in den verre. Wat ontzettend tof dat jij de cover van mijn boek 
hebt willen ontwerpen! Van “utter despair” naar “radiant flair” kent slechts een dunne 
scheidslijn. Vanaf nu hebben we hopelijk meer tijd voor ook de ontspannende dingen 
in het leven.
Lieve vrienden en vriendinnen, dit boek is de reden dat ik soms feestjes moest skippen 
of later kwam op onze afspraken. Ik ben heel blij met jullie interesse, steun en begrip! “Ik 
ben bezig met de afronding”, is nu “de afronding is gepland” geworden. Voor jullie ligt 
het bewijs. 😉 Vanaf nu wordt het tijd om het leven te vieren.
Lieve Hanna, born without a zip on her mouth. Wat heerlijk om af en toe te mogen “ven-
ten”! Gelukkig kunnen we ook (in stilte) ontspannen samen. Heel veel succes in Nkhoma!
Lieve Lidwien, sinds 2005 mijn “partner in medical crimes”, van uren keten tijdens col-
lege of tijdens het zoveelste practicum, naar wonen en afspreken in de Randstad. Echt 
top! Ik ben blij dat we dat anno 2019 nog steeds doen.
Lieve Jaarclub Admiratio, lieve Catherine, Fabienne, Maud en Nienke, wat hebben we 
een heerlijke tijd gehad in Maastricht. Eindeloze jaarclubavonden en feesten op de 
kroeg. Inmiddels is iedereen uitgevlogen, maar spreken we elkaar gelukkig nog wel 
geregeld. Ik hoop jullie snel weer te zien!
Weledelzeergeleerde dr. Lucieer, lieve Suus, eerst kende ik je alleen als “zusje van”. In 
2011 kruisten onze paden elkaar weer in het Erasmus MC. Beiden deden we onderzoek 
bij professor Lange. Jij vanuit de onderwijskant, ik vanuit de chirurgie. Nu mag ook ik 
mijn proefschrift verdedigen. Veel dank dat je me wegwijs wilde maken in de statistiek 
en mijn manuscript wilde helpen reviseren. Nu wordt het snel tijd voor die borrel.
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Lieve Frederieke, als twee brugklassers kwamen we elkaar voor het eerste tegen en 
sindsdien zijn we niet gestopt met kletsen. Nu 20 jaar later kunnen we nog steeds onbe-
daarlijk hard lachen om alle mooie dingen in het leven. Wat heerlijk om je zo gelukkig 
te zien met Lot!
Lieve Lijn, sinds de middelbare school zijn we onafscheidelijk. Zelfs meermaals emigre-
ren krijgt onze band niet stuk. Ik geniet van alle verhalen over je avonturen in Australië, 
maar ik verheug me enorm op jullie terugkeer naar Nederland. Ik kan niet wachten om 
weer ouderwets te komen theeleuten!
Weledelzeergeleerde dr. Molegraaf, lieve Marijke, mede-REPAIR’der, een jaar geleden 
stond jij te schitteren achter het katheder en mocht ik aan jouw zijde staan. Ik voel me 
zeer vereerd dat je nu ook bij mijn verdediging mijn paranimf wilt zijn. Ik hoop op een 
mooie toekomst voor jou en Wouter in Zwolle!
Weledelzeergeleerde dr. Halm, lieve Jens, oud-buiksluiter, wat geweldig dat ook jij mijn 
paranimf wilt zijn. Ruim 12 jaar geleden pionierde jij al met de stelling “Herstel van een 
navelbreuk dient met een kunststof mat verricht te worden”. Het onderzoek dat hieruit 
volgde kreeg afgelopen jaar een climax. Wat hebben we een te gekke tijd achter de rug. 
Met de HUMP trial op zak had ik de beste weddenschap ooit gewonnen: én The Lancet, 
én een krat champagne..! 😉 Lieve Purdey, Amélie en Juliette, wat fijn dat ik Jens even 
mag ‘lenen’ voor deze bijzondere dag. Op naar veel mooie momenten samen!
Liebe Oma, vielen lieben Dank für dein Interesse an meinen Studien. Es ist letztendlich 
fertig! Ich hoffe das du noch lange gesund bleibst. Ich komme dich bald wieder besu-
chen. Alles Liebe!
Lieve oma Henny, opa Dick, opa Horst-Arthur en oma en opa Posthuma, ik had gehoopt 
deze dag nog samen met jullie te mogen beleven. Dank voor jullie steun en liefde!
Zeer geachte hooggeleerde emeritus professor Kaufmann, lieve papa. We hebben veel 
meegemaakt de afgelopen jaren. Heel veel dank voor je onvoorwaardelijke steun en 
liefde! Die beloofde gezamenlijke publicatie gaat er hopelijk ook nog komen. Binnen-
kort wordt het eerst tijd voor die veelbesproken reis naar Japan.
Lieve Dia, het allermooiste cadeau was jouw aanwezigheid bij mijn verdediging ge-
weest. Helaas mocht het niet zo zijn. Onze tijd samen was een cadeau van onschatbare 
waarde. Ik mis je!
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Zeer geachte weledelgeleerde drs. Posthuma, lieve Victor, geen woorden kunnen be-
schrijven hoe dankbaar ik je ben voor je onvoorwaardelijke liefde en steun tijdens dit 
soms bizarre traject! Je humor, adviezen en frisse kijk op de wereld hebben me enorm 
geholpen. Hoe heftig zo’n traject kan zijn kun je binnenkort zelf ervaren, want “jouw tijd 
komt nog wel”. Ik vind het echt superstoer dat je nu zelf begonnen bent aan een pro-
motietraject! Hopelijk doe je dat niet alleen om mij terug te pakken voor de afgelopen 
jaren. 😉 Ik ben ontzettend trots op jou en kijk uit naar een mooie toekomst samen! Ik 
hou zielsveel van jou!
Ruth

335
a
PhD PORTFOLIO
Name PhD fellow: Ruth Kaufmann
Erasmus MC Department: Surgery
PhD period: December 2011 – February 2015
Promotor(s): Prof. dr. J.F. Lange
Supervisors: Prof. dr. J. Jeekel
1. PhD training
Courses Year ECTS
-  BROK (“Basiscursus Regelgeving Klinisch Onderzoek”) 2012 1.5
-  Systematic literature retrieval 2012 1
-  Laboratory animal science (“Artikel 9”) 2012 4.5
-  Biostatistics for clinicians (NIHES) 2012 2
-  “Omgaan met groepen” 2012 0.5
-  CPO mini course 2013 0.5
-  Biomedical English Writing and Communication 2013 4
Presentations
-  Rotterdam Interactive Congress on Hernia 2.0, Rotterdam, the Netherlands. Invited 
speaker
2019 1
-  Najaarsdag, Hilversum, the Netherlands. Oral presentation 2018 1
-  American College of Surgeons, Boston, USA. Invited speaker 2018 1
-  Chirurgendagen, Veldhoven, the Netherlands. Invited speaker 2018 1
-  American Hernia Society, Miami, USA. Poster presentation 2018 1
-  European Hernia Society, Vienna, Austria. Oral presentation 2017 1
-  European Hernia Society, Rotterdam, the Netherlands. Invited speaker 2016 1
-  American Hernia Society, Washington, USA. Oral (1×) & poster (2×) 2016 3
-  Wetenschapsdag Erasmus MC, Rotterdam, the Netherlands. Oral presentation 2015 1
-  Najaarsdag, Hilversum, the Netherlands. Oral presentation 2015 1
-  World Conference on Abdominal Wall Hernia, Milan, Italy. Oral (1×) & poster (2×) 2015 3
-  Wetenschapsdag Erasmus MC, Rotterdam, the Netherlands. Oral presentation 2014 1
-  Rotterdam Interactive Congress on Hernia, Rotterdam, the Netherlands. Invited speaker 2014 1
-  Najaarsdag, Utrecht, the Netherlands. Oral & poster presentation 2014 1
-  Stichting Experimenteel Onderzoek Heelkundige Specialismen, Groningen, 
the Netherlands. Poster presentation (2×)
2014 2
-  European Hernia Society, Edinburgh, United Kingdom. Oral presentation 2014 1
-  Chirurgendagen, Veldhoven, the Netherlands. Oral presentation 2014 1
-  American Hernia Society, Las Vegas, USA. Poster presentation 2014 1
-  Stichting Experimenteel Onderzoek Heelkundige Specialismen, Maastricht, 
the Netherlands. Poster presentation (3×)
2013 3
-  Najaarsdag, Den Bosch, the Netherlands. Oral presentation 2013 1
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-  OK dagen, Veldhoven, the Netherlands. Invited speaker 2013 1
-  International Surgical Week, Helsinki, Finland. Oral presentation 2013 1
-  European Society for Surgical Research, Istanbul, Turkey. Oral presentation (2×) 2013 2
-  Chirurgendagen, Veldhoven, the Netherlands. Poster presentation 2013 1
-  European Hernia Society, Gdansk, Poland. Oral presentation 2013 1
-  Association of Surgeons of Great Britain and Ireland, Glasgow, United Kingdom. Poster 
presentation
2013 1
-  Wetenschapsdag Erasmus MC, Rotterdam, the Netherlands. Oral presentation 2012 1
-  European Society for Surgical Research, Lille, France. Oral presentation 2012 1
-  Chirurgendagen, Veldhoven, the Netherlands. Oral presentation 2012 1
Attended conferences
-  Chirurgendagen, Veldhoven, the Netherlands 2017 1
-  Chirurgendagen, Veldhoven, the Netherlands 2016 1
-  Acelity™ Make Better Summit, Madrid, the Netherlands 2015 1
-  Acelity™ Advanced Educational Forum – Complex Abdominal Wall Hernia, Amsterdam, 
the Netherlands
2015 1
-  Rotterdam Interactive Congress on Hernia, Rotterdam, the Netherlands 2012 1
Research grants
-  DSM Medical, Exton, USA (€ 4.600,–) 2014
-  LifeCell, New Jersey, USA (€ 91.375,–) 2013
-  Stichting Coolsingel, Rotterdam, the Netherlands (€ 20.000,–) 2012
-  Stichting Coolsingel, Rotterdam, the Netherlands (€ 44.000,–) 2012
Other
-  Journal club 2012-2015 2
-  REPAIR research meeting 2011-2015 2
-  Organiser “Rotterdam International Congress on Hernia” (congress in Rotterdam, 
the Netherlands)
2013-2014 3
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2. Teaching Year ECTS
Lecturing
-  College “Dokter, ik ben zo moe” (1st year medical students) 2013 1
Supervising practicals and tutoring
-  Supervising first aid exams medical students 2012-2014 1
-  Tutor to 1st year medical students 2012-2014 3
-  “Kennismaking met de Beroepspraktijk” (1st year medical students) 2013-2014 2
Supervising Master’s theses
-  Kevin Wiese 2012 2
-  Vivian Zwart 2012 2
Total 74
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CURRICULUM VITAE AUCTORIS
Ruth Posthuma-Kaufmann werd geboren op 15 februari 1987 
in Kamp-Lintfort te Duitsland. Ze verhuisde in december 1992 
naar Nederland. In 2005 behaalde zij haar Gymnasiumdi-
ploma en werd ingeloot voor de studie Geneeskunde aan de 
Universiteit van Maastricht. Tijdens haar studie deed Ruth een 
keuze-coschap Traumatologie in Paarl, Zuid-Afrika (onder su-
pervisie van prof. dr. P.R.G. Brink). Haar oudste coschap deed ze 
op de afdeling Intensive Care in Maastricht (prof. dr. W.N.K.A. 
van Mook en dr. D.C.J.J. Bergmans). Eind 2011 begon Ruth als 
arts-onderzoeker bij de REPAIR onderzoeksgroep (prof. dr. J.F. 
Lange, prof. dr. J. Jeekel, prof. dr. G.J. Kleinrensink en dr. A.G. 
Menon), waar zij meewerkte aan verschillende onderzoeken in zowel de kliniek als in 
het laboratorium. Vanaf maart 2015 was Ruth naast haar promotieonderzoek achter-
eenvolgens werkzaam als ANIOS (arts-assistent niet in opleiding tot specialist) op de 
afdelingen chirurgie van het Maasstad Ziekenhuis te Rotterdam (drs. R.A. Klaassen), het 
Albert Schweitzer Ziekenhuis te Dordrecht (dr. P.W. Plaisier) en het Tergooi te Hilversum 
(dr. A.A.W. van Geloven). Het onderzoek dat Ruth in de afgelopen jaren verrichtte heeft 
geresulteerd in dit proefschrift.
Ruth Posthuma-Kaufmann was born on February 15th 1987 in Kamp-Lintfort in Germany. 
She moved to the Netherlands in December 1992. In 2005, she obtained her Gymnasium 
degree and started her study in Medicine at the Maastricht University. During her study 
she enrolled in an elective rotation Trauma surgery in Paarl, South Africa (supervised by 
prof. dr. P.R.G. Brink). She did her last year’s rotation in the Intensive Care department of 
the Maastricht University Medical Center in Maastricht (prof. dr. W.N.K.A. van Mook and 
dr. D.C.J.J. Bergmans). At the end of 2011, Ruth started working as a research fellow in 
the REPAIR research group (prof. dr. J.F. Lange, prof. dr. J. Jeekel, prof. dr. G.J. Kleinrensink, 
and dr. A.G. Menon), where she collaborated in both clinical and experimental research. 
Since March 2015 is Ruth concurrently working on her research and working as a resident 
not in training in the surgical departments of the Maasstad Hospital (drs. R.A. Klaassen), 
the Albert Schweitzer Hospital in Dordrecht (dr. P.W. Plaisier) and the Tergooi Hospital in 
Hilversum (dr. A.A.W. van Geloven). The research that Ruth conducted in the past years 
resulted in this thesis.
Always laugh when you can. 
It is cheap medicine.
(Lord Byron)


